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vABSTRACT
Understanding the cement injection behaviour in cancellous bone and accurately
predicting the cement placement within the vertebral body is extremely challenging. We
propose a novel method using reproducible and pathologically representative 2D and 3D
bone surrogates to help study the influence of cement properties on injection behaviour.
Bespoke methodology was developed to control the injection volume and flow rate,
measure the injection pressure, and allow visualization and quantitative analysis of the
spreading distribution. Morphology analysis showed that the variability in the 2D and 3D
bone surrogates was very low, indicating that the geometrical structure of the surrogates
was constant. The overall pore size of the surrogates was very similar to that reported for
human osteoporotic vertebral cancellous bone, indicating that the surrogates were
pathologically representative. Injections performed into the 3D surrogates revealed that
an increase in the fluid starting viscosity significantly increases the injection pressure in all
surrogates, decreases the risk of leakage for osteoporosis surrogates only, decreases the
mean spreading distance for multiple myeloma surrogates only and increases the
sphericity causing a more uniform spreading pattern for the metastasis surrogates only.
Injections performed into the 2D surrogates highlighted the influence of cement
formulations and model structure on the injection behaviour and showed that (i) cements
with similar composition/particle size have similar flow behaviour, (ii) cements with a
high liquid-to-powder ratio cause irregular filling patterns and have a high risk of leakage,
and (iii) the injection behaviour of certain cement formulations improves in the presence
of lesion or fracture, suggesting the notion of pathology specific bone cements. The
developed methodology provides a fast, robust tool for discerning subtle differences in
bone cement formulations and allows comprehensive assessment of cement flow
behaviour through controlling the surrogate morphology, controlling the injection
parameters, measuring the injection pressure, and allowing the visualization and
quantitative analysis of the spreading distribution. The advantage of this methodology is
that it provides a clinically relevant representation of cement flow patterns and a tool for
validating computational simulations.
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GLOSSARY
Bone Mass The amount of bone tissue as the total of protein
and mineral in the whole skeleton or in a specific
segment of bone.
Bone Mineral Density BMD is the amount of mineral matter per cubic
centimeter of bone and is generally used as an
indicator for Osteoporosis (< 70 mg/cm3) and
Osteopenia (70 - 100 mg/cm3).
Cancellous Bone Referred to as trabecular or spongy bone is a type
of osseous tissue composed of multiple trabeculae
which form a three dimensional lattice-like
structure.
Functional Spinal Unit The smallest physiological motion unit of the
spine to exhibit biomechanical characteristics
similar to the entire spine. Mainly made up of the
intervertebral disc, two vertebrae, and the
interconnecting ligaments.
Morbidity A diseased state, disability, or poor health due to
any cause.
Multiple Myeloma A cancer of plasma cells which accumulate in
bones, where they cause small, multiple bone lytic
lesions.
Percutaneous Vertebroplasty This is a minimally invasive procedure performed
under fluoroscopic image-guidance in which bone
cement is injected into a fractured vertebra with
the goal of relieving pain and restoring spinal
stability.
Rapid Prototyping A special class of machine technology that
produces physical three-dimensional models using
a layer-by-layer additive approach.
Spinal Metastases Tumor cells that migrate from a primary site to the
spine where they often cause a large bone lesion.
Stereology The study of methods for obtaining estimators of
geometric properties from samples of a structure.
It provides practical techniques for extracting
quantitative information about a three-dimensional
material from measurements made on two-
dimensional planar sections of the material.
1CHAPTER 1 INTRODUCTION
Osteoporosis is a disease that weakens the bone mainly by reducing the bone mineral
density (BMD) and deteriorating the bone microarchitecture. Known to affect
postmenopausal women and elderly men, osteoporosis is increasingly becoming a
major public health problem due to its impact on morbidity and social cost. The
morbidity associated with osteoporosis arises principally from fractures. In the United
States, the burden of osteoporosis for the year 2005 was estimated to be >2 million
incident fractures resulting in a direct cost of $17 billion [1-4]. Vertebral fractures
(VF) account for the majority (~30%) of these osteoporotic-induced factures [4, 5].
For the European Union (EU) countries, a prospective osteoporosis study showed that
the annual incidence of VF was (approximately 440,000) 10.7/1000 in woman and
5.7/1000 in men [6]. The annual incidence of osteoporotic-induced fractures is on the
rise and it is projected that this increase will reach 50% by the year 2025 [4].
Consequently, the procedures used to treat the chronic pain associated with VF, which
are mainly caused by osteoporosis and other skeletal pathologies such as spinal
metastasis or multiple myeloma, are also on the rise.
Percutaneous vertebroplasty (PVP) is a minimally invasive procedure in which
bone cement is injected into a fractured vertebra with the goal of relieving pain and
restoring mechanical stability [7, 8]. The number of PVP performed in the United
States has increased by 72.4% between 2001 and 2010 [9-12]. Although the number of
procedures is on the rise, several hurdles are currently preventing PVP from becoming
the standard of care for the treatment of pain related to VF. The Food and Drug
Administration (FDA) has issued a warning about possible complications following
the injection of bone cement into a fractured vertebra [13]. The primary concern of the
FDA is cement leakage into the surrounding structures which may cause serious
clinical complications such as nerve root or spinal cord compression as well as
pulmonary embolism. These complications may lead to paraplegia or, in severe cases,
death [14-19]. This thesis is focused on the development of in vitro assessments and
their subsequent usage to study cement injection behaviour in cancellous bone.
21.1 SPINE ANATOMY AND PHYSIOLOGY
The spine is a flexible, multi-segmented anatomic structure that provides support and
balance for an upright posture and allows motion in six degrees of freedom [20].
Despite the fact that the spine appears straight in the coronal plane, when viewed in
the sagittal plane, the normal adult spine has four distinct curves: two in kyphosis and
two in lordosis (Figure 1.1). Kyphosis is a curvature in the sagittal plane with a
concavity towards the front (anterior concavity); whereas, lordosis is a curvature in the
sagittal plane with a concavity towards the back (posterior concavity). Based on
vertebral shape and sagittal plane curves, the spine is divided into four regions:
cervical (lordosis), thoracic (kyphosis), lumbar (lordosis), and sacral (kyphosis).
Figure 1. 1 Sagittal (a) and coronal (b) views of the normal adult spine. Adapted from [20].
3The cervical spine supports the skull and is made up of seven vertebral segments:
C1 to C7. The normal cervical spine has a lordosis ranging from 20 to 40. Inferior to
the cervical is the thoracic spine which consists of twelve vertebral segments: T1 to
T12. The normal thoracic spine forms part of the rib cage and has a kyphosis ranging
from 20 to 40. Following the thoracic is the lumbar spine, consisting of five
vertebral segments: L1 to L5. The normal lumbar spine has a lordosis ranging from
30 to 50. The last region of the spine is the sacrococcygeal, which is made up of
nine fused vertebrae. The first five vertebrae, S1 to S5, form the sacrum, and the
remaining four vertebrae form the coccyx. The normal sacrococcygeal spine has a
kyphosis with a wide range of concavities [20]. The size of the vertebrae increases
from the cervical to the sacrum. However, the structure of each vertebral segment is
similar in all regions of the spine (except in the cervical, where C1 and C2 have a
distinct structure). The following reviews the basic structures common to all vertebrae.
Each vertebral segment is divided into the vertebral body which is located on the
anterior side and the vertebral arch which is located on the posterior side (Figure 1.2).
Figure 1. 2 Structures common to all vertebrae. Adapted from [21].
4The vertebral body is a semi-cylindrical structure made of a thin layer of cortical
bone encompassing cancellous bone. The vertebral arch is made up of two pedicles,
two laminae, two transverse processes, one spinous process and four articular
processes. The two pedicles are short, rounded structures that extend posteriorly from
the lateral edges of the dorsal side of the vertebral body. The two laminae are flat
structures that extend medially from the two pedicles. The spinous process extends
posteriorly from the junction of the two laminae and serves as an attachment point for
tendons and ligaments. The two transverse processes extend laterally from each
pedicle and also serve as attachment points for tendons and ligaments. The four
articular processes (two superior and two inferior) extend from the junction of the
pedicles and the laminae. The two superior processes extend superiorly from each
vertebra, and the two inferior processes extend inferiorly from each vertebra. The
inferior processes of a vertebra join with the superior processes of an adjacent vertebra
below to form the facet joints, which are synovial joints containing lubricating
synovial fluid that allows the articular surfaces to glide over each other. The facet
joints and the intervertebral discs, located between the articular surfaces of the
vertebral body endplates, work in conjunction to regulate intervertebral segment
motion [20].
The spine achieves its main functions by being both resistant and flexible.
Resistance to axial loading forces, arising from both body weight and muscle action, is
accomplished via: (1) the alternating lordosis and kyphosis curves in the four regions
of the spine, and (2) the increase in the size of each vertebra from C1 to the sacrum,
which compensates for the increase in load demand from C1 to the sacrum.
Conversely, the flexibility of the spine is mainly due to intervertebral segment motion,
which is accomplished by the facet joints and the intervertebral discs. This segment
motion allows the spine to achieve a wide range of motion in six degrees of freedom
[20]. Whilst the osteoligamentous spine is relatively unstable, muscles are the key
feature of the stable spine, which provide the mechanism for upright posture and
dynamic stability achieved during a range of daily activities.
51.2 CANCELLOUS BONE MICROARCHITECTURE
Cancellous bone, also referred to as trabecular or spongy bone, is a type of osseous
tissue composed of multiple trabeculae which form a three dimensional lattice-like
structure. The individual trabecula is mainly composed of hydroxyapatite and
collagen. The scale of a trabecula can be as small as 20 µm and its shape can often be
in the form of a plate or rod. The trabecular orientation and the degree of anisotropy
drastically vary between anatomical sites. Some regions may be very dense with
consistently coarse trabeculae, while others may be sparse with thin trabeculae. This
trabecular arrangement or architecture is not random and forms the basis for the
formulation of Wolf’s law, which links the trabecular architecture to the load
environment it is placed under by adaptation. However, the challenge in relating
specific mechanical properties to the trabecular architecture lies mainly in the explicit
definition of the architectural variables to be included [22, 23].
Three-dimensional morphometric indices (Table 1.1) have been used to describe
the cancellous or trabecular bone microarchitecture [24-27]. These indices have been
previously derived from two-dimensional images using stereological methods and
assuming a fixed plate or rod model. However, with the advent of microcomputed
tomography (microCT), it has been possible to assess these indices directly from the
three-dimensional images. Such imaging techniques are independent of model type
and therefore not biased by the deviations of the actual structures from the assumed
models, although the resolution of the imaging system has been shown to greatly
affect the measurement of the morphometric indices, particularly the trabecular
thickness (Tb.Th). A high resolution (< 5µm) is required to obtain reliable
measurements [28, 29]. Other challenges are mainly in the post-processing of the
images. Selecting an appropriate image threshold to discriminate bone tissue
(foreground) from the surrounding environment (background) is subjective and often
difficult. Ridler T.W. and Calvard S. [30] have developed an objective method that
automatically chooses a threshold value based on an iterative process, where
successive iterations are performed to achieve increasingly reliable extractions of the
foreground (bone tissue).
6Table 1. 1 Three-dimensional morphometric indices used to describe the trabecular
microarchitecture
Symbol Parameter DefinitionBV/TV (%) Bone Volume/TissueVolume Number of bone voxels divided by totalnumber of voxels in the volume ofinterestTb.Th (m) Trabecular Thickness Average length of continuous bonevoxels along a surface. Provides aquantitative estimate of trabecularthinningTb.Sp (m) Trabecular Separation Average length of gaps between bonevoxels. Can be interpreted as thethickness of the marrow cavitiesTb.N (mm-1) Trabecular Number The number of trabeculae per unit lengthConnD (mm-3) Connectivity Density The number of trabecular elements thatmay be removed without separating thenetwork. Provides an estimate of thenumber of trabecular connections/mm3SMI Structure Model Index The estimate of plate-rod characteristicsof the structure. SMI value is 0 for idealparallel plate structure and 3 for idealrod structureDA Degree of Anisotropy The direction of the preferredorientation of trabeculae
Several studies have used microCT imaging to quantify vertebral trabecular bone
morphology and have demonstrated significant variations in the 3D morphometric
indices within various regions of the vertebral body and with age [25, 31-35]. Table
1.2 summarizes the specimens and techniques used in these five studies to quantify
vertebral trabecular bone morphology. Figure 1.3 illustrates details of the specimens
used in these five studies. The figure provides information on the location where the
specimens were obtained within the vertebral body as well as the regions that were
visualized using microCT and analyzed for three-dimensional morphometric indices.
Hildebrand et al. [25] were the only group that did not provide detailed information on
where their specimens were obtained and simply stated that their specimens were
obtained from the center of the vertebral body. Table 1.3 compares the trabecular bone
7morphometric indices across the five studies providing an indication for the range of
values.
Table 1. 2 Specimens and techniques used to quantify vertebral trabecular bone morphology.
Study BoneCondition Specimen VertebralLevels Quantification MethodLochmulleret al., 2008[31] OsteoporosisandOsteopenia Total:118Mean Age:79.1
T10 and L2 - Direct 3D- µCT 20 Scanco Medical
- Resolution 26 µm
- Threshold 22% of max grey value
- Software provided bymanufacturerChen et al.,2008[32] OsteoporosisandOsteopenia Total:56Mean Age:77.5
L4 - Direct 3D
- µCT, Hitachi Medical
- Resolution 15 µm
- Software TRI/3D-BON (RactoSystem Engineering Co. Ltd., Japan)Hulme etal., 2007[33] Osteoporosis Total:40Mean Age:74.2
T9 to L5 - Direct 3D
- XtremeCT, Scanco Medical
- Resolution 82 µm
- Threshold to preserve structure
- Software provided bymanufacturerGong et al.,2006[34, 35] Nopathologiesaffectingstructure
Total:6Mean Age:65.7
L4 - Direct 3D
- µCT 40 Scanco Medical
- Resolution 20 µm
- Threshold based on volumefractions
- Software provided bymanufacturerHildebrandet al., 1999[25] N/A Total:52Mean Age:67.3
L2 and L4 - Direct 3D and Traditional indirect
- µCT 20 Scanco Medical
- Resolution 28 µm
- Software provided bymanufacturer and stereologicaltechniques
Chen et al. [32], Gong et al. [34, 35], and Hildebrand et al. [25] all analyzed
lumbar trabecular structure, however Lochmuller et al. [31] and Hulme et al. [33]
analyzed both thoracic and lumbar trabecular structure. Hildebrand et al. [25] were the
only group that analyzed the trabecular structure using both direct 3D methods and
traditional indirect methods which were derived from 2D images using stereological
techniques and assuming a fixed plate model.
8Figure 1. 3 Details of specimens used in studies quantifying vertebral trabecular bone
morphology. a) Lochmuller et al. [31] obtained a 8 mm full length cylinder in the superior-
inferior direction at the middle along the transverse direction and the transition of the anterior
third and posterior two thirds of the sagittal VB (left) then the center 6 mm was visualized /
analyzed (right). b) Chen et al. [32] obtained a 8 mm thick sagittal section close to the midline of
the VB then 5 cubes of 8 x 8 x 8 mm3 were visualized / analyzed. c) Hildebrand et al. [25]
visualized / analyzed specimens from the center of the VB. d) Gong et al. [34, 35] obtained and
visualized 5 full length squared columns 8 x 8 mm2 (top) which were divided into 3 layers
(bottom) resulting in 15 regions of interest per specimen then 5 x 5 x 5 mm3 in the center of each
region were analyzed. e) Hulme et al. [33] visualized the VB then analyzed 10 regions.
Abbreviations: vertebral body (VB), anterior (A), posterior (P), superior (S), inferior (I), left (L),
right (R), and center (C).
They found that direct 3D methods systematically yielded higher indices compared to
the traditional indirect methods. This is possibly due to the deviation of the trabecular
structure form the ideal plate model. The indirect methods underestimated the derived
9indices by 30%. They also found no statistically significant differences in
morphometric indices between the two analyzed lumbar vertebral levels (L2 and L4).
However, when compared to other anatomical sites, specifically the femoral head, the
lumbar spine tended to have lower bone volume, thinner trabeculae and a more rod-
like structure. Lochmuller et al. [31] also found no statistically significant differences
in morphometric indices between the thoracic (T10) and the lumbar (L2) spine. They
also compared the trabecular structure of 62 male specimens with a mean age of 78.3
years to 56 female specimens with a mean age of 79.9 years and found no statistically
significant gender differences in morphometric indices at either of the two analyzed
vertebral levels (T10 and L2).
Table 1. 3 Comparison of vertebral trabecular bone morphometric indices across five studies.
Parameter Lochmulleret al., 2008[31] Chen et al.,2008[32] Hulme et al.,2007[33] Gong et al.,2006[34, 35] Hildebrandet al., 1999[25]BV/TV (%) 10.7 ± 3.90 13.5 ± 1.60 12.5 ± 2.40 8.26 ± 1.40 8.30 ± 2.40Tb.Th (mm) 0.150 ± 0.02 0.112 ± 0.09 0.215 ± 0.02 a 0.116 ± 0.01 0.122 ± 0.02
Tb.Sp (mm) 0.96 ± 0.18 0.81 ± 0.08 1.11 ± 0.11 - 0.79 ± 0.13
Tb.N (mm-1) 1.03 ± 0.19 1.15 ± 1.17 0.89 ± 0.08 1.17 ± 0.20 1.28 ± 0.20
ConnD (mm-3) 2.50 ± 1.51 3.04 ± 0.25 1.32 ± 0.37 3.76 ± 1.44 -
SMI 1.75 ± 0.52 2.21 ± 0.23 2.42 ± 0.31 1.76 ± 0.40 2.13 ± 0.35
DA 1.51 ± 0.21 1.62 ± 0.19 1.36 ± 0.08 1.46 ± 0.15 1.42 ± 0.16
a Hulme at al. had a relatively low resolution of 82 µm (Table 1.2), hence the large value for Tb.Th.
Gong et al. [34, 35], Hulme et al. [33] and Chen et al. [32] all investigated the
differences in morphometric indices between various regions of the vertebral body
(VB). They all found that the posterior-inferior (posterior in general) regions of the
VB had higher bone volume, higher number of trabeculae, higher connections and
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lower trabecular separation compared to the central and anterior-superior regions
(anterior in general). Furthermore, Hulme et al. [33] and Chen et al. [32] both found
no statistically significant differences in trabecular thickness between any regions of
the VB. However, Chen at al. [32] also found no statistically significant differences in
the degree of anisotropy and the structural model index in any regions of the VB.
Gong et al. [34, 35] and Chen et al. [32] also investigated the differences in
morphometric indices with age and gender. They both found that bone volume tended
to decrease (on average by 22%) with age for both men and women, however in the
central regions it tended to remain the same. Furthermore, in all regions of the VB, the
trabecular number and the connectivity density tended to decrease (on average by
17.5% and 40%, respectively), however the trabecular spacing and the structural
model index tended to increase (on average by 19%) with age for both men and
women. Gong et al. [34, 35] found that the trabecular thickness slightly decreased with
age, whereas the degree of anisotropy increased with age in all regions of the VB. On
the other hand, Chen et al. [32] found no statistically significant age-related changes in
the degree of anisotropy and the trabecular thickness for both men and women though
they report a 10% decrease in trabecular thickness from ages 62 to 92 years.
From the current literature review, it can be concluded that the vertebral trabecular
bone morphology tends to remain constant between thoracolumbar vertebral levels
and with gender. However, there are significant variations in the three-dimensional
morphometric indices within various regions of the vertebral body and with age. With
respect to regional variations within the VB, the differences in morphometric indices
seem to decrease with age and are more pronounced in young, adult individuals.
Furthermore, the posterior-inferior regions of the VB seem to have higher bone
volume, higher number of trabeculae, higher connections and lower trabecular
separation. A possible rationale for this regional variation is that the posterior-superior
region of the VB is reinforced via the pedicles and therefore relies less on trabecular
structure for strength. However, the posterior-inferior region of the VB relies more
directly on trabecular structure for strength as there is no reinforcement via the
posterior elements. The age-related changes in the vertebral trabecular bone
morphology include:
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 Decrease in bone volume, thickness, number and connectivity density
 Increase in trabecular spacing
 Shift from plate-like to rod-like structure
1.3 VERTEBRAL CIRCULATORY SYSTEM
The vertebral circulatory system is mainly a large open venous network within and
around the vertebral column. The volume of this venous network is around 20 times
larger than that of the contributing arterial network. The vertebral venous network is
not controlled by valves, thus blood flow can occur in either direction depending on
changes in thoracic and abdominal pressure, such as coughing and straining. The
vertebral venous network can be divided into three inter-communicating systems: (1)
the internal vertebral venous plexuses (IVVP), (2) the basivertebral veins, and (3) the
external vertebral venous plexuses (EVVP) [36, 37].
Figure 1. 4 Schematic of a thoracolumbar vertebral circulatory system showing the (1) anterior
internal vertebral venous plexus, (2) posterior internal vertebral venous plexus , (3) basivertebral
veins, (4) posterior external vertebral venous plexus, (5) anterior external vertebral venous
plexus, and (6) intervertebral vein. Adapted from [36].
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The IVVP consist of a network of veins that lie within the spinal canal surrounding the
dura matter. They run mainly in the vertical direction and form four longitudinal veins,
two anterior and two posterior (Figure 1.4). The anterior and posterior IVVP
communicate freely with one another, however the anterior IVVP consist of larger
veins located along the posterior surface of the vertebral bodies and connect to one
another by transverse branches into which the basivertebral veins unite. The posterior
IVVP are located in front of the vertebral arches and connect to the posterior EVVP
via veins passing through the vertebral arches and the posterior vertebral processes
[36, 38]. The basivertebral veins emerge horizontally from the anterior to the posterior
surface of the vertebral body where they unite and drain directly into the anterior
IVVP, often breaching the cortical wall as a single vein but sometimes as two separate
branches. On the anterior surface of the vertebral body, they directly connect to the
anterior EVVP through small openings that breach the cortical wall on the front and/or
sides (Figure 1.4). The basivertebral veins are contained within the bony channels of
the vertebral body and converge with the bone marrow which is also present within
these bony channels. Consequently, the bone marrow can be considered as part of the
vertebral venous network [36, 38, 39].
1.4 PATHOLOGY
The lifetime prevalence of low back pain is between 70 to 90% [40]. Although the
specific causes of most back pain are unknown, a significant portion of the problem is
of mechanical origin and related to clinical spinal instability. However, clinical spinal
instability is controversial and not well understood. Some researchers define clinical
spinal instability as the loss of the spine’s ability under physiological conditions to
maintain normal intervertebral segment motion so that there is no initial or additional
neurologic deficit, no major deformity, and no incapacitating pain [41-44].
Mechanical spinal stability plays a crucial role in the basic biomechanical function
of the spine allowing segment motion, load transfer as well as protection of the spinal
cord and the nerve roots. Panjabi [45, 46] has conceptualized the overall mechanical
spinal stability under physiological conditions as consisting of three main subsystems:
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(i) the passive musculoskeletal subsystem which provides intrinsic stability and
consists of the vertebrae, the intervertebral discs, the facet joints, the spinal ligaments
as well as the passive muscle action, (ii) the active musculoskeletal subsystem which
provides dynamic stability and consists of the muscles surrounding the spinal column,
and (iii) the neural feedback control which evaluates the requirements for stability and
coordinates the muscle’s response accordingly. Under normal conditions, these three
subsystems work in harmony providing the necessary mechanical stability in response
to instantaneously varying demands due to changes in spinal posture as well as static
and dynamic loads. A disruption in any of these three subsystems due to trauma,
degradation and/or disease can lead to spinal instability which overtime is likely to
cause chronic dysfunction and pain [45, 46]. This section focuses on the disruption of
the passive stabilization of the spine via diseases, particularly osteoporosis and cancer,
which disrupt the mechanical integrity of the vertebrae leading to vertebral
compression fractures at the site of the weakened vertebrae.
1.4.1 Osteoporosis
Osteoporosis is increasingly becoming a major public health problem due to its impact
on morbidity and social cost. The morbidity associated with osteoporosis arises
principally from fractures. In the United States, the burden of osteoporosis for the year
2005 was estimated to be >2 million incident fractures resulting in a direct cost of $17
billion [1-4]. Osteoporosis is a skeletal disease which systematically weakens the bone
via reducing the bone mass and deteriorating the bone tissue microarchitecture
consequently increasing bone fragility and susceptibility to fracture [47]. Peak bone
mass results from linear growth, which is generally completed at around 30 years of
age. An equilibrium period is then followed where bone mass is maintained for a
duration of 5 to 15 years, after which it starts to gradually decrease regardless of
gender. However, peak bone mass is lower for women and the rate at which bone loss
occurs is higher for a period after menopause due to increased osteoclast activity and
turnover rates which are mainly caused by estrogen deficiency (Figure 1.5) [48, 49].
Thus, osteoporosis is more common in women with a lifetime fracture risk of up to
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40% [50], however this also implicates a significant problem for men with a lifetime
fracture risk of up to 25% [51, 52].
Figure 1. 5 Changes in bone mass throughout aging for both men (black) and women (red).
Three distinct trends can be observed: 1) linear growth till the age of about 30 years (green), 2)
maintenance of bone mass for about 10 years (yellow), and 3) gradual decrease in bone mass with
age (pink). Adapted from [48].
Osteoporotic bone loss occurs due to an imbalance in the remodeling process
which increases the osteoclast resorption activity, and inhibits sufficient formation of
replacement bone tissue by osteoblasts. The central skeleton is mostly affected due to
its higher remodeling activity compared to the peripheral skeleton, thus increasing
fracture risk particularly in the vertebrae [53]. There are three mechanisms of
remodeling that can influence net bone loss or gain. The first is metabolic remodeling
which occurs continuously whereby old bone tissue is replaced by new bone tissue.
The second is adaptive remodeling which occurs as a result of the mechanical loading
conditions applied to the bone. This mechanism causes bone mass to increase in areas
which are subject to high mechanical loads and decrease in unloaded or redundant
areas. The third mechanism is microdamage remodeling which occurs preferentially in
areas of high microdamage where osteoclasts are activated causing the resorption of
damaged bone tissue which eventually gets replaced by new bone tissue [54-59]. It is
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hypothesized that metabolic remodeling is the main cause for the deterioration of the
bone tissue microarchitecture in age-related osteoporosis, however this bone loss is
also modulated by adaptive and microdamage remodeling (Figure 1.6) [48, 60].
Figure 1. 6 Hypothesized remodeling for osteoporotic bone loss showing a healthy structure
(left) with a microfracture which undergoes 1) preferential resorption of unloaded and
maintenance of loaded trabeculae (adaptive remodeling), 2) uniform thinning and perforation of
trabeculae (metabolic remodeling) and 3) preferential remodeling of damaged trabeculae
(microdamage remodeling). This results in an osteoporotic structure (right) with vertical
trabeculae maintaining thickness, horizontal trabeculae preferentially being resorbed and
microdamged trabeculae undergoing remodeling. Adapted from [48].
The highest risk of fracture is at skeletal sites where cancellous bone is
predominant, particularly the head of the femur and the vertebra. Low bone mass is
not the only factor that increases bone susceptibility to fractures. Bone mass in this
context refers to the amount of bone tissue as the total of protein and mineral in the
whole skeleton or in a specific segment of bone. There are other aspects of bone
quality such as microarchitecture, tissue properties and levels of microdamage which
also contribute to the risk of fractures [61, 62]. However, the current standard
diagnostic tool for predicting fracture risk focuses on the measurement of areal bone
mineral density (BMD) which only provides information on the amount of bone
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mineral per area [63, 64]. The most widely used BMD measurement technique is
based on X-ray absorptiometry, particularly dual-energy X-ray absorptiometry (DXA),
although other techniques are also available including quantitative ultrasound (QUS),
quantitative computed tomography (QCT) and other radiographic techniques [65-68].
BMD values are typically expressed with respect to a reference population in standard
deviation (SD) units. The diagnostic criteria for osteoporosis, as suggested by the
World Health Organization (WHO), is a BMD value more than 2.5 SD below the
young adult mean [1, 69]. As BMD measurements only reflect one aspect of bone
quality, the quantity of bone mineral, novel imaging modalities and biomarkers, which
are capable of assessing various components of bone quality, have the potential to
improve the diagnosis of osteoporosis, the prediction of fractures as well as the
monitoring of treatment response. A study by Wehrli et al. [70] showed that magnetic
resonance imaging (MRI) of the calcaneus had superior diagnostic accuracy for
discriminating vertebral fracture patients from control subjects compared to vertebral
BMD measurements. In terms of biomarkers, Gamero [71] showed that currently
available biochemical indices, particularly those of bone resorption, can predict
fracture risk independently of BMD.
1.4.2 Spine Tumors
Primary spine tumors do not frequently occur (roughly 6 per 100,000 per year) [72],
however the thoracolumbar spine is the most common site for bone metastasis which
is a frequent complication of cancer occurring in up to 70% of terminal cancer patients
[73]. These secondary or metastatic spine tumors originate from a wide range of tumor
types including prostate (90%), breast (75%), lung (45%), and renal (30%) cancer
[74]. Furthermore, multiple myeloma (MM) is a plasma cell neoplasm that also
frequently involves the spine. In the United States alone, MM represents 10% of all
hematological malignancies with an annual incidence of 16,000 mainly in patients
who are older than 60 years of age [75]. The consequences of spinal metastasis and
MM are often devastating causing severe pain, pathologic fractures due to poor bone
quality as well as spinal cord compression and other neurological syndromes [76-78].
Furthermore, the prevalence of spinal metastases and MM is likely to increase due to
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improved cancer treatments and prolonged survival rates [79]. Many factors account
for the frequency of metastatic spine tumors and MM, however blood flow is the most
common means of malignant tumor spread to the spine. This is in part related to the
paravertebral venous plexus system (refer to section 1.3) which communicates with
multiple other venous systems including the vena cava, azygous, intercostals,
pulmonary and renal. As the blood flow changes direction depending on intrathoracic
and intraabdominal pressures, tumors get deposited in the spine from multiple sites of
the major body cavities [79, 80]. Spine metastases are generally classified according to
their anatomical location. Tomita et al. [81] devised a classification system which
grouped tumors into three categories and subdivided them into seven types. The three
categories are based on whether the tumors are (i) contained within the vertebral bones
(Intra-compartmental), (ii) extending into the paravertebral region and/or the epidural
space (Extra-compartmental), and (iii) involving multiple vertebrae (Figure 1.7).
Figure 1. 7 Schematic showing the surgical classification of spine tumors. Adapted from [81].
Spine metastases can be either osteoblastic causing abnormal bone formation,
osteolytic causing bone destruction, or a mix of both [82]. Osteoblastic lesions are
generally observed in patients with metastatic prostate carcinoma. The mechanism of
osteoblastic lesions and the factors involved are not well understood, however the
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levels of Endothelin-1, which stimulates the formation of bone and the proliferation of
osteoblasts in bone organ cultures, have been shown to increase in patients with
osteoblastic metastasis from prostate cancer [83]. In osteolytic lesions, bone
destruction is primarily mediated by osteoclasts rather than the tumor cells. Osteoclast
stimulating factors, which vary depending on the tumor, play a significant role in the
process of bone resoprtion [84, 85]. Most osteolytic lesions have been observed in
patients with multiple myeloma and metastatic renal cell carcinoma. However, only in
myeloma do pure lytic bone lesions occur due to the increase in bone resorption as
well as the suppression of bone formation. Also, the osteoclasts in multiple myeloma
accumulate at surfaces adjacent to the myeloma cells thus causing pure lytic lesions
only in areas with tumor involvement (Figure 1.8) [86, 87]. A mixture of osteoblastic
and osteolytic lesions are mainly observed in patients with metastatic breast
carcinomas, although the lesions are predominantly osteolytic [78].
Figure 1. 8 In-house microCT scan showing lytic lesions in a human thoracic vertebra (T6)
from a donor whose cause of death was multiple myeloma.
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The biomechanical effect of spine tumors and the mechanisms of neoplastic
vertebral fractures remain controversial; however, mechanical pain causes significant
morbidity in this patient population. Tumor involvement of the cancellous bone within
the vertebral body may not result in spinal instability, especially when the cortical wall
is intact. Pathological compression fractures are more likely to occur when the tumor
involves the posterior half of the vertebral body (the middle column) as extrusion of
tumor, bone, or disc into the spinal canal may result in neurological compromise.
There are no standardized methods for predicting the risk of pathological fractures
even if the lesions have been well characterized by various imaging modalities such as
CT scans and MRI. Some fractures can be prevented via radiotherapy which inhibits
the growth of radiosensitive tumors and stops lytic destruction of the vertebra. If the
tumors reach a critical size, fractures can only be prevented via prophylactic surgical
stabilization such as vertebroplasty which reinforces and stabilizes the weakened
vertebra. These surgical techniques also alleviate mechanical pain which is the
presenting complaint in the majority of patients with spinal metastasis and multiple
myeloma, thus improving the quality of life in these patients who often have limited
life expectancy [88-91].
1.4.3 Vertebral Fractures
In the United States, of the 1.5 million fractures that occur annually due to
osteoporosis, almost half (700,000) are attributed to vertebral fractures (VF) [5]. For
the European Union countries, a prospective osteoporosis study showed that the
annual incidence of VF was approximately 440,000 [6]. VF represent a catastrophic
structural failure of bone which is initiated at the material level. The ability of any
structure to carry load depends on the amount and distribution of matter which makes
up the structure, the intrinsic properties of the matter itself, and the loading conditions
applied. The key factors that influence the ability of bone to resist fracture include: (i)
the overall composition of the bone tissue (mineral, collagen, water and matrix
proteins), (ii) the physical and biochemical characteristics of these components, (iii)
the bone morphology which includes the bone size, cortical cross-sectional geometry,
porosity, as well as trabecular microarchitecture, and (iv) the amount of pre-existing
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microdamage [61]. The loading conditions applied on the spine arise from daily living
activities as well as trauma such as falls or motor vehicle accidents. The applied
compressive forces are transferred from the intervertebral discs to the vertebral
endplates then distributed over the trabecular microarchitecture. Osteoporosis and
spine tumors compromise the structural integrity of the vertebra, thus increasing its
fragility and susceptibility to fracture [61, 92, 93].
Osteoporotic vertebral compression fractures which result from structural failure
can be classified into three groups: (i) wedge fractures which involve anterior collapse
while the posterior height remains relatively the same, (ii) biconcave fractures which
involve central compression and fracture of the endplate regions with relative
maintenance of anterior and posterior heights, and (iii) crush fractures which involve
compression of the vertebral body resulting in posterior collapse while the anterior
height remains relatively unchanged (Figure 1.9). Different loading patterns, which are
influenced by the local biomechanics of the spine level, can cause different
deformities although most fractures have characteristics of more than one deformity.
Wedge deformities are most frequent in the mid-thoracic region and occur due to
loading in flexion. However, biconcave deformities more frequently occur in the
lumbar spine due to the more posterior position of the center of gravity in this region
[94, 95]. Genant et al. [96] devised a semi-quantitative method for assessing vertebral
fractures. This method provides insight on the severity of the fracture regardless of the
type of deformity present (wedge, biconcave or crush fractures). A vertebra receives a
severity grade based upon the visual estimation of apparent vertebral height reduction
and morphological change (Figure 1.9). Thoracolumbar vertebrae from T4 to L4 are
graded as normal (grade 0), mildly deformed (grade 1: reduction of 20-25% in height
and 10–20% in projected vertebral area), moderately deformed (grade 2: reduction of
25–40% in height and 20–40% in projected vertebral area), and severely deformed
(grade 3: reduction of >40% in height and projected vertebral area). Furthermore,
visual inspection of the endplate deformities, the lack of parallelism of the endplates
and the general altered appearance compared with adjacent vertebrae provide a strong
qualitative aspect to the assessment. The reproducibility of this semi-quantitative
method for the diagnosis of prevalent and incident vertebral fractures is high, with
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intra- and inter-observer agreement of 90-99%. The limitation of this method, which
may also apply to other standardized visual approaches, is that the experience of the
examiner has great influence on the ability to distinguish between normal variations
and degenerative changes due to true fractures. In normal patients, the vertebrae in the
mid thoracic spine (especially in women) and thoracolumbar junction (especially in
men) are slightly more wedged than in other regions. Also, some degree of
biconcavity is observed in the mid to lower lumbar spine. Based on the experience of
the examiner, these normal variations in vertebral morphology can be misinterpreted
as mild vertebral deformities [95-98].
Figure 1. 9 Schematic showing various types vertebral fractures: wedge, biconcave and crush.
The severity of the fracture increases from top to bottom and can be graded as normal (grade 0),
mildly deformed (grade 1), moderately deformed (grade 2), and severely deformed (grade 3).
Adapted from [96].
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1.5 TREATMENT
Vertebral augmentation procedures are primarily used for the treatment of chronic
pain resulting from vertebral fractures (VF) which are caused by osteoporosis and
other skeletal pathology such as spinal metastasis or multiple myeloma. Patients
typically present with axial back pain at the site of the fractured vertebra. This pain is
exacerbated with weight-bearing and simple daily living activities such as rising from
a chair or getting out of bed. In a physical assessment, palpation over the spinous
process of the affected vertebra can reproduce the patient’s pain. As augmentation
procedures are only useful for treating pain related to fractures, it is essential to
identify that the pain is due to the fracture itself and no other abnormalities such as
spondylosis, disk disease or nerve compression. Clinical features which indicate
symptomatic canal stenosis or nerve root compression are relative contraindications to
these procedures as pressurization during the augmentation increases the risk of
exacerbating the nerve compression. Furthermore, extreme vertebral collapse with a
height loss greater than 70% is another contraindication as displaced fracture
fragments can also compress the spinal cord or nerve roots. In some instances,
augmentation procedures are the treatment of choice due to the patient’s poor bone
quality, which precludes successful implantation of screw-rod constructs and cages
used for complex reconstruction [99-101]. This section focuses on two vertebral
augmentation procedures: percutaneous vertebroplasty (PVP) and kyphoplasty (PKP).
1.5.1 Percutaneous Vertebroplasty
Percutaneous vertebroplasty (PVP) is a minimally invasive surgery performed under
fluoroscopic image-guidance in which bone cement is injected into a fractured
vertebra with the goal of relieving pain and restoring mechanical stability [7, 8].
Single-plane or biplane fluoroscopy is required for needle placement as well as direct
visualization of the cement flow during injection. The cement injection is generally
performed via a posterior approach through the pedicles into the vertebral body (VB)
(Figure 1.10).
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Figure 1. 10 Schematic of a PVP procedure. Anteroposterior and lateral views of a bone biopsy
needle being inserted through the pedicles (top). Comparison of unilateral and bilateral
transpedicular vertebral cement filling along the transverse plane (bottom). Adapted from [90]
(top) and [13] (bottom).
The target site for cement deposition is the anterior third and center of the VB in
the weight-bearing portion. Care must be taken in positioning the needle tip at the
target site while minimizing complication risks by avoiding critical structures such as
traversing nerve roots and local blood vessels. Unilateral transpedicular approaches
are most commonly used in the mid to lower lumbar spine where the pedicles are large
and oriented obliquely which often allows placement of the needle tip at the target site.
In the thoracic and upper lumbar spine, the pedicles are smaller and oriented in a near
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sagittal plane, thus midline positioning of the needle tip may be difficult from a
unilateral transpedicular approach while using conventional straight needles. In these
scenarios, a bilateral transpedicular approach or sometimes even an extra-pedicular
approach may be required for optimum augmentation. Transpedicular needle
placement is performed with the patient lying prone. The needle entry site is localized
over the pedicle by positioning the fluoroscope obliquely to allow anteroposterior
(AP) visualization along the pedicle. The needle is then advanced slowly until it
breaches the cortex of the pedicle and remains relatively fixed. Subsequently, the
fluoroscope is rotated to the orthogonal position allowing lateral visualization of the
needle to ensure the plane of entry is parallel to the pedicle and the needle trajectory
will not perforate the pedicle, especially medially into the spinal canal (Figure 1.11)
[99].
Figure 1. 11 Schematic showing that the needle tip should not cross the medial border of the
pedicle on the AP view before it reached the posterior cortex of the VB on the lateral view.
Adapted from [13].
The vertebral level being treated dictates the choice of needle being used.
Typically 13-gauge needles are used in the upper thoracic spine, whereas 11-gauge
needles are used in the lower thoracic and lumbar spine. Furthermore, some needles
have a diamond tip which facilitates perforation of the cortex; while, others have a
bevel tip which may assist in needle tip steering and redirection. The bone cement
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most widely used in PVP is poly(methyl methacrylate) (PMMA). Many commercial
PMMA cements are available on the market, however the ones typically used in PVP
contain radio-opacifiers such as barium sulfate to allow visualization of the cement
mixture under fluoroscopy. This is essential to ensure that the PMMA fills the VB and
does not leak into the surrounding vasculature, through the endplates into the disks, or
into the posterior aspect of the VB near the spinal canal. The injection is typically
performed under lateral visualization however intermittent AP projections are
performed to ensure the PMMA does not leak lateral of the VB. The injection is
terminated if the cement leaks from the VB, the cement extends into the posterior third
of the VB in the direction of the basivertebral vein, the filling is considered adequate,
or the mixture becomes too viscous to inject [99].
1.5.2 Percutaneous Kyphoplasty
Percutaneous kyphoplasty (PKP) is an extension of PVP that uses an inflatable bone
tamp (IBT) to create a cavity within the VB into which the bone cement is injected
(Figure 1.12). Needles are inserted through the pedicles similar to PVP, however the
target site for the needle tip is within the posterior third of the VB. Once the needle
placement is achieved, the uninflated IBT is inserted through the access needle under
intermittent fluoroscopy. The needle can then be retracted to its ready for injection
position at the base of the pedicle. Fluoroscopy visualization along the AP and lateral
directions is perfomed to help position the IBT within the vertebral body at least 1-2
mm beyond the tip of the access needle. The IBT is a high-pressure balloon which
upon inflation aims to restore the VB height by creating a cavity into which the
PMMA is injected. Balloon inflation is performed under lateral fluoroscopy and is
stopped if the fracture is reduced, the balloon comes into close contact with any
cortical surface, or the maximum inflation pressure is attained. IBT’s are typically
selected based on the AP diameter of the VB. They are available in various sizes with
a maximum volume of 6 ml [90, 99].
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Figure 1. 12 Schematic of a PKP procedure using a transpedicular approach. The inflatable
bone tamp is inserted through the access needle (A) then inflated creating a cavity (B) into which
the PMMA cement is injected (C). Adapted from [101].
1.5.3 Safety and Efficacy
PVP first became popular in the early 1980s when Galibert et al. injected PMMA bone
cement into a partially destroyed cervical vertebra (C2) and successfully relieved the
patient’s long-term pain [102, 103]. This initiated the use of PVP for the treatment of
chronic pain resulting from VF. Subsequent adaptations of the procedure, expansion
of indications, and development of novel injectable biomaterials have led to an
increase in the number of vertebral augmentations performed. For instance, the
number of PVP performed in the United States has increased by 72.4% between 2001
and 2010 [9-12]. Although the number of procedures is on the rise, several hurdles are
currently preventing PVP and PKP from becoming the standard of care for the
treatment of chronic pain related to VF. The Food and Drug Administration (FDA) has
issued a warning about possible complications following the injection of PMMA into
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a fractured vertebra [13]. The primary concern of the FDA was cement leakage into
the surrounding structures which may cause clinical complications such as nerve root
or spinal cord compression as well as pulmonary embolism. These complications may
lead to paraplegia or, in severe cases, death [14-19].
The incidence of cement leakage is high, particularly in PVP. It has been reported
to occur in 30% [104] to 65% [105, 106] of patients with osteoporotic-induced VF,
and in 38% [107] to 72.5% [108] of patients with malignant-induced VF. Although
cement leakage is tolerated in the majority of patients, it is the root cause for clinical
complications. The cement may leak into various anatomical structures including the
needle track, the paravertebral soft tissue (52.5% [108]), the surrounding vasculature
(5% [108] to 16.5% [109]), the spinal canal (37.5% [108]) and the intervertebral discs
(25% [110]). Leakage into the paravertebral soft tissue is generally asymptomatic with
the exception of two studies which have reported clinical complications [108, 109].
This type of leakage usually occurs due to anterior cortical breach, either pre-existing
or resulting from wrong needle placement (Figure 1.13).
Figure 1. 13 Schematic showing an example of a wrong needle placement. Although the needle
tip appears to be within the VB on both the AP and lateral views, it is actually partly in the
prevertebral space due to the round shape of the vertebral body. Adapted from [13].
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Leakage into the surrounding vasculature may cause pulmonary embolisms
especially when venous migration of cement is not recognized early in the procedure
[16, 19, 111]. Leakage into the spinal canal and the foramen may also cause serious
complications such as spinal cord and nerve root compression. However, leakage into
the spinal canal may be more tolerated, especially in cases where there is enough
residual space for the thecal sac. Cotton et al. [108] reported no complications
following spinal canal leakage in all 15 patients while 2 out of 8 patients with
foraminal cement leakage presented with nerve root compression which required
surgery 1 month later. Although this type of leakage is most frequent when a breach in
the posterior cortex of the VB is present, leakage may also be due to medial or inferior
perforation of the pedicles during needle placement (Figure 1.14). Leakage into the
intervertabral discs is generally asymptomatic, however long-term mechanical
consequences on adjacent vertebrae (i.e. adjacent fractures) may occur. This type of
leakages is most frequent in severe VF where the cement has a tendency to leak
through cortical osteolysis or fractures in the endplates [112, 113].
Figure 1. 14 Schematic showing an example of a breach in the medial cortex of the pedicle
during needle placement creating a risk of cement leakage into the spinal canal. Adapted from
[13].
There has been many studies in the literature that point to the suitability of PVP in
reducing both short and long term pain in patients with osteoporotic vertebral
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compression fractures [114-118]. However, two recent studies [119, 120] have caused
controversy over the efficacy of PVP. These studies performed a multicenter clinical
trial to determine the short-term efficacy of PVP for improving pain and pain-related
disability in patients with osteoporotic VF up to a year old. Patients were randomly
assigned to undergo PVP or a sham procedure without cement injection (control
group). Kallmes et al. [120] and Buchbinder et al. [119] found no significant benefit of
PVP over a sham procedure during their 1 month and 6 months follow-up,
respectively. However, both studies were criticized mainly about their patient
selection and other methodological issues which hampered their clinical interpretation
[121]. In a more recent study, Klazen et al. [122] aimed to clarify whether PVP has
additional value compared to conservative treatment in patients with acute VF and
persistent pain. Their results showed immediate pain relief after PVP which was
sustained for a least a year and was significantly greater than that achieved with
conservative treatment.
Although augmentation procedures have been limited largely for treating
osteoporotic-induced VF, they are increasingly being used to treat malignant induced
VF. Fourney et al. [90] devised a treatment algorithm for painful thoracolumbar VF in
cancer patients (Figure 1.15). PVP and PKP procedures were considered when
disabling pain was present and conservative therapy which consisted of analgesic
medication, bed rest, and in some cases external bracing had failed. Contraindications
for both procedures include epidural compression, failure to localize symptomatic
level(s), pain that was predominantly radicular in nature and local infection at the
planned injection site. The choice for performing PVP or PKP at a given symptomatic
level depended on several factors. PKP was favoured in the presence of i) kyphosis
(>20º) which was deemed to be a significant contributor to morbidity, ii) destruction
of the posterior vertebral cortex, and iii) significant vertebral collapse where height
restoration was desired. On the other hand, PVP was the procedure of choice when the
vertebral collapse did not permit insertion of the inflatable bone tamps and the patients
could not tolerate general anesthesia or the relatively longer procedure time required
for PKP.
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Figure 1. 15 Flow chart showing the treatment algorithm for painful thoracolumbar vertebral
fractures in cancer patients. Adapted from [90].
Several prospective studies have reported on the safety and efficacy of PVP [108,
123-126] and PKP [127-132] for the treatment of malignant-induced VF (Table 1.4).
In the five PVP studies, 96 patients were treated for VF due to spinal metastases
(76%) and multiple myeloma (24%). PKP was used in six studies to treat 204 patients
with VF due to spinal metastases (45%) and multiple myeloma (55%). In terms of
safety, cement leakage using PVP was almost five times higher compared to PKP and
caused neurological complications in four patients (4.1%). The symptoms of one
patient resolved in a couple of days, however the remaining three patients required
surgical decompression [108, 124]. In all the studies which included 300 patients, only
one experienced an adverse medical condition. Khanna et al [129] reported one
myocardial infarction which occurred in the post-anaesthesia care unit following PKP.
Furthermore, adjacent fractures were only reported following PKP and occurred in 6
of the 204 patients with 3 of the patients requiring subsequent PKP stabilization [131,
132]. In terms of efficacy, all studies reported significant improvement in pain which
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was assessed via various methods including the Visual Analog Scale [123, 126, 128,
131], the Verbal Rating Scale [124], the McGill and Melzack classiﬁcation [108], the 
Site Speciﬁc Pain Score [125], and the Short-Form 36 Bodily Pain sub-score  [127, 
129]. All studies also reported successful improvement in function which was assessed
by various methods including the Eastern Cooperative Oncology Group Performance
Scale [124, 126], the Townsend Functional Assessment Scale [7], the Oswestry
Disability Index [11, 37, 40], and the Short Form 36 Physical Function [112, 123].
Table 1. 4 Summary of prospective studies using PVP and PKP in cancer patients.Prospective Studies Verterboplasty KyphoplastyNo. studies 5 6No. patients 96 204
Tu
m
or
Ty
pe
s Metastases 73 (76%) 91 (44.6%)Multiple Myeloma 23 (24%) 113 (55.4%)
Le
ak
ag
e Total per level 59/101 (58.4%) 12/239 (12.1%)Symptomatic Patients 3 (3.1%) 0
Co
m
pl
ic
at
io
ns Medical 0 1 (0.5%)Neurological 4 (4.1%) 0Corrective Surgery 3 (3.1%) 0
Ad
ja
ce
nt
Fr
ac
tu
re Total Adjacent Fractures 0 6 (2.9%)
Corrective Surgery 0 3 (1.5%)
Some correction in sagittal alignment was reported following PKP, however only two
studies by Pflugmacher et al. [131, 132] included reliable long-term data. In the first
study [131], 20 patients were treated for VF due to multiple myeloma. Post-operative
improvement in vertebral height by a mean of 4.3 mm (P < 0.05) was observed in
64.5% of fractures, whereas kyphotic deformity correction by a mean of 6.3 (P <
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0.05) was observed in 78.5% of patients. This statistical significance in height
improvement and kyphotic correction was lost at the 1-year follow-up. In the second
study [132], 41 of the 65 patients treated for VF caused by metastases were followed
for two years. Although significant post-operative improvement in height and
kyphotic deformity was observed, both improvements returned to preoperative levels
at the 2-year follow-up.
1.6 FLUID FLOW IN CANCELLOUS BONE
During vertebral augmentation procedures, bone cement is injected through a cannula
into the cancellous bone of the vertebral body. The cements used, such as PMMA, are
chemically complex, multi-component and significantly non-Newtonian with their
viscosity having differing degrees of time and shear-rate dependency. These cements
also interact with other fluids present within the porous media and with the porous
structures through which they flow [133]. When two or more fluids are present within
a porous media, the displacement of these fluids can be characterized as miscible or
immiscible. Miscible flow occurs when the fluids are completely soluble in one
another with no distinct fluid-fluid interface due to a zero surface tension between the
fluids, where surface tension is a measure of the force or energy required to deform
the fluid-fluid interface per area. However, immiscible flow is the simultaneous
displacement of the fluids or phases in the porous media due to the nonzero surface
tension between the fluids, resulting in a distinct fluid-fluid interface which separates
the fluids within each pore. In vertebral augmentation, the biomaterial used (PMMA
cement) is generally assumed insoluble in any biofluid (bone marrow) it comes into
contact with, thus the cement-marrow displacement is characterized as a two-phase
immiscible flow in porous media. A rationale for this assumption is that the PMMA
cement is hydrophobic and does not dissolve into the red bone marrow which is
hydrophilic [134, 135].
Vertebral cancellous bone has highly complex geometrical structures and displays
architectural inhomogeneities over a range of length scales (refer to section 1.2). Thus,
the pore-scale cement viscosity varies due to its non-linear dependency on
33
deformation rates which are affected by variations in the local tissue morphology.
Small pores (< 0.8 mm) in the cancellous bone reduce the void volume available for
cement flow, thus the cement’s interstitial velocity increases in order to preserve the
continuity with the entering superficial flow. This leads to an increase in the
deformation rate, which causes a decrease in the viscosity as the cements are known to
exhibit shear-thinning behaviour. Furthermore, the vertebral cancellous bone
microarchitecture varies among the patients being treated, thus making the scientific
understanding of the cement flow behaviour difficult in clinical or cadaveric studies. It
is also extremely difficult to measure the patient’s local tissue morphology due to x-
ray dosage limitations and geometrical constraints, which inhibit the use of micro-
computed tomography to scan patients prior to the treatment [136, 137].
1.7 RHEOLOGY
Most techniques that are used to measure the rheological properties of a fluid apply a
kind of shear flow referred to as viscometric flow. Figure 1.16 represents a fluid
confined between two plates of area A and separated by a distance D.
Figure 1. 16 Viscometric flow of a fluid confined between two plates. Adapted from [138].
In a viscometric flow, the fluid motion is along one coordinate direction (x1) while the
fluid velocity varies along the orthogonal direction (x2). When the upper plate is
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moved along the x1 direction relative to the lower plate, the fluid is subjected to an
amount of shear strain () defined as:
ߛ= ܽݐ ݊ߠ = Amount of shear displacement, SDistance between shearing surfaces, D (1)
the rate of shear strain, also referred to as the shear rate, can be computed as:
(2)
The constant force (F) required to move the top plate at a constant velocity with
respect to the bottom plate is referred to as the shear force. Dividing the shear force
(F) by the plate area (A) gives rise to the shear stress () [138]. Under steady flow
conditions, the viscosity () of a fluid may be defined as the ratio of the shear stress
() to the shear rate ( ). Based on this relationship, the fluid can be classified as
Newtonian or non-Newtonian. For Newtonian fluids, the shear stress is a linear
function of the shear rate, thus the viscosity is a constant independent of the shear rate.
Conversely, for non-Newtonian fluids, the shear stress is a non-linear function of the
shear rate (Figure 1.17). The power law is commonly used in polymer engineering to
describe the relationship between the shear stress and the shear rate for various types
of fluid behaviour, although other mathematical relationships are available including
Cross, Williamson and Sisko [139]. The power law states that shear stress is
proportional to shear rate raised to the power n:
(3)
where C and n are constants used to describe the fluid flow behaviour. C is referred to
as the consistency index and n is referred to as the power index. Taking the logarithm
of both sides of the equality results in the equation of a straight line on the log-log
graph:
  lognCloglog (4)
D
velocityRelative


 nC  
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where n is equal to the slope and C is equal to the intercept with the ordinate axis
(shear stress) when log of the shear rate is zero. Since viscosity relates shear stress to
shear rate, it can also be expressed as a power relationship by substituting equation (1)
in the expression for viscosity in terms of the ratio of the shear stress to the shear rate:
(5)
The power index (n) is a measure of the non-Newtonian behaviour of the fluid.
Newtonian fluids have a power index (n) which equals to one. However, many fluids
exhibit a form of non-Newtonian behaviour. Some fluids exhibit increasing viscosity
with increasing shear rate, a behaviour known as shear-thickening or dilatant (n > 1).
Other fluids exhibit decreasing viscosity with increasing shear rate, a behaviour
known as shear-thinning or pseudoplastic (n < 1). A further type of fluid behaviour is
that of Bingham plastic fluids which behave similar to Newtonian fluids, however a
minimum shear stress, known as the yield stress, must be applied before the material
will start to flow [140, 141]. This section focuses on the rheological properties of two
fluids: bone cement and bone marrow.
Figure 1. 17 Forms of viscous flow showing shear stress – shear rate relationship and viscosity –
shear rate relationship between Newtonian (solid) and non-Newtonian fluids (dashed).
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1.6.1 Bone Cement
Acrylic bone cements are most commonly used for vertebral augmentation, however
other cements such as calcium phosphates, calcium sulphates and composite cements
are currently in development. Acrylic cements are typically prepared directly before
injection via mixing methyl methacrylate (MMA) liquid monomer with poly(methyl
methacrylate) (PMMA) powder. An x-ray contrast agent, such as barium sulfate
(BaSO4), is generally added to the powder to increase the radiopacity of the cement
[140, 142]. The PMMA cement is a self-curing polymer which polymerizes by a free
radical exothermic reaction causing the cement to change over a short period of time
(10-15 minutes) from a viscous liquid to an elastic solid. There are many factors that
influence the curing process of PMMA bone cements, some of these include:
 Temperature [143, 144]
 Humidity [145]
 Sterilization [146]
 Handling [147-149]
 Mixing ratio and technique [141]
 Size of powder particles [150]
PMMA bone cements exhibit two flow characteristics: rheopectic (increasing
viscosity with time) and pseudoplastic (decreasing viscosity with increasing shear
rate). The ISO and ASTM standards state that the rheological properties of bone
cements used as injectable biomaterials can be determined via the capillary extrusion
method [140]. In this method, the test fluid (PMMA) is forced from a reservoir
through a capillary under pressure from some kind of piston (Figure 1.18).
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Figure 1. 18 Schematic of the capillary extrusion rheometer. Adapted from [142].
The basic requirements for the capillary extrusion method include a large narrow tube
or capillary, means of determining the pressure drop along the capillary and means of
measuring the volumetric flow rate (Q) through the capillary. Under steady state flow,
isothermal conditions and assuming the PMMA to be incompressible, the viscous
resistance to the motion in the capillary is equal to the force acting from the reservoir.
Thus, the shear stress at the capillary wall can be calculated as:
(6)
where R is the radius of the capillary, οܲ is the pressure drop along the capillary, and
L is the length of the capillary. For a Newtonian fluid the shear rate at the capillary
wall is given as:
(7)
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For non-Newtonian fluids such as PMMA, correction factors must be applied to
obtain the true shear stress and the true shear rate [142]. The Bagley correction (e) is
used to correct the shear stress at the capillary wall. Equation (6) then becomes:
(8)
The Rabinowitsch equation is used to correct the shear rate at the capillary wall.
Equation (7) then becomes:
(9)
where n is the power index value. In some instances, these correction factors are either
not applicable or their values may not be derived at the time of computation. Thus, the
expressions used to compute the shear stress and shear rate for Newtonian fluids are
used to compute those for non-Newtonian fluids. In this case, the shear stress and the
shear rate are referred to as the false apparent shear stress and the false apparent shear
rate. Then, the derived viscosity is designated the false apparent viscosity which is
expressed by combining equations (6) and (7) as:
(10)
The advantage of using a capillary rheometer is that the flow and the shear rate are
similar to those used in current cement injection systems. The disadvantages include
the varying shear across the radius of the capillary and the necessity to apply
corrections factors in order to measure more accurate viscosity values [138, 142, 150].
Other traditional techniques for measuring PMMA viscosity include the rotational
rheometer (cone-plate or plate-plate). Depending on the geometry used, the test fluid
(PMMA) is contained within the annular space of the cone-plate or the plate-plate. In
the cone-plate arrangement, the cone is rotated at a constant speed while the resisting
torque (T) of the fluid is measured on the bottom plate. By knowing the angular
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rotation of the cone (), the cone angle (), and the radius of the plate (R), the
viscosity can be derived as [138]:
(11)
The major limitation for using either capillary or rotational rheometers when
measuring PMMA viscosity is that such methods assume the cement to be a viscous
material. Although this is a safe assumption at the early stages of mixing, as the
cement cures it behaves more like an elastic solid and this assumption fails to be true.
For this reason, it is more reasonable to treat PMMA cement as a viscoelastic material,
for which it is convenient to use an oscillatory rheometer to measure viscosity [140,
141]. The set-up is very similar to a rotational rheometer in terms of the fluid being
contained within the annular space of the cone-plate or the plate-plate. However, in
this method the fluid is subjected to an oscillatory displacement which is typically
sinusoidal in nature. Either a compressive () or shear strain () can be applied. These
are in the form:
tsin0  (12a)
or
tsin0  (12b)
where 0 and 0 are the amplitude or maximum strain,  is the frequency of oscillation
and t is the time. The resulting compressive () or shear () stress oscillates with the
same frequency but is shifted by a phase angle :
  tsin0 (13a)
or
  tsin0 (13b)
The equations for stress can be expanded to give:
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 sintcoscostsin 00 (13c)
or
 sintcoscostsin 00 (13d)
This indicates that the stress has two components, one which is in phase with the strain
while another which is /2 out of phase with the strain. Therefore, the complex
modulus (compressive E or G shear ) also has two components: the real component
(or elastic), which is referred to as the storage modulus ( E  or G ), is in-phase with
the strain and the imaginary component (or viscous), which is referred to as the loss
modulus ( E  or G  ), is /2 out of phase with the strain. These can be expressed as:
 


 sinicosEiEE
0
0 (14a)
or
 


 sinicosGiGG
0
0 (14b)
Similarly, the true or complex viscosity (*) has two components and is expressed as:
 i (15)
where  is referred to as the dynamic viscosity and is related to the loss modulus via:
GorE


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

 (16)
  does not have a special name and is related to the storage modulus via:
GorE





 (17)
The loss angle () can also be calculated via:
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The advantage of using the cone-plate geometry is that the shear rate is nearly constant
throughout the system which is crucial when testing fluids that are very sensitive to
shear rate, such as the case with PMMA. This allows reducing variability and
obtaining more reliable measurements of viscosity. However, problems can occur with
the cone-plate geometry particularly when the testing fluid, such as PMMA, is a
suspension containing particles. These problems may be resolved by increasing the
shear gap in the rheometer so that the gap becomes significantly (at least 5 times)
greater than the size of the particles. As the particles in PMMA cements are typically
on the order of 100 m, the shear gap must be at least 500 m. With the cone-plate
geometry, this condition may be more difficult to achieve compared to a plate-plate
geometry [140].
Farrar and Rose [140] studied the rheological properties of the following acrylic
bone cements: Palacos R (Merck Biomaterial, Darmstadt, Germany), Simplex P
(Howmedica International Ltd., London, UK), Zimmer low viscosity cement (Zimmer,
Indiana, USA), Zimmer regular (Zimmer, Indiana, USA), Osteobond (Zimmer,
Indiana, USA) and CMW 3 (Wright Medical Technology Inc., Tennessee, USA). The
viscosity measurements were performed using a CarriMed CSL500 rheometer (TA
Instruments Ltd., Leatherhead, Surrey, UK) in dynamic oscillation mode with a
parallel plate configuration. The radius of the upper plate was 20 mm, the gap between
the plates was 2 mm, and the frequency of oscillation was set to 5 Hz. The rheometer
was used in ‘constant strain mode’ thus the applied stress was varied to achieve
constant strain amplitude of 5 x 10-4 rad. This mode was selected, rather than constant
stress, to maintain the applied strain throughout the curing of the cements. The
dynamic viscosity as a function of time is presented in Figure 1.19.
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Figure 1. 19 Dynamic viscosity as a function of time for commercial acrylic bone cements. The
shear rate at the rim of the plate was 50 s-1. All measurements were performed at 23ºC. Adapted
from [140].
The data shows that the cements have different initial viscosities as well as marked
differences in their viscosity-time curves. These differences reflect the way the
cements are intended to be used. For instance, Zimmer LVC is intend to be injected
using a cement gun, thus the cement has a low initial viscosity which is maintained for
some time before it starts to rise. On the other hand, Palacos R has a high initial
viscosity as this cement is generally used for prosthesis fixation. There are two
processes which contribute to the rise in viscosity as a function of time: 1) swelling of
the PMMA polymer particles in the MMA monomer and 2) polymerisation of the
monomer itself. This implies that the rate of viscosity rise is affected by various
factors including particle size/shape/distribution, composition of the polymer particles,
and molecular weight distribution of the polymer component [140]. There have been
two categories of formulations for acrylic bone cements that are used as injectable
biomaterials for vertebral augmentation. The first comprises the same commercially
available brands that are used in cemented arthroplasties with an extra amount of
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radiopacifier added by the surgeon to bring the concentration to 20–30 wt/wt % of the
PMMA powder. The most common brand used is Simplex P with the addition of
BaSO4 to increase its radiopacity. The second category comprises commercially
available brands that are specifically formulated with a high radiopacifier
concentration, such as Osteopal V (Heraeus Medical GmbH, Hanau, Germany) for
example [151]. One of the main concerns for using acrylic bone cements is related to
the exothermal polymerization of the cement which generates a temperature elevation
(reaching 100°C) high enough for causing thermal necrosis of the soft tissues at the
peri-augmentation site. Based on post-mortem histological examination of a vertebra 6
month post-augmentation, San Millan et al. [152] showed that acrylic bone cements
can cause necrosis of tumor tissue within and around the augmentation site. Other
disadvantages for using acrylic bone cements include the non-biologic potential to
remodel or integrate into the surrounding bone, the excessive inherent stiffness, and
the potential for residual liquid monomer to cause toxicity and chemical necrosis of
the surrounding tissue.
Ceramic bone cements such as calcium phosphate (CaP) and calcium sulphate
(CaS) have also been used as injectable biomaterials for vertebral augmentation.
Ceramic cements have been extensively investigated as bone substitutes due to their
chemical characteristics and bioactive properties. They have the advantage of
resorbing over time and allowing new bone to form, thereby restoring the vertebral
body mass. Another key advantage is that these cements cure through a slow
exothermic reaction which prevents the attainment of high curing temperatures and
avoids any potential thermal effects within and around the augmentation site. When
CaP cements are mixed in an aqueous solution, the setting is generally initiated by an
acid-base reaction, where a relatively acidic CaP reacts with a relatively basic CaP to
produce a neutral CaP. Based on the degradation rate, CaP cements can be classified
as apatite or brushite. The degradation of apatite cements (although faster than
hydroxylapatite) is considered slow in vivo and some formulations (such as
tetracalcium phosphates) experience increase in strength with time. Brushite cements,
on the other hand, have a faster degradation rate compared to apatite cements and
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suffer a rapid decrease in strength in vivo. CaS cements, more commonly known as
plaster of Paris or gypsum, have a long clinical history for use as a bone substitutes in
various skeletal sites. When these cements are mixed in an aqueous solution, the
powder is converted to calcium sulfate dihydrate producing a paste with a solid or
partial solid structure. CaS cements resorb in vivo mainly by dissolution within about
2 months depending on the volume and location. The primary concern regarding
ceramic cements is their rapid rate of resorption in vivo before the bone tissue has had
time to grow into the defect which limits the mechanical support for spinal stability.
Another major drawback for using ceramic cement as injectable biomaterials is that
during injection the liquid and solid components of the suspension may separate. Once
pressure is applied for injection, the suspension separates and only the liquid medium
passes through the cannula while the particles accumulate at the tip and cannot
infiltrate through the interstices of the bone. This separation effect is referred to as
filter-pressing and can be detrimental to the patient. Other limitations for ceramic
cements include their high cost, low viscosity and handling characteristics which
differ to PMMA [151, 153, 154].
1.6.2 Bone Marrow
In vertebral augmentation procedures, bone marrow has been shown to affect the
cement flow behaviour. Bohner et al. [136] have demonstrated that an increase in bone
marrow viscosity significantly increases the tendency of cement leakage. Furthermore,
bone marrow plays a crucial role in modulating the shear stress experienced by the
cancellous bone in the vertebral body when subject to vibratory loads [155]. However,
the rheological properties of bone marrow in various sites of the human body as well
as the changes in these properties due to osteoporosis and other bone pathology are
largely unknown. The only studies which have reported on the rheological properties
of bone marrow are summarized in Table 1.5 [156-159].
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Table 1. 5 Viscosity measurements reported in the literature for bone marrow and blood.
Study Specimen Location Temperature(°C ) Viscosity(mPa·s)
Bo
ne
M
ar
ro
w
Bryant et al.,1983[156] Bovine Proximalradius 35 400Distal radius 35 44Gurkan andAkkus, 2007[158] Bovine Femur 37 123Davis andPraveen, 2006[157] Human Calcaneus 36 38Zhong andAkkus, 2011[159] Human Femur 37 44 - 142
Bl
oo
d Eguchi andKarino, 2008[160] Human - 36 66
Bryant et al. [156] were the first to show that the viscosity of bovine bone marrow
was dependent on temperature and varied across anatomical sites. The samples tested
in their study were taken from proximal and distal ends of five radii. Newtonian fluid
characteristics (viscosity independence to both shear rate and temperature) was
reported in measurements performed at temperatures above 37°C for samples from the
distal site and above 42°C for samples from the proximal site. All viscosity
measurements performed above these temperatures reached a lower limit of 0.04 Pa·s
and below these temperatures the measured viscosity of the proximal samples (0.4
Pa·s at 35°C) were about ten times higher compared to the distal samples (0.04 Pa·s at
35°C). This variation in viscosity can be associated with compositional variations of
the marrow along the bone. The proximal site contains red marrow whereas the distal
site contains yellow (fatty) marrow [161, 162]. This suggests that the increased fat
content in the marrow may reduce its viscosity. Furthermore, the proximal marrow
solidified at temperatures below 30°C, whereas the distal marrow remained liquid up
till temperatures below 20°C. Bryant et al. also showed that removing blood cells and
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other granular matter from the bovine marrow via centrifuging decreased the
dependency of its viscosity on temperature. In a more recent study, Gurkan and Akkus
[158] reported viscosity values of 0.123 Pa·s for bovine bone marrow taken from the
femur.
Two studies [157, 159] have reported on the rheological properties of human bone
marrow. The first study [157] was performed on specimens taken from the calcaneus
of nine freshly amputated human legs within approximately 30 minutes of above- or
below-knee amputation. This bone marrow, which is mainly yellow or fatty, exhibited
Newtonian fluid characteristics (viscosity independence to shear rate) and had a
viscosity value around 0.038 Pa·s at a temperature of 36°C. However, bone marrow
samples containing red components or high blood cell concentration exhibited non-
Newtonian behaviour. This result is not very surprising especially when human blood
is known to exhibit non-Newtonian behaviour [160]. The second study [159]
examined the effects of age on the rheological properties of human yellow bone
marrow. Their samples were harvested from the femurs of male donors ranging
between 22 to 82 years of age (N = 19). Their results showed that age did not have a
significant effect on the viscosity of the marrow which decreased with increasing
shear rates, ranging from 0.142 to 0.044 Pa·s at shear rates of 0.5 and 10 s−1,
respectively. However, at shear rates above 10 s−1, the marrow behaved as a
Newtonian fluid with its viscosity remaining constant.
The answer to this variation in bone marrow composition along the bones and at
various sites in the human body remains unknown. One explanation is the temperature
dependency of bone marrow which may affect its composition. Huggins et al. [163,
164] have demonstrated that the fat content of bone marrow in the limb bones (such as
the femur or the radius) is higher compared to the bones in the central parts of the
body (such as the vertebrae or the ribs) which may be associated with the greater body
temperature in the central bones.
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1.8 TWO-PHASE FLOW IN POROUS MEDIA
The rheological properties play a crucial role in the cement flow behaviour during
injection and within a porous structure such as cancellous bone. Many factors
influence the injection biomechanics and the tendency of cement leakage, however the
cement viscosity has been identified as a key determinant of the cement flow patterns
and therefore the risk of cement leakage [136, 165, 166]. Furthermore, cement
placement has been identified as a critical parameter in the biomechanical behaviour
of the construct post-augmentation [167, 168]. This section focuses on the theoretical
and experimental approaches used to describe and characterize the non-Newtonian
cement flow behaviour in cancellous bone during vertebral augmentation procedures.
1.8.1 Theoretical Models
The classic examples of two-phase flow in porous media are associated with oil
recovery processes (oil-gas, -water, -polymers and/or -surfactants) and ground water
flow (water-air) [169]. Predictive theories started with Darcy who investigated the
flow of water in vertical homogenous sand filters and concluded that the rate of flow
Q is: a) proportional to the cross-sectional area of the sand filter, b) proportional to the
hydraulic head difference measured between the top and bottom of the sand filter and
c) inversely proportional to the length of the filter [135, 170]. This gave rise to the
Darcy formula:
(19)
where K is a constant of proportionality and is referred to as the hydraulic
conductivity which is a characteristic of the sand filter but does not provide any
information about the degree of homogeneity in the sand filter. The hydraulic
conductivity is a measure of the resistance to fluid flow through the porous media and
can be separated into two parts: the first is related to the morphological properties of
the porous matrix, expressed as the intrinsic permeability ks and the second is related
L
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to the dynamic viscosity of the injected fluid [135, 171]. The hydraulic conductivity is
given as:
(20)
Thus, high resistance occurs when the injected fluid has a high viscosity and the
porous media through which the fluid flows has a low permeability, where zero
permeability would give rise to infinite resistance. Baroud et al. [172, 173] described
the intrinsic permeability of cancellous bone as a function of bone porosity () by
introducing a constitutive law in the form:
(21)
where is the intrinsic permeability fitting coefficient and is the intrinsic
permeability in the  direction. Their results showed that the fitting coefficient in
the superoinferior direction (SI) and the anteroposterior (AP) direction were
(R2=0.66) and (R2=0.82), respectively.
Although their results showed no significant difference in porosity, the permeability in
the AP direction was lower compared to the SI direction. This suggested that other
morphological parameters, such as trabecular separation, may contribute to bone
permeability. However, their model properly predicts the limits of the permeability (k)
as a function of porosity (), where k approaches zero as  approaches zero, and k
approaches inﬁnity as  approaches one. Furthermore, Teo et al. [174] performed
experiments to estimate the local bone porosity via linear mapping and found a strong
correlation (R=0.83) with Hounsfield unit (HU) values from calibrated computed
tomography (CT) images. Their results led to the following relationship with respect
to the position in space :
(22)
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To describe fluid flow through complex porous structures such as cancellous bone,
Darcy’s law can be expressed more generally in the form of a differential equation:
(23)
where  is the specific fluid phase, is the apparent fluid velocity vector, is the
intrinsic permeability second-order tensor and is the pressure gradient. These
parameters are most often a function of position in space and time t [133].
However, a major limitation for Darcy’s law is that its validity applies only when the
fluid is Newtonian and the flow is dominated by viscous forces, where the ratio of
inertial to viscous forces is considerably smaller than one. Therefore, Darcy’ law must
be extended to cover fluids with non-Newtonian rheological behaviour, such as
PMMA. Most mathematical and numerical models used to quantify cement flow
through cancellous bone assume that the definitions and intrinsic properties of the
cement velocity, the cement pressure and the permeability of the cancellous bone are
not altered by the rheological properties of the fluid. Thus, all non-Newtonian effects
are taken into account via a suitable definition of viscosity at the continuum length
scale. Consequently, this apparent or Darcy viscosity is determined from the pressure
drop due to steady state and is a function of the fluid rheological properties, the
apparent fluid flow and the morphology of the porous media [133, 137].
Baroud and Yahia [175] introduced the time-dependency factor into the power law
(Eq. 5) in order to capture the non-Newtonian rheopectic and shear-thinning behaviour
of PMMA cement. The extended form of the power law is expressed as:
(24)
where a, b, c and d are the viscosity material constants which are derived
experimentally from empirical rheological tests. and are the characteristic
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values for time and shearing rate, typically 60 s and 1.0 s-1, respectively. is
the new term for the consistency index (C) which captures the time-dependent average
viscosity of the cement and is the new term of the power index (n) which
captures the time-dependent deviation of the cement from Newtonian behaviour. Their
results showed that the revised from of the power law (Eq. 24) provides an accurate fit
to previously derived experimental data [138] and the viscosity material constants for
Simplex (Stryker Corporation, Michigan, USA) were determined to be ,
, , and . However, their study was limited to the
characterization of cement flow through a cannula and provides little description of
the cement infiltration process through cancellous bone. Lian at al. [176] extended the
rheological model proposed by Baroud and Yahia [175] to simulate the flow of
PMMA cement through cancellous bone by approximating it geometrically as
branching-pipe network. Due to the varying permeability and structure of cancellous
bone, their geometrical model consisted of channels with continuously varying
diameters. Thus, they chose a conical pipe to represent the elementary segment for
each branch in their network and assumed that the PMMA flow is steady,
incompressible and Newtonian in order for the Hagen–Poiseuille law (Eq. 10) to be
applicable and the wall shear-rate to be calculated using Eq. 7. These equations were
then modified to estimate the pressure drop and shear-rate across each elementary
segment. Consequently, for a general branch segment that is filled and represented via
a conical pipe with radii R1 and R2 at its ends, the overall pressure drop becomes:
(25)
and the effective shear-rate at the wall becomes:
(26)
To account for the non-Newtonian behaviour of PMMA, the viscosity was updated
prior to the pressure drop computation based on the computed shear-rate, the elapsed
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time from cement mixing and the extended form of the power law (Eq. 24) proposed
by Baroud and Yahia [175]. Their methods improved the characterization of PMMA
flow through cancellous bone and provided an estimation of the overall injection
pressure, hence the reaction force required during manual injection. Teo at al. [177]
presented a more clinically relevant model for PMMA flow through cancellous bone.
They used patients CT datasets to compute the permeability of cancellous bone in the
superior-inferior (SI) direction as a function of bone porosity and found good
correlation (R2=0.69). The permeability was expressed as:
(27)
They also characterized the cement viscosity using the extended form of the power
law (Eq. 24) with the viscosity material constants derived by Baroud and Yahia [175]
for Simplex bone cement. The cement flow through the cancellous bone was
determined via Darcy’s law (Eq. 23). Several user inputs, which reflect the decisions
made by surgeons during vertebral augmentation, were required for their
computational model. These included needle position, needle gauge, flow rate and
injected volume. Their main findings revealed that the injection pressure increases as
the volume of the cement increases and as the distribution of the cement is in close
proximity to the cortical walls.
Bohner et al. [136] were the first to present a theoretical model of cement
spreading in cancellous bone with a special focus on the characterization of cement
leakage. However, their models assumed spherical spreading patterns and Newtonian
fluid properties. They considered that the cement leakage occurs along a path of least
resistance, thus they assumed that leakage path is cylindrical with a diameter De and
length Le. For given cement and marrow viscosities (c and m, respectively), the
pressure (Pe) required to inject the cement through the leakage path is the sum of two
pressures: 1) the pressure required to inject the cement into the path and 2) the
pressure required to extrude the marrow outside the path. The extravasation pressure
Pe is given by:
  038.19 1104  =kSI
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where Qc is the cement flow rate and Lc is the length of the path which is filled with
cement. Furthermore, they considered that the total pressure required to augment bone
with cement (Pa) is also a function of two pressures: 1) Pa,c the pressure required to
inject the cement into the bone and 2) Pa,m the pressure required to push the marrow
out of the bone. These pressures are given by:
(29)
and
(30)
These equations are then combined to calculate the total augmentation pressure Pa:
(31)
where Ro is the radius of the cavity at the injection point, rc is the radius of the
spherical cement bolus, and Rv is the radius of the bone sphere into which the cement
is injected. The cement spreading can be represented in terms of time, flow rate and
matrix porosity () via:
(32)
The ratio between the augmentation pressure and the extravasation pressure
determines the risk of cement leakage , which is given by:
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Their theoretical model predicts that cement leakage increases with a decrease in the
matrix porosity (), a decrease in permeability (k) and an increase in the diameter of
the leakage path De. The radius at injection point Ro has a significant effect on the
augmentation pressure only. Based on this model, an increase in Ro decreases the
augmentation pressure, thus decreasing the risk of cement leakage.
Widmer et al. [135] improved previous models by introducing methods to describe
and simulate the displacement of bone marrow by bone cement in cancellous bone.
They devised a strategy to efficiently incorporate the fluid-fluid boundary information
into the local properties in order to govern the Darcy flow. They consider the cement-
marrow boundary as a one-dimensional, arbitrarily oriented column of length l,
referred to as the finite element Ωe. Then, instead of treating the cement and marrow
as separate entities, they treat them as one continuum and represent the apparent
cement-marrow property as the homogenization or mixture of both fluid properties
according to the element factor δe. Thus, the pressure drop ΔPi occurring along each
fluid portion  (i=1, 2) is replaced with the total pressure drop ΔPe occurring along
the column Ωe. Darcy’s Law is now expressed as:
(34)
where Ke is the overall hydraulic conductivity of the element Ωe and is expressed as:
  mece
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The expression of Ke provides a linear interpolation between the fluid properties c
and m with δe as the weighting factor of the interpolation. Furthermore, they
hypothesize that the relation in Eq. 35 remains valid if the scalar intrinsic property (ks)
is replaced by its second-order tensor counterpart and assume that the fluids are
incompressible so the principles of mass conservation may be replaced by the
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principles of volume or flux conservation. Subsequently, they replaced ( ) with
( ) to express Darcy’s law in the form of one single constitutive equation in
terms of the mixed boundary representation rather than two separate fluid phase
properties. They also characterized the cement viscosity using the extended form of
the power law (Eq. 24) and recovered the shearing rate magnitude from the specific
discharge of the fluid interface which is represented by the flux vector field :
(36)
In a more recent study, Widmer at al. [137] introduced a multi-scale approach to the
characterization of the cement flow through cancellous bone. They proposed that the
Reynolds number can be used to relate the pore and continuum length-scale
rheological properties and showed a strong correlation between the viscosity and .
Their results also showed that a viscosity change of the order of one magnitude was
observed on the pore length scale, whereas the shear-thinning properties caused a
viscosity change of the order of only 10% on the continuum length scale. Their
findings highlight the importance of incorporating the non-Newtonian cement
properties at the appropriate length scale.
1.8.2 Experimental Studies
Due to the high frequency of cement leakage and the potential cause for serious
clinical complications, in vitro studies have been designed to better understand the
fundamental mechanisms underlying cement leakage [136, 166, 178-180]. However,
this is just one part of a wider requirement to understand how the cement flows within
the bone and accurately predict the cement placement, which has been identified as a
critical parameter in the biomechanical behaviour of the construct post-augmentation
[167, 168]. All in vitro studies on cement leakage have generally differed in terms of
q K
eq eK
eq
 Tee qq 
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experimental setups and protocols, cements used, means of cement mixing and cement
injection (Table 1.6).
Table 1. 6 Comparison of cements used, means of cement mixing and cement injection
between experimental studies on cement leakage.
Study Bohner et al.,2003 Loeffel et al.,2008 Baroud et al.,2006 Mohamed et al.,2010
Cement Used Palacos LV-40(Essex ChemieAG, Luzern,Switzerland)
Vertecem(Synthes Inc,Bettlach,Switzerland)
DP-Pour(DenPlus Inc,Montreal,Quebec)
DP-Pour (DenPlusInc, Montreal,Quebec)
Means ofCementMixing
10.45 g ofpowder with 4.7ml of monomerin a 20 mlsyringe using aspatula for 40 s
7 g of powderwith 3.07 g ofmonomer in a 10ml syringe usinga steel rod for 60s
liquid-to-powderratiorecommended bymanufacturerthen oscillatorymixer for 90 s at400 rpm
liquid-to-powderratio recommendedby manufacturermixed with aspatula for 30 sthen an oscillatorymixer for 80 sMeans ofCementInjection 50 ml syringewith two needlediameters 7 and11- gauge
6 ml syringe with9-gauge needleand a computer-assisted injectiondevice
20 ml syringewith 8-guageneedle
10 ml syringe andnovel aspirationneedle with doubleconcentric tubing
InjectionParameter constant flowrates of 13.6 and27.1 mL/min cement volume of4 mL injected atflow rates of 3and 9 mL/min
cement volumeof 5 mL injectedat a rate of 7mL/min
cement volume of 5mL injected at arate of 4 mL/min
Bohner et al. [136] aimed to determine the effects of various parameters on the
tendency of cement leakage. Their experiments were performed according to a
factorial design and aimed at testing the following parameters: (1) with and without
bone marrow substitute, (2) elapsed time after cement mixing of 1.5 min and 3 min,
and (3) leakage hole diameter of 2 mm and 4 mm. Their results showed that the risk of
cement leakage significantly increased in the presence of marrow substitute and when
the leakage hole diameter was 4 mm (p < 0.0001). Among these factors, the only
parameter that did not depend on the bone structure was cement viscosity. Hence, their
findings suggested that the simplest means of reducing cement leakage was via
increasing cement viscosity. However, increasing the cement viscosity would
drastically increase the injection pressure which might not be suitable for a clinical
setting as the force that a human hand can apply limits the injection pressure.
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Subsequently, Baroud et al. [166] performed a study to test the hypothesis that high
viscosity cement spreads more uniformly compared to low viscosity cement which
follows the path of least resistance. They performed injection tests over a range of 5 to
11.5 minutes after cement mixing in 30-seconds increments. Their results showed that
cement viscosity significantly affected all the recorded parameters and recommended
that surgeons must inject the cement as late as possible in order to reduce cement
leakage and increase the safety of the vertebral augmentation procedure. They also
emphasize that the point in time at which the cement becomes manually non-injectable
depends on the syringe diameter and the needle gauge used. Loeffel et al. [180] aimed
to characterize cement distribution and quantify the effects of cement viscosity, bone
porosity and injection speed on cement spreading. They tested four different cement
viscosities (50, 100, 200 and 400 Pa·s) and used two indicators, circularity and mean
cement spreading distance, to quantitatively describe the differences in the resulting
cement distribution patterns. Similar to Baroud et al., their results showed that an
increase in cement starting viscosity had a significant impact on both indicators and
produced a more predictable flow pattern. Their results also suggested that an increase
in porosity negatively affected the compactness of the cement cloud and was more
likely to cause irregular flow patterns especially with low viscosity cements. On the
other hand, Mohamed et al. [178] aimed to test the hypothesis that a novel hybrid
approach for cement injection via aspirating the bone marrow and imposing a pressure
gradient to direct cement flow would improve the uniformity of cement filling,
consequently minimizing cement leakage. Their experiments had two factors: (1)
Elapsed time of 4 minutes and 8 minutes corresponding to low and high cement
viscosity, respectively. (2) Aspiration with four levels: (i) valve closed, (ii) valve
open, (iii) simultaneous aspiration and injection, and (iv) suction 1 minute before and
continued during injection. Their results supported their hypothesis and showed that
cement leakage significantly decreased with simultaneous aspiration and injection,
especially with the low cement viscosity. However, establishing suction before
delivering the cement did not have a significant effect on cement leakage.
Furthermore, aspiration had no significant effect on the force required to perform the
cement injection.
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All the bone surrogates that have been used in these experimental studies on
cement leakage have been made of open-porous aluminum foam. Generally,
aluminum foam has been selected due to its well-controlled porosity. However, the
surrogates have differed in terms of shape, size, manufacturer used, porosity, vertebral
shell mimic, bone marrow mimic and the generated cement leakage paths (Table 1.7).
Bohner et al. [136] and Loeffel et al. [180] both used off-the-shelf surrogates with an
overall porosity of 90%, conversely Baroud et al. [166] used surrogates with 91%
porosity and Mohamed et al. [178] used surrogates with 95% porosity. To mimic the
vertebral shell, Loeffel et al. [180] used PMMA enclosure of outer dimensions
60×60×32 mm, while Baroud et al. [166] and Mohamed et al. [178] coated their
surrogates with a 1 mm layer of PMMA cement. On the other hand, Bohner et al.
[136] did not include any enclosure in their surrogates. To mimic bone marrow,
Bohner et al. [136] and Loeffel et al. [180] both used melted cow butter, whereas
Baroud et al. [166] and Mohamed et al. [178] both used a water/gelatin solution. To
generate a cement leakage path, Bohner et al. [136], Baroud et al. [166] and Mohamed
et al. [178] all drilled a cylindrical channel through the main plane of their surrogates,
however Loeffel et al. [180] drilled vent holes through each of the four sides of their
reusable PMMA enclosure.
The bone surrogates that have been used in these cement leakage experiments
have several limitations that our future work will endeavour to overcome. An
important limitation is that although the porosity was controlled among a group of
respective surrogates, the geometrical structure within these surrogates was irregular
and uncontrolled. Thus, the surrogates were inherently unique. Achieving a bone
surrogate with constant porosity as well as structural geometry is crucial to reduce the
variability, render the experiments reproducible and shift the focus onto understanding
the cement flow behaviour. Another important limitation is that the surrogates did not
provide a true representation of the leakage phenomenon. It is essential to simulate the
vertebral boundary, particularly the blood vessels that breach the cortex to supply
blood in and out of the vertebral body as well as other breaches in the cortex due to
skeletal pathology or vertebral fractures. This is crucial as such breaches create paths
of least resistance providing means for cement leakage outside the vertebral body.
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Further limitation of previous surrogates is the true representation of bone marrow as
such properties significantly affect the cement flow behaviour [136].
Table 1. 7 Comparison of bone surrogates used in experimental studies on cement leakage
following percutaneous vertebroplasty.
Study Bohner et al.,2003 Loeffel et al.,2008 Baroud et al.,2006 Mohamed et al.,2010Shape Cubic Rectangular Cylindrical CylindricalSize 50x50x50 mm 45x45x12 mm Diameter 38.1Height 25.4 mm Diameter 38.1Height 25.4 mmManufacturer Filter platesSivex; Pyrotek SA,Sierre,Switzerland m-Pore GmbH,Dresden,Germany ERC Aluminumand Aerospace,CA ERC Aluminumand Aerospace,CAPorosity 90% 90% 91.10.6% 95%Cortical Mimic None PMMA enclosure60x60x32 mm 1 mm layer ofPMMA cement 1 mm layer ofPMMA cementMarrow Mimic Melted cowbutter Melted cowbutter Water/gelatin Water/gelatinCementLeakagePath Cylindricalchannel 2 and 4mm in diameter
4 mm hole ineach of the 4sides of PMMAenclosure
Cylindricalchannel 3 mm indiameter Cylindricalchannel 3 mm indiameter
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1.9 THESIS AIMS AND OBJECTIVES
From the assessment of the current literature, it is evident that the cement leakage
during vertebral augmentation is an important cause for serious clinical complications.
The high frequency of cement leakage is a major hurdle preventing augmentation
procedures from becoming the standard of care for the treatment of chronic pain
related to vertebral fractures, which are caused by osteoporosis and other skeletal
pathology such as metastasis or multiple myeloma. Although many factors influence
the injection biomechanics and the tendency of cement leakage, the rheological
properties play a crucial role in the cement flow behaviour during injection and within
a porous structure such as cancellous bone. Furthermore, cement placement has been
identified as a critical parameter in the biomechanical performance of the construct
post-augmentation. We hypothesize that a novel method using reproducible and
pathologically representative bone surrogates can be developed to comparatively
assess the injection behaviour of different cement formulations and help study cement-
fluid interaction.
1.9.1 Study Aim
To develop novel methodology for assessing cement injection behaviour using
reproducible and pathologically representative bone surrogates. The goal is to better
understand how the cement flows within cancellous bone and address issues of cement
placement following vertebral augmentation.
1.9.2 Objectives
Objective 1: Development and manufacturing of reproducible and pathologically
representative 2D and 3D bone surrogates
Objective 2: Assessment of bone surrogate morphology and surface properties.
Objective 3: Development of methods for allowing controlled injections into the 2D
and 3D bone surrogates.
Objective 4: Comprehensive assessment of bone cements via in vitro experiments.
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CHAPTER 2 MATERIALS AND METHODS
This chapter outlines the materials and methods used in this thesis for the in vitro
assessment of cement injection into vertebral cancellous bone. The first step was to
develop reproducible and pathologically representative bone surrogates to mimic the
vertebral body with different skeletal conditions including osteoporosis, spinal
metastasis and multiple myeloma. This required comprehensive understanding of the
morphology of the cancellous bone microarchitecture and the vertebral body anatomy
with its rheological environment to establish key requirements for these bone
surrogates. Then, a suitable manufacturing technique had to be identified to ensure
accurate and precise reproduction of the surrogates. The next step was to develop and
validate methods that allow fluid injection into the bone surrogates under a controlled
environment, through measuring the injection pressure and flow rate as well as
monitoring the cement flow distribution. Two experimental testing rigs were
developed to allow the injections to be performed under a constant flow rate. The first
system uses a syringe pump, while the other uses a material testing machine to control
the displacement of the syringe plunger and achieve a constant injection flow rate. The
final step was to utilize this developed methodology for assessing the flow behaviour
of different bone cement formulations through the visualization and quantitative
analysis of the cement spreading at various time intervals during the injection.
2.1 BONE SURROGATE REQUIREMENTS
There are several key requirements for bone surrogates used in experimental studies
on cement leakage following vertebral augmentation (Table 2.1). In addition, the
surrogates must be manufactured using a technique that allows their accurate and
precise reproduction. Achieving a constant surrogate is crucial to reduce the
variability, render the experiments reproducible and shift the focus onto understanding
the cement flow behaviour.
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Table 2. 1 Key requirements for bone surrogates used in experimental studies on cement flow
during percutaneous vertebroplasty.
Parameter Requirement ReferenceTrabecular BoneMorphology Normal: Tb.Th (vertical/horizontal) = 0.2 mmTb.Sp (vertical/horizontal) = 0.5 mmOsteoporotic: Tb.Th (horizontal) = 0.15 mmTb.Th (vertical) = 0.25 mmTb.Sp (horizontal) = 1.0 mmTb.Sp (vertical) = 0.8 mmMetastasis: normal or osteoporotic morphology withone large lesion (11% vertebral body volume)Myeloma: osteoporotic morphology with multiplesmall lesions (> 1.7 mm in diameter)Porosity: Normal 75%Osteoporotic 90%
[181]
[182, 183]
[184]
[166]
Vertebral Shell Solid thin layer surrounding the surrogates [185]Boundary Blood vessels that breach the vertebral shell toexchange blood in and out of vertebral body:
- Posterior: 1 or 2 holes through the cortexmidway along the craniocaudal and lateraldirections, with a 3 mm overall diameter
- Anterior: front and/or side holes through thecortex one-third below the superior endplatein the craniocaudal direction, with 2 mmheight and 1 mm width
[36]
RheologicalEnvironment Surface properties must match those of trabecularboneA true representation of the rheological properties ofred bone marrow must be included [136]Shape / Size Semi-cylindrical to match the vertebral body withdimensions of 40 x 30 x 30 (Width x Depth x Height) tomatch the size of thoracolumbar vertebrae [186]Manufacturing Reproducible, accurate and cost effective
The surrogates must also simulate the trabecular bone morphology, particularly the
trabecular separation (TbSp) and trabecular thickness (Tb.Th). Three-dimensional
morphometric indices are used to describe the trabecular microarchitecture (refer to
section 1.2). Several studies have demonstrated significant variations in the three-
dimensional morphometric indices with age amongst other variables [25, 31-35].
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Thus, it is important that the bone surrogates provide a representation of the trabecular
bone morphology that reflects the underlying pathology or age. Furthermore, the
surrogates must also mimic the vertebral shell which confines the flow and controls
the intravertebral pressure, significantly affecting the filling pattern [185]. Another
important requirement is simulating blood vessels that breach the cortex to supply
blood in and out of the vertebral body. This is crucial as these breaches create paths of
least resistance providing means for leakage outside the vertebral body. Finally, it is
essential to simulate the rheological environment within the vertebral body. The
surface properties of the surrogates must match those of trabecular bone. This is
crucial as surface properties (particularly the surface wettability) may influence the
cement flow. The surrogates must also include a true representation of the rheological
properties of red bone marrow. This is extremely important as such properties
significantly affect the cement flow behaviour [136]. Although there has been data in
the literature that describes the rheological properties of human yellow bone marrow
[157, 159], there is still a need to test the rheological properties of human red bone
marrow (contains stem cells and may have different viscosity) which is found within
the trabecular bone of the vertebral body.
2.2 THREE-DIMENSIONAL BONE SURROGATES
The three-dimensional (3D) bone surrogates were achieved by first developing
computer aided design (CAD) models then manufacturing the physical models
through a suitable rapid prototyping (RP) technique. To mimic prescribed vertebral
trabecular bone, CAD models were developed in SolidWorks (Dassault Systèmes,
Vélizy, France). The models were based on square beams and an open-cell geometry
with a lattice structure [187]. Data from Mosekilde [181] was used to adjust the
dimensions of the geometry and mimic osteoporotic bone. Mosekilde studied age
related morphometric changes in human vertebral trabecular bone and described the
geometrical changes in terms of trabecular thickness and spacing, which were
measured in both horizontal and vertical directions [181]. Figure 2.1 (a) shows the unit
cell of the 3D surrogates and the dimensions associated with normal and osteoporotic
bone conditions. Figure 2.1 (b) illustrates cubic samples of the 3D bone surrogates
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with their respective porosities. It is important to note that a uniform structure was
chosen and the loss of connectivity typically observed in osteoporotic bone was not
simulated to simplify the representation of the bone morphology and facilitate the
manufacturing process.
Figure 2. 1 (a) The unit cell and the dimensions associated with normal and osteoporotic bone
conditions. (b) cubic models with their respective porosities.
The external shape of the 3D bone surrogates was semi-cylindrical (refer to Figure
2.2) with outer dimensions of 40 x 30 x 30 mm (width x depth x height) to better
mimic the overall shape of the vertebral body [21, 186, 188]. The boundary of the
surrogates was 1 mm thick to mimic the cortex of the vertebral body. Openings in the
boundary were applied to mimic blood vessels that breach the vertebral shell and
exchange blood in and out of the vertebral body. Furthermore, 11-gauge insertion
channels were incorporated to allow consistent needle placement during injection.
This was essential to minimize error and ensure that the flow inlet (i.e. needle tip) was
in the same location for all the injections. The needle entry site on the posterior
boundary was 6.0 mm below the superior surface in the craniocaudal direction and
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16.5 mm from the midline along the left and right transverse directions. The
inclination of the insertion channels was 20.0 and 6.0 in the sagittal and transverse
planes, respectively. The location and inclination of the needle insertion channels were
chosen to mimic those of human thoracolumbar pedicles [21, 188].
Figure 2. 2 The boundary of the 3D bone surrogates showing: (a) two identical and symmetrical
elliptical openings 2 mm in height and 1 mm in width applied to mimic breaches due to anterior
blood vessels, (b) one circular opening 3 mm in diameter applied to mimic breaches due to
posterior blood vessels, and (c) the insertion channels that were incorporated to allow consistent
needle placement during injection. The superior and inferior surfaces of the surrogates were kept
open due to manufacturing restrictions. All dimensions are in millimeters.
The size and location of the breaches in the cortex of the vertebral body due to
blood vessels were determined based on in-house microCT scans of five human
thoracic vertebrae. The DICOM stack of each scan was imported into imageJ [189]
and visually inspected slice by slice until a breach (anterior or posterior) in the cortex
of the vertebral body was detected. The number of slices that spanned the breach in
the craniocaudal direction was recorded. The width of the breach was measured on the
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middle slice and the height (h) of the breach was determined through multiplying the
number of slices by the scan resolution. The location of the breach in the craniocaudal
direction was determined based on the total number of slices and the range of slices
that spanned the breach. Table 2.2 summarizes the measurements performed on the
five human thoracic vertebrae to determine the size and location of the breaches and
Figure 2.3 shows the measurements performed on a T6 vertebra to determine the
width of the breaches.
Table 2. 2 Summary of measurements performed on five human thoracic vertebrae to
determine the size and location of breaches in the cortex due to blood vessels. Slice increments are
in the craniocaudal direction.
VertebralLevel ScanResolution(µm) TotalNumberof Slices
Anterior Blood Vessels Posterior Blood VesselsSliceRange h(mm) w(mm) SliceRange h(mm) w(mm)
T1 74 233 65-95 2.2 1.1 100-140 3.0 2.5*
T2 74 232 60-90 2.2 1.4 95-135 3.0 3.4*
T3 74 219 60-85 1.85 1.1 70-120 3.7 2.8
T6 74 253 70-100 2.2 1.3 90-135 3.3 3.2
T8 74 285 90-120 2.2 1.2 120-170 3.7 3.3
* The blood vessel breached the cortex as two separate branches. The value presented is the sum of the
two widths.
The analysis of the data revealed that the blood vessels consistently breached the
posterior cortex of the vertebral body approximately midway along the craniocaudal
and lateral directions, generally as a single vessel but sometimes as two separate
branches. The average height and width of the posterior breaches were 3.3 ± 0.4 and
3.0 ± 0.4 mm, respectively. In the 3D bone surrogates, the posterior breach was
therefore chosen to be circular with a 3 mm diameter, and the location was chosen to
be on the posterior wall midway along the craniocaudal and lateral directions.
Breaches due to the anterior blood vessels were not consistent. Single or multiple
breaches were along the anterior cortex of the vertebral body in the front and/or sides.
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In the craniocaudal direction, the breaches were consistently located approximately
one-third below the superior endplate. The average height and width of the anterior
breaches were 2.1 ± 0.2 and 1.2 ± 0.1 mm, respectively. Two elliptical openings, 2
mm in height and 1 mm in width, were therefore applied to the boundary of the 3D
bone surrogates to simulate beaches due to the anterior blood vessels. The two
openings were located on the anterior boundary one-third below the superior surface
in the craniocaudal direction and one-fifth from the left and right edges along the
transverse direction, respectively.
Figure 2. 3 MicroCT slices of a human thoracic vertebra (T6) showing the measurements
performed to determine the width of the anterior (left) and posterior (right) breaches in the
cortex due to blood vessels. Slice increments are in the craniocaudal direction.
The boundary including the openings and the needle insertion channels (Figure
2.2) were kept constant for all the 3D bone surrogates. However, the structure of the
surrogates was tailored to mimic three skeletal pathologies: osteoporosis (Osteo),
spinal metastasis (Lesion) and multiple myeloma (MM). To achieve the Lesion and
MM surrogates, voids were incorporated into the Osteo structure (refer to Figure 2.1)
to mimic the presence of lytic lesions. One large spherical void, 19.0 mm in diameter,
was incorporated into the Lesion structure and occupied 11% of the total volume of
the surrogate. The size of the void was based on data reported by Ahn et al. [183] and
the location was chosen, breaching the posterior wall, to simulate a worst case
scenario. The size and location of the voids in the MM structure were based on in-
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house microCT scans of six human vertebrae from three donors whose cause of death
was multiple myeloma. The DICOM stack of each scan was imported into imageJ
[189] and visually inspected slice by slice until a structural void was detected within
the vertebral body. The number of slices that spanned the void in the craniocaudal
direction was recorded. The width (w) of the void was measured on the middle slice
along the anteroposteior and lateral directions. The height (h) of the void was
determined through multiplying the number of slices by the scan resolution. Table 2.3
summarizes the measurements performed on the six human thoracolumbar vertebrae
to determine the size and location of lytic lesions within the vertebral body.
Table 2. 3 Summary of measurements performed on human thoracolumbar vertebrae to
determine the size and location of lytic lesions within the vertebral body due to multiple myeloma.
Slice increments are in the craniocaudal direction.
Donor Level ScanResolution(µm) TotalNumberof Slices
Lesion Size Lesion
SliceRange h(mm) w*(mm) Location %vertebravolume
1
T6 74 192 28-75** 3.5 4.5 S, A and C 3.7
L4 74 280
34-87 3.9 7.1 S, P and C
1.9
38-69 2.3 4.2 S, P and L
2
T6 74 182
74-128 4.0 7.3 S, P and L
9.5
88-153 4.8 5.3 S, P and R
L4 74 247 45-174 9.5 15.0 S and C 20.8
3
T6 74 182 86-142 4.1 6.5 I, A and L 3.3
L4 74 455
347-402 4.1 4.2 I, P and C
1.6
393-451 4.1 5.0 I, P and L
* Width (w) presented as the average of measurements along the anteroposteior and lateral directions.
** Three identical, collinear lesions were present (refer to Figure 2.4).
S = Superior, I = Inferior, A = Anterior, P = Posterior, L = Left, R = Right and C = Central
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Figure 2.4 shows microCT scans of human thoracolumbar vertebrae with lytic lesions
present within the vertebral body. There was no clear trend in the size and location of
the lytic lesions among the analyzed microCT scans of the thoracolumbar (T6 and L4)
vertebrae from the three donors.
Figure 2. 4 Examples of lytic lesions that have been detected in microCT scans of human
thoracolumbar vertebrae (T6 and L4) from two donors whose cause of death was multiple
myeloma.
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Most vertebrae had multiple small lesions, on average 4.1 ± 0.9 mm in height and 5.4
± 1.3 mm in width. The L4 vertebra from donor 2 was the only case having one large
lesion 9.5 mm in height and 15.0 mm in width. Three spherical voids, 6.0 mm in
diameter each, were therefore incorporated into the MM structure and occupied 9% of
the total volume of the surrogate. The voids were located 8.0 mm below the superior
surface and were collinear along the anteroposterior direction with one of the voids
breaching the posterior cortex to simulate a worst case scenario.
Figure 2.5 illustrates the developed Osteo, Lesion and MM bone surrogates with a
section-view (left) showing the internal structure of each surrogate and a craniocaudal
view (right) showing the elements incorporated into each surrogate. Table 2.4
describes the elements that were incorporated into each bone surrogate.
Table 2. 4 Details of the location and size of all the elements incorporated into the 3D bone
surrogates. All coordinates are measured with respect to the centre of each element.
Surrogate Element Coordinate Descriptionx y z
Osteo,Lesion andMM
1 0.0 0.0 0.0 Reference point2 20.0 0.0 15.3 Outlet, circular Ø 3.0 mm3 13.5 -20.6 8.0 Inlet, circular Ø 2.1 mm4 8.2 -26.1 9.3 Outlet, elliptical width 1.0 and height 2.0 mm5 31.8 -26.1 9.3 Outlet, elliptical width 1.0 and height 2.0 mm
Lesion 6 14.3 0.0 10.0 Outlet, circular Ø 2.7 mm7 14.3 -8.9 10.0 Spherical void Ø 19.0 mm
MM
6 14.3 0.0 8.0 Outlet, circular Ø 2.6 mm7 14.3 -2.2 8.0 Spherical void Ø 6.0 mm8 14.3 -14.9 8.0 Spherical void Ø 6.0 mm9 14.3 -23.4 8.0 Spherical void Ø 6.0 mm
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Figure 2. 5 The developed 3D bone surrogates. (Left) Section-view of the Osteo, Lesion and
MM surrogates. The white arrows show the needle insertion channels with respect to the lesions.
(Right) Craniocaudal view showing the location of all elements incorporated into each surrogate
(refer to Table 2.4).
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2.2.1 Benchmarking and Manufacturing
Once the models were developed in SolidWorks, they were converted to a special file
format known as stereolithography (STL), which is the de facto standard for the RP
industry. RP is a special class of machine technology that produces physical 3D
models using a layer-by-layer additive approach. RP techniques are most widely
classified according to the initial form of raw material used. Liquid based systems
begin with the build material in the liquid state, which is then converted to a solid state
via a curing process. Powder based systems begin with the build material in granular
form, then an energy source is used to increase the temperature and soften the powder
particles which results in layer-by-layer particle bonding forming a solid. The RP
techniques that have been selected as potential means for manufacturing the proposed
models are summarized in Table 2.5.
Table 2. 5 List of selected RP techniques for manufacturing the 3D bone surrogates.
RP Technique Company HeadquartersHP DesignJet3D Printer Hewlett-Packard California, USAProjet HD 30003D Printer 3D Systems South Carolina, USAVanguard HS HiQSelective Laser Sintering 3D Systems South Carolina, USAEnvisionTEC Prefatory EnvisionTEC GmbH Gladbeck, Germany
The EnvisionTEC Perfactory is a liquid based technique which builds 3D objects
using a projector to cure the liquid resin. Sequential voxel planes are projected into the
liquid resin with each voxel having dimensions as small as 16 × 16 × 15 µm in the
lateral (x), anteroposteior(y) and craniocaudal (z) directions, respectively. Although
this technique has a high manufacturing resolution, the main disadvantages are the
limited material choice (photopolymer), the inherent distortion of the manufactured
object due to the phase change of the liquid resin, and the small build envelope of 80 ×
80 × 120 mm in the x, y and z directions, respectively. The selective laser sintering
(SLS) machine and the 3D printers are powder based techniques. The SLS machine
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uses a laser to heat the powder particles and cause the layer-by-layer particle bonding
which forms the solid. The laser spot size (Ø = 0.7 mm) generally limits the
manufacturing resolution of such techniques. However, the SLS machine has a large
build envelope of 370 × 320 × 445 mm in the x, y and z directions, respectively. The
3D printers, on the other hand, use a binder material (similar to ink-jet printing
technology) to selectively join the powder particles. The resolution of such techniques
is mainly dictated by the material used and the machine’s mechanical components
(screw driven systems tend to have a higher resolution in the x-y plane compared to
belt and pulley systems). When a thermal RP process is employed, such as in the
powder based techniques, the main disadvantage is material shrinkage, which does not
always occur uniformly as areas at high temperatures tend to shrink more than those at
a lower temperatures [190, 191].
Figure 2.6 illustrates the benchmark part developed to obtain an objective view on
the performance of the selected RP techniques and choose the most suitable for
manufacturing the 3D bone surrogates. Table 2.6 summarizes the geometrical features
included in the benchmark part and their purpose.
Table 2. 6 The geometrical features included in the benchmark part and their purpose.
Label Feature Purpose Number and Size
A Square Base Form (base for otherfeatures) Size: 30 x 30 x 5 mmLikely to fit build size of all machines
- Walls Linear accuracy and thinwall build x-direction: 5 and y-direction: 10width: 1, 0.3, 0.2, 0.1 and 0.05 mmz-direction: height 4, 3 and 2 mm
B Slots Linear accuracy andrepeatability x and y-directions: 9width: 0.4, 0.3, 0.2, 0.1 and 0.05 mmspacing : 0.5, 0.4, 0.3, 0.2 and 0.1 mm
C Solid Beams Linear accuracy andrepeatability x-direction: 12 and y-direction: 9square base: 0.06, 0.1, 0.12 and 0.17 mmz-direction : 12square base: 0.15, 0.18, 0.2 and 0.25 mmD SolidCylinders Comparison with solidbeams Same as Solid Beams but with cylindersE CircularHoles Build capability x, y and z-directions: 5diameter: 0.5, 0.4, 0.3, 0.2 and 0.1 mm
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The benchmark part was developed in SolidWorks and adapted to include geometrical
features that were related to our own work [192]. The aim of the benchmark part was
to comparatively test the selected RP techniques in terms of geometrical accuracy and
repeatability in the x, y and z-directions, respectively. A detailed drawing of the
benchmark part is presented in Appendix A.
Figure 2. 6 The benchmark that was used to comparatively test the geometrical accuracy of the
selected RP techniques.
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Qualitative and quantitative assessments were performed once the benchmark part was
manufactured. Visual inspection was used to identify the benchmark part with the best
quality and form. The dimensions of the various benchmark features were quantified
using a profile projector (Model V-16D, Nikon Corporation, Tokyo, Japan) to
determine the RP technique with the highest geometrical accuracy and repeatability
(i.e. build resolution). The benchmark part was placed on the x-y table of the profile
projector (Figure 2.7).
Figure 2. 7 The profile projector used to quantify the dimensions of the benchmark features.
(A) is the 400 mm projection screen with reference lines along the x and y-axes showing the Projet
HD benchmark using a ‘×10’ magnification. (B) is the light source. (C) is the 230 × 170 mm x-y
table where the benchmark part is placed. (D) is the dial that controls the rotation of the table
about the z-axis. The two knobs (E and F) and the wheel (G) control the movement of the table
along the x, y and z-axes, respectively. (H) is the 0.001 mm precision display for movements along
the x and y-axes.
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The height of the table was adjusted using the wheel (G) to ensure that the edges of the
desired features are in focus. The dial (D) was used to adjust the rotation of the table
and ensure that the square base of the benchmark was aligned with the x and y-axes.
The knobs (E and F) were used to move the x-y table and target a particular feature
(i.e. walls, slots, beams, etc.). Once the reference lines on the screen (A) were aligned
with the edge of a feature, the precision display was zeroed and the knobs were used to
move the table until one of the reference lines (along the x or y-axis) reached the
opposite edge of that feature. The value of the precision display was recorded. This
process was repeated for each visible geometrical feature. Three independent
measurements were obtained and the results were presented in terms of the average of
the three measurements and the range of the measurement error. The overall linear
dimensional accuracy of each RP technique was calculated by taking the total average
difference between the measured geometrical dimensions and their respective actual,
true dimensions in SolidWorks.
The benchmark surface finish was assessed using a non-contact profiling system
(Wyko® NT3300™, Veeco, Plainview, New York, USA) to compare the surface
characteristics to that of cortical bone from a dry human femur. The surface texture
analysis was performed on the same 0.9 × 1.9 mm area of each benchmark part
(Figure 2.6 adjacent to label A) using white light interferometry to produce the surface
topographical image of each area. In this technique (Figure 2.8), light from a single
source (i.e. laser or LED) is split into two beams: one goes to an internal reference
mirror and the other goes to the sample. The two beams are then reflected and
recombined inside the interferometer. This causes the beams to undergo constructive
and destructive interference producing patterns of light fringes that represent the
surface topography of the area being tested. The fringes result from the difference in
optical path lengths that the beams travel in the reference and test arms. This process
allows the measurement of a number of different parameters including the ISO 25178
height parameters, which were compared between all the benchmark parts. The height
parameters included in the comparison were: Sa which is the average roughness
evaluated over the complete three-dimensional surface as well as Sp and Sv which are
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evaluated from the absolute highest and lowest points found on the surface. Sp is the
height of the highest point and is referred to as the maximum peak height. Sv is the
depth of the lowest point and is referred to as the maximum valley depth, which is
expressed as a negative number [193, 194].
Figure 2. 8 Mechanism of white light interferometry. Light is divided by a beamsplitter (solid
black rectangle) into two beams: one is reflected from the reference mirror and the other from
the sample. These two beams are then recombined by the beamsplitter and the difference in
optical path lengths that the beams travel in the reference and test arms is captured on the CCD
camera. Adapted from [194].
2.2.2 Morphology Characterization
From the analysis of the manufacturing methods described in section 2.2.1, the bone
surrogates presented in Figure 2.5 were manufactured. MicroCT (µCT 100, Scanco
Medical, Switzerland) was used to assess the variability in the morphology. Eight
osteoporotic type (Osteo) 3D bone surrogates were scanned at a 24.6 µm spatial
resolution (isotropic voxel size) with an integration time of 300 ms, a tube voltage of
70 kV, a tube current of 114 µA and a 0.1 mm aluminum filter. Then, a cylindrical
volume of interest 15 mm in diameter and 15 mm in length was consistently defined at
the center of each specimen. Within this volume of interest, three-dimensional
structural parameters were determined using the following settings: Sigma 1.2,
Support 2.0, Threshold -120 HA mg/ccm (based on Ridler’s method [30]), and the
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software provided by the manufacturer. Only the bone volume fraction (BV/TV) in %,
trabecular thickness (Tb.Th) in mm, and trabecular separation (Tb.Sp) in mm were
compared.
Porosity
The porosity of the Osteo surrogates was obtained from the microCT data (100 -
BV/TV) and cross-validated using Archimedes' suspension method of measuring
volume [195] which was performed using six cubes (2 × 2 × 2 cm3) with the same
structure as the Osteo surrogates. Based on this method (Figure 2.9), a container filled
with purified water was weighed using an electronic balance with an accuracy of ±
0.01 g. Each cube was suspended below the surface of the water and a slight vacuum
was applied for five minutes to ensure all air bubbles were removed.
Figure 2. 9 Schematic representation of Archimedes’ suspension method of measuring volume.
An object is suspended below the surface of the water in a container placed on an electronic
balance. Since the object is stationary, the sum of the forces acting on it is zero. Thus, the
downward force due to gravity (g) is balanced by the upward buoyancy (b) and line tension (t).
Consequently, the immersed object is equivalent to a ‘virtual’ volume of water of exactly the same
size and shape. Adapted from [195].
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The container (with the suspended cube) was weighed again using the electronic
balance and the change in weight was recorded. The volume of each cube was
calculated using V = ∆w ρ⁄ , where ∆w is the change in weight recorded by the
balance and ρ is the density of the water. This allowed measuring the material volume
(Vm) of each cube. A caliper was used to measure the outer dimensions, thus calculate
the total volume (Vt) of each cube. The porosity or void fraction was therefore
calculated using φ = 1 − V୫ V୲⁄ .
Permeability
One of the six cubes (2 × 2 × 2 cm3) that were used for measuring the porosity was
also used to experimentally derive the permeability of the Osteo surrogates using
Darcy’s law [172, 196]. The cube with the same structure as the Osteo surrogates was
fixed at the end of a long (1.0 m) clear rigid tube held vertically (Figure 2.10). A
silicone sealant was used to seal the perimeter of the cube. A valve was used to
continuously fill water into the top end of the tube. The valve flow rate was controlled
to achieve a constant column of water at various heights. Once this was achieved, the
height was recorded and a container was used to collect the water filtering through the
sample. A stopwatch was started as the container was placed under the sample and
stopped as it was removed. The time was recorded and the container was weighed
using an electronic balance with an accuracy of ± 0.01 g. A temperature probe was
used to measure the temperature of the water. This process was repeated three times
for each constant column of water. The time and the weight (i.e. volume) allowed
calculating the flow rate of the water passing though the Osteo structure. The height of
the water column allowed calculating the pressure using the hydrostatic pressure
equation (p = ρ·g·h). The flow rate was then plotted against the pressure and the
permeability was computed using Equations 19 and 20.
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Figure 2. 10 Schematic of the experimental set-up designed to measure the permeability of the
Osteo structure.
Contact Angle
Contact angle measurements were performed on the material used to manufacture the
3D bone surrogates to compare the surface wettability to that of cortical bone from a
dry human femur and a fresh ovine vertebra. Static contact angle analysis (FTA 4000,
First Ten Angstroms, Virginia, USA) was performed on each sample in six locations.
For the 3D bone surrogates, samples were obtained from four different manufacturing
time points (total of 24 measurements). Each sample was placed on a round stage,
approximately 100 mm in diameter, and rotated under a dispense tip. A drop of water
was dispensed onto the surface of the samples. An analytical microscope with a
horizontal field of view ranging from 2 mm down to 200 µm was used to allow lateral
visualization of the water droplet on the surface of the samples (Figure 2.11). As the
water droplet touched the surface, the image was captured and analyzed using
proprietary software (FTA32, First Ten Angstroms, Virginia, USA). The results were
assessed using Kruskal-Wallis one-way analysis of variance by ranks (α = 0.05). 
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Figure 2. 11 Contact angle measurement performed on the surface of the material used to
manufacture the 3D bone surrogates showing the dispense tip (A) through which the water drop
(B) is dispensed onto the surface of the material (C).
2.3 2D FLOW MODELS
Flow models represent an alternative simulated environment to quickly and effectively
study the flow behaviour of different bone cement formulations. Although they only
allow fluid flow in one plane, the flow models have a key advantage over 3D bone
surrogates in terms of monitoring the cement flow during the injection, which is
performed using a camera instead of a fluoroscope. This simplifies the experimental
set-up and avoids exposure to x-rays.
Flow models were developed to represent a cross-section of the vertebral body.
Each model was placed in a specimen holder (Removable Cage Plate, Thorlabs, New
Jersey, USA) with its pattern facing up. A circular glass window (Ø= 50 mm) was
placed on top of the model and a threaded ring was used to press the window against
the model creating a tight seal (Figure 2.12). The trabeculae were represented as a
series of solid columns (Ø= 0.25 mm; h= 0.5 mm) with a 1 mm intercolumnar spacing
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to simulate the trabecular separation that has been reported for human vertebral
osteoporotic bone [31, 33]. The injection inlet (Ø= 2.4 mm) was chosen to simulate
the inner diameter of 11-gauge needles. The external shape was circular with a solid
boundary to mimic the vertebral shell. A single flow exit point (Ø= 2.5 mm) was
applied at the outer boundary to simulate a breach through the cortex due to a fracture
or a blood vessel exchanging blood in and out of the vertebral body.
Figure 2. 12 Section-view of the specimen holder showing the threadeding (A) into which an
aluminum ring is screwed to press the glass window (B) against the flow model (C) which is
placed on the surface of an aluminum cylinder (D) with its pattern facing up. (E) shows the
injection inlet and (F) shows the flow exit point. Fluid injections are performed using a luer-lok
syringe which is attached to the threaded hole (G) via a female luer to 1/4-28 UNF adapter. The
call-out shows a lateral view of the actual structure as visualized using a profile projector.
The structure of the flow models (Figure 2.13) was tailored to mimic three
different skeletal conditions: osteoporosis (Osteo), spinal metastasis (Lesion) and
vertebral fracture (Fracture). For the Osteo models, the solid columns representing the
82
trabeculae were uniformly distributed in a grid pattern. The thickness and spacing of
the columns were chosen to yield a nominal porosity of 95.1%. To achieve the Lesion
and Fracture models, voids were incorporated into the Osteo structure. The Lesion
model included one large circular void, 19.0 mm in diameter, breaching the outer
boundary at the flow exit point. The size and position of the void were chosen to
simulate a cross-section of the developed 3D Lesion surrogates (Figure 2.5).
Conversely, the fracture model included a horizontal cylindrical void, 2.5 mm wide,
along the flow exit point. The void in this model was chosen to study and highlight the
effect of a fracture plane (breaching the cortex) on the flow behaviour.
Figure 2. 13 The developed 2D flow models with 1 mm channel spacing, 0.25 mm column
thickness, 50 mm outer diameter and a solid boundary representing the vertebral shell.
The 2D flow models were first designed in a graphic suite (CorelDRAW, Corel
Corporation, Ontario, Canada) then manufactured via flexography (AFP-SH/DSH,
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Asahi Photoproducts Europe, Brussels, Belgium), a technology used extensively
within the print industry where a high degree of reproducibility is required. Once the
models were manufactured, inter- and intra-variability in the model geometry was
assessed. Left and right cuts were consistently performed through the sagittal plane
close to the centre of three osteoporosis type models. A profile projector (Model V-
16D, Nikon Corporation, Tokyo, Japan) was used to visualize the cuts from a lateral
perspective and test the geometrical variations in terms of valley-to-valley (Dvv) and
edge-to-edge (Dee) distances as well as the total height (h) of the profiles (Figure
2.14). The profile projector was also used to measure the porosity of the flow models.
Furthermore, static contact angle analysis (FTA 4000, First Ten Angstroms, Virginia,
USA) was performed on two samples obtained from different manufacturing time
points, each in six locations (12 measurements), to compare the surface wettability to
that of cortical bone from a dry human femur and a fresh ovine vertebra.
Figure 2. 14 Lateral profile of a cut through the sagittal plane of a flow model showing the
measurements performed to test the geometrical variations in terms of the valley-to-valley (Dvv)
and edged-to-edge (Dee) distances as well as the total height (h).
2.4 BONE MARROW SUBSTITUTE
The developed bone surrogates were filled with bone marrow substitute to simulate
the rheological environment of the vertebral body in terms of bone marrow present
within the bony channels. An aqueous solution of carboxymethyl cellulose (Mw
~250,000 - Sodium carboxymethyl cellulose, Sigma-Aldrich, MO, USA) 2.5% w/w
was used as the bone marrow substitute with a nominal viscosity of 0.4 Pa·s which has
been reported for red bovine marrow [156]. An additional formulation for the marrow
substitute was also tested to assess its effect on the injection behaviour. This marrow
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substitute formulation was prepared using an aqueous solution of carboxymethyl
cellulose 1.25% w/w to reach a nominal viscosity of 0.06 Pa·s which has been
reported for human blood [160]. The viscosity of the marrow substitutes was verified
using a rheometer (Section 2.8).
2.5 CEMENT PREPARATION
Four brands of commercially available acrylic bone cements were comparatively
tested (Table 2.7): Opacity+ (OC, Teknimed S.A.S, Bigorre, France), Osteopal V (OP,
Heraeus Medical GmbH, Hanau, Germany), Parallax (PL, ArthroCare Corporation,
Austin, TX, USA), and Simplex P (SP, Stryker Corporation, Kalamazoo, MI, USA).
Table 2. 7 Bone cement compositions and liquid/powder (L/P) ratios. A modified formulation
was used for Simplex P and two L/P ratios were tested for comparison (SP1:2 and SP1:1).
Composition Opacity+ Osteopal V Parallax Simplex P(Regular) Simplex P(Modified)
Liquid(v/v %)
Methyl methacrylate 99.0 92.0 99.0 97.5 97.5N,N-dimethyl-p-toluidine(DMPT) 1.00 2.00 1.00 2.50 2.50Other additives a - 6.00 - - -
Powder(w/w %)
Poly(methylmethacrylate) 49.5 - - 15.0 13.5Poly(methyl acrylate-co-methyl methacrylate) - 54.6 - - -Poly(methylmethacrylate-co-styrene) - - 69.9 73.7 66.4Zirconium dioxide (ZrO2) 45.0 45.0 - - -Barium sulphate (BaSO4) - - 29.4 10.0 19.0Hydroxyapatite (HA) 5.00 - - - -Benzoyl peroxide (BPO) 0.50 0.40 0.70 1.30 1.10L/P 1/2.7 1/2.6 1/2.4 - 1/2 b 1/1 c
a Usually hydroquinone is added as monomer stabilizer in concentrations on the order of ppm.
b SP1:2 prepared using 10 g of the modified Simplex P powder + 5 mL of liquid
c SP1:1 prepared using 10 g of the modified Simplex P powder + 10 mL of liquid
All the selected cements, except for Simplex P, are specifically formulated with a high
radiopacifier concentration for use in PVP. However, commercially available brands
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used in cemented arthroplasties (mainly Simplex P) have been used in PVP with an
extra amount of radiopacifier added by the surgeon to bring the concentration to 20–
30% w/w of the powder and increase the radiopacity of the cement [90, 151]. For this
reason, a modified formulation for Simplex P was also used in this study. Each batch
of cement was prepared according to the liquid-to-powder (L/P) ratio recommended
by the manufacturer. For Simplex P, an additional L/P ratio (SP1:1) was also tested to
assess its effect on the injection behaviour [122]. All powders were weighed in vials
with an accuracy of ± 0.01 g and all liquids were measured using micropipettes with
an accuracy of ± 2 μL. The timer on a stopwatch was started as the liquid monomer 
was added to the powder. Subsequently, the vial was capped and vigorously shaken
for 30 s to uniformly distribute the liquid monomer throughout the powder. A metal
spatula was then used to further mix the components for another 30 s ensuring no dry
powder areas were visible in the vial. The times for which the cements were mixed
and handled are summarized in Table 2.8. A standard protocol was adopted in all the
experiments and involved mixing the cement for 1 min (shaking and stirring) then
allowing the mixing vial to rest on its side for 1.5 min before the cement was
transferred into a luer-lok syringe.
Table 2. 8 Procedure times from the addition of the liquid to the powder.
Brand Notation Mixing time (min) Waiting time (min) b Maximum applicationtime (min)Protocol A Protocol B Protocol A Protocol B Protocol A Protocol B
Opacity + OC 1.0 1.0 4.0 3.0 8.0 12.5Osteopal V OP 1.0 0.5 4.0 2.5 8.0 8.0Parallax PL 1.0 1.0 4.0 3.0 8.0 12.0
Simplex P SP1:2 1.0 1.0 a 4.0 - 8.0 10.0SP1:1 1.0 1.0 a 4.0 - 8.0 10.0
Protocol A was standardized for all the materials.
Protocol B is recommended by the manufacturer for a temperature of 20°C and is included for comparison.
a Mixing time is recommended as a range between 1 and 2.5 minutes.
b Waiting time is the total time after mixing prior to cement application, including the time the cement is in the syringe.
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Due to its known contribution to the flow behaviour [140], the morphology of the
powder components was assessed through Scanning Electron Microscopy (SEM). The
specimens were sputter-coated with palladium prior to image acquisition. The images
were acquired on a LEO 1550/EVO MA15 (Carl Zeiss AG, Oberkochen, Germany)
microscope, operated at an acceleration voltage of 2 kV with a secondary electron
detector to achieve topographic contrast.
2.6 SILICONE OIL
As acrylic bone cements are chemically complex, multi-component and significantly
non-Newtonian with their viscosity having differing degrees of time and shear-rate
dependency, Newtonian fluids 10 and 60 Pa·s silicone oil (200® Fluid, Dow Corning
Corp, Michigan, USA) were tested to compare their effect on the injection behaviour.
The silicone oils were mixed with 20% v/v Lipiodol (Guerbet, Villepinte, France),
which is an oil-soluble radiopacifier, to allow their visualization under fluoroscopy. A
high concentration was chosen to ensure that the oil was saturated with the Lipiodol.
The viscosity of the silicone oil was verified using rheology to ensure Newtonian fluid
behaviour after the addition of the Lipiodol (Section 2.8).
2.7 TESTING PROTOCOL
This section details the methods that were developed to allow fluid injections into the
bone surrogates under a controlled environment through measuring the injection
pressure and flow rate as well as monitoring the flow distribution. Two experimental
testing rigs were developed to allow the injections to be performed under displacement
control achieving a constant flow rate. One system uses a syringe pump, while the
other uses a materials testing machine to control the displacement of the syringe
plunger and achieve a constant injection flow rate. For the 3D bone surrogates, a
fluoroscope was used to monitor the flow distribution. However, the 2D flow models
have a key advantage over the currently developed and previously used 3D bone
surrogates in terms of monitoring the flow distribution during the injection, which is
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performed using a camera instead of a fluoroscope. This simplifies the experimental
set-up and avoids exposure to x-rays.
2.7.1 3D Bone Surrogate Injections
This section details the methods that were designed to allow injections into the 3D
bone surrogates under a controlled environment. The schematic of the experimental
set-up is presented in Figure 2.15.
Figure 2. 15 Schematic of the experimental set-up designed for use with the developed 3D bone
surrogates. The main components include a syringe pump, a load cell, an LVDT, a 10mL luer-lok
syringe, a gauge 12 needle, a specimen holder, and a fluoroscope. A personal computer running
LabVIEW software was used to allow data acquisition.
The syringe pump (Nexus 6000, Chemyx, Texas, USA) was used to control the
displacement of the syringe plunger and achieve a constant injection flow rate. This is
a high pressure, screw-driven syringe pump with a 0.05 µm step resolution and is
capable of delivering up to 2.2 KN of linear force. The LVDT (LDC2000A, RDP
Electronics Ltd, Wolverhampton, UK) was used to determine the displacement of the
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syringe plunger and obtain a second, independent measure of flow rate. The
displacement measurements were calculated based on previously determined
calibration curves (Appendix B). The load cell (Model 31, Honeywell-Sensotec,
Minneapolis, USA) was used to measure the force (N) applied on the syringe plunger,
thus calculate the pressure (MPa) in the system. The force measurements were also
calculated based on previously determined calibration curves (Appendix B). A
photograph of the actual set-up (without the fluoroscope) is presented in Figure 2.16.
Figure 2. 16 Photograph of the experimental set-up designed for use with the developed 3D bone
surrogates showing: (A) the specimen holder with (B) the 3D bone surrogate, (C) the 12 gauge
needle, (D) the 10 mL luer-lok syringe with (E) a custom built plastic plunger (Delrin®, DuPont,
Delaware, USA), (F) the syringe pump, (G) the load cell and (H) the LVDT.
A fluoroscope (BV-25, Philips, Eindhoven, Netherlands) was used to radiographically
monitor the injection, while a specimen holder attached to a tripod was designed to
keep the 3D bone surrogates at the same height with respect to the fluoroscope and
ensure that the top plane of the surrogates was parallel to the plane of the fluoroscope
(Figure 2.17). The video data from the fluoroscope was captured using Debut software
(NCH Software, Canberra, Australia). All data was acquired at a sampling frequency
of 25 Hz.
LabVIEW software (2010 SP1, National Instruments, Texas, USA) was used
control the syringe pump through serial communication. A custom LabVIEW code
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(refer to Appendix C) was developed to allow starting and stopping the pump as well
as setting the injected volume and flow rate. LabVIEW software was also used to
acquire the load cell and LVDT data. The signals from both transducers were pre-
conditioned using appropriate amplifiers (RDP Electronics Ltd, Wolverhampton) then
acquired using a data acquisition system (cRIO-9074 chassis, National Instruments,
Newbury, UK).
Figure 2. 17 Schematic showing the height of the specimen holder that was standardized for all
injections performed using the 3D bone surrogates.
A custom LabVIEW code (refer to Appendix C) was developed to allow real-time
reading of the signals at a pre-defined sampling frequency (25 Hz) and logging of the
data into a spread sheet. The architecture of the program was based on the
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Producer/Consumer design. In this design, the signal is acquired in the producer loop
then streamed using a data queue to the consumer loop, where it is handled based on
the state machine algorithm. The state machine divides the handling algorithm into
simple tasks (i.e. data plotting, calibration, logging, etc.), which execute depending on
the pre-determined conditions. The data acquisition was tested and validated to ensure
that the LVDT and load cell data were synchronized and simultaneously saved into a
spread sheet.
Fluid Injection
As the superior and inferior surfaces of the 3D bone surrogates were kept open due to
manufacturing restrictions, silicone rubber sheets were placed on these surfaces, then
superior and inferior plates (Delrin®, DuPont, Delaware, USA) were used to push the
rubber sheets against the surrogates creating a tight seal (Figure 2.18).
Figure 2. 18 3D surrogate ready for injection with the plates used to push the silicone rubber
sheets against the superior and inferior surfaces (blue lines) of the surrogates creating a tight seal.
The injections were consistently performed through the left insertion channel (L), while the entry
point of the right insertion channel (R) was closed off on the outer surface of the boundary.
A standardized protocol was used to fill the surrogates with the bone marrow
substitute. A high strength adhesive tape was used to seal all openings incorporated
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into the boundary of the surrogates (Figure 2.2). The surrogates were then placed on
top of the inferior plate and submerged in a container filled with the marrow
substitute. The container was vacuumed for five minutes to ensure all air bubbles were
removed. While the surrogates were still in the container, the superior plate was placed
on top of the surrogates and nylon screws (Nylon 6.6 M6×50, Premier Farnell plc,
London, United Kingdom) were used to fasten the superior and inferior plates pushing
the silicone rubber sheets against the surrogates, thus creating a tight seal and
confining the marrow substitute within the surrogates
Following this, the adhesive tape was removed from all openings except the one
used to seal the entry point of the right needle insertion channel. The surrogates were
then placed into the experimental set-up (Figures 2.15 and 2.17) and 5 mL of
Newtonian fluid 10 and 60 Pa·s silicone oil as well as Simplex P (SP1:1, Table 2.7)
bone cement were separately injected into each bone surrogate (Osteo, Lesion and
MM) at a constant flow rate of 3 mL/min. This process was repeated three times. The
injections were performed using a 10 mL luer-lok syringe (Becton Dickinson, New
Jersey, USA) with a 12-gauge needle (Blunt SS 12-gauge × 4 inch, W. W. Grainger
Inc, Illinois, USA). For the Simplex P bone cement, two injection time points (4 and 8
min from the addition of the liquid to the powder) were tested to assess the effect on
the flow behaviour. The same syringe, needle and cement were used to perform the
two injection time points into separate surrogates. All the injections were performed at
room temperature (21.5±0.1ºC) using a unilateral approach. The needles were
consistently placed through the left insertion channel, while the entry point on the
outside of the right insertion channel (i.e. outer surface of the surrogate boundary)
remained closed off to prevent any fluid from escaping through the cortex. The error
in the needle placement within the 3D bone surrogates was quantified through
measuring the needle length (d) from the posterior wall and the needle angle (α) 
relative to the posterior wall (Figure 2.19).
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Figure 2. 19 Measurements performed to quantify the error in the needle placement within the
3D surrogates.
Data Analysis
The data acquired from the LVDT and the load cell was analyzed for the duration of
the injection. The LVDT data was used to confirm that the injection flow rate was
constant at 3 mL/min. The displacement of the syringe plunger was plotted against
time and the slope (mm/s) was multiplied by the cross-sectional area of the syringe
(mm2) to determine the injection flow rate. The load cell data was used to calculate the
pressure drop in the system with respect to time. The measured force (N) applied on
the syringe plunger was divided by the cross-sectional area of the syringe (mm2) to
determine the pressure drop in the system (MPa). As the load cell was used to measure
the force applied on the syringe plunger, the calculated pressure drop was the sum of
two pressures: 1) Pn, the pressure required to inject the fluid through the needle and
2) Ps, the pressure required to inject the fluid into the structure of the bone
surrogates. For this reason, injections were also performed without the surrogates to
determine the pressure drop across the needle (Pn). This was then subtracted from the
calculated pressure drop in the system to determine the pressure drop (Ps) at the inlet,
which is required to inject the fluid into the structure of the bone surrogates.
To quantitatively describe the resulting flow patterns, the video data from the
fluoroscope was analyzed in Matlab (R2009b, MathWorks, Massachusetts, USA). A
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custom Matlab script (refer to Appendix D) was developed to allow automated
segmentation of the flow distribution by subtracting the first frame of the video
sequence, which shows the surrogates with no fluid injected, from the remaining
frames. Two parameters were measured: (1) the time and type of leakage (i.e. anterior
or posterior) which was obtained directly from the captured video sequences, and (2)
the mean spreading distance (MSD) in the filled region of the surrogates measured on
the superior view of the fluoroscopy projection. The segmented image of the flow
distribution was imported into imageJ [189] and the ‘Analyze Particles’ function was
used to calculate the maximum and minimum Feret diameters, which are the longest
and shortest distances, respectively, along the geometric center of the flow contour,
also referred to as the caliper diameters. MSD in pixels was then calculated by taking
the mean of the two distances and converted to millimeters using a conversion factor
(refer to Fluoroscopy Error Quantification and Correction).
The cement injections were microCT scanned post-augmentation at a spatial
resolution of 73.6 µm (isotropic voxel size) with an integration time of 300 ms, a tube
voltage of 70 kV, a tube current of 114 µA and a 0.5 mm aluminum filter. The
DICOM stack of each scan was processed in imageJ [189] to obtain the final shape of
the cement bolus and measure its sphericity (Eq. 37), which is defined as the surface
area of a sphere enclosing the same volume (V) as the 3D object, divided by the
surface area (A) of the 3D object. A perfect sphere has a sphericity of one and the
value is below one for non-spherical objects [197].
Sphericity =
√ଷ଺గ௏మ
య
஺
(37)
Two functions within the BoneJ plug-in for imageJ were used to calculate the
sphericity: (1) the ‘Volume Fraction’ function, which was used to obtain the volume
of the cement bolus, and (2) the ‘Isosurface’ function, which was used to obtain the
surface area of the cement bolus. These functions were validated on a sphere (Figure
2.20) that was designed in SolidWorks then converted using a Matlab script into a
DICOM stack with a spatial resolution of 70 µm (isotropic voxel size) to match that of
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the microCT scans of the cements post-augmentation. The DICOM stack was then
processed in imageJ to obtain the sphericity.
Figure 2. 20 (a) The sphere designed in SolidWorks then (b) processed in imageJ to obtain its
sphericity. (c) The processed image of a cement bolus post-injection included for comparison.
Statistical Analysis
All data were presented as mean ± standard deviation. The influence of the viscosity
and the structure on the measured parameters was evaluated using the Mann–Whitney
U and the Kruskal-Wallis one-way analysis of variance with a significance level set at
α = 0.05. All statistical analyses were performed in SPSS version 21 (SPSS Inc, 
Illinois, USA).
Experimental/Computational Cross-validation
The work described in this section was completed by R. P. Widmer as part of the
collaboration that was formed with the ETH, Zürich to cross-validate our experimental
data with their computational code for simulating the displacement of bone marrow by
bone cement in porous media [135, 198]. The developed CAD model of each bone
surrogate was converted into a continuum scale finite element (FE) model. The
computer simulation was set up with the same boundary conditions as in the
experiments. Then, the flow behaviour of 60 Pa·s silicone oil as well as Simplex P
bone cement was simulated in each bone surrogate for an injected volume of 5 mL at a
flow rate of 3 mL/min. The marrow substitute (aqueous solution of carboxymethyl
cellulose 2.5% w/w) and the silicone oil formulation (oil + 20% v/v Lipiodol) that
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were used in the experiments were modeled in the simulation based on viscosity
measurements performed in this thesis (Section 2.8). The Simplex P formulation
(SP1:1, Table 2.7) was modeled in the simulation for injections performed at 4 min
after cement mixing (i.e. from the addition of the liquid to the powder), while the
viscosity was modeled based on previously published rheological tests [198]. A
flowchart of the cross-validation study is presented in Figure 2.24.
Figure 2. 21 Flow chart of the experimental / computational cross-validation study. The work
completed in this thesis is shown in blue while that completed by R. P. Widmer is presented in
red.
Fluoroscopy Error Quantification and Correction
Five glass beads, 2.5 mm in diameter, were inserted into each of the superior and
inferior plates of the 3D bone surrogates (Figure 2.21). Prior to insertion, the bead
diameters were measured using a caliper (Table 2.9). In the plane closest to the top
surface of the 3D surrogates, one bead was inserted at the centre of the superior plate
and four beads, labelled 1 to 4, were inserted at the vertices of a 1 cm square, which
was concentric with the plate. In the plane closest to the bottom surface of the 3D
surrogates, one bead was inserted at the centre of the inferior plate and four beads,
labelled 6 to 9, were inserted at the vertices of a 2 cm square, which was also
concentric with the plate. To ensure that the beads inserted in both plates were
concentric and formed a prism, the sides made up of beads 1 – 3 and 6 – 8 were
centered with respect to screw A (Figure 2.21).
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Figure 2. 22 The beads inserted into the superior and inferior plates of the 3D bone surrogates.
Once the beads were inserted into each plate, a profile projector (Nikon Profile
Projector, Nikon Corporation, Tokyo, Japan) was used to measure the perpendicular
distances between adjacent beads within a plate. This included the distances between
beads 1 – 2, 2 – 4, 3 – 4, and 1 – 3 within the superior plate and the distances between
beads 6 – 7, 7 – 9, 8 – 9, and 6 – 8 within the inferior plate (Table 2.10).
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Table 2. 9 The bead diameters measured using a caliper and the corresponding diameters of
the bead projections with their associated scaling factors.
Plate Bead Caliper Diameter(mm)
Projection Diameter
(px)
Scaling Factor
(mm/px)
Top
1 2.49 10.77 0.231
2 2.60 11.18 0.233
3 2.48 10.77 0.230
4 2.61 11.705 0.223
Bottom
6 2.58 12.083 0.214
7 2.49 11.705 0.213
8 2.88 14.318 0.201
9 2.58 12.649 0.204
Table 2. 10 The nominal and projected distances between adjacent beads within a plate and the
error associated with the measured distances.
Plate Beads Nominal Distance (mm)
Projected Distance
% Error
(px) (mm)
Top
1 – 2 9.955 44.851 9.802 1.54
2 – 4 9.680 46.533 10.170 5.06
3 – 4 9.797 45.641 9.975 1.81
1 – 3 10.019 45.982 10.049 0.30
Bottom
6 – 7 19.819 95.090 20.782 4.86
7 – 9 20.347 101.557 21.647 10.48
8 – 9 19.898 95.067 22.195 9.08
6 – 8 19.594 99.049 20.777 4.42
The fixed height (h) between the superior and inferior planes in which the beads were
inserted was measured using a caliper. Three measurements (h1 to h3) were performed
to obtain the average height (h), which was 32.32 ± 0.23 mm. Subsequently, the
98
nominal angle (α) was analytically calculated (Figure 2.22) on each of the four 
surfaces of the prism: the sides consisting of beads 3 – 4 and 8 – 9 were used to
calculate α1, the sides consisting of beads 1 – 2 and 6 – 7 were used to calculate α2, the
sides consisting of beads 1 – 3 and 6 – 8 were used to calculate α3, and the sides
consisting of beads 2 – 4 and 7 – 9 were used to calculate α4. The average nominal
angle was α = 81.2 ± 0.4º. 
Figure 2. 23 Analytical calculation of angle α. 
The specimen was then placed into the experimental set-up (Figure 2.17) and an x-ray
was taken to obtain a projection of the beads (Figure 2.23). Image processing was
performed using a custom Matlab script (Appendix D), which was developed to
correct the inherent pincushion distortion and export the binary image of the beads.
This image of the beads was imported into ImageJ [189] to measure the bead centroids
and diameters using the ‘Analyze Particles’ function. The bead centroids were used to
measure the perpendicular distances (in pixels) between adjacent beads within the
fluoroscopy projection (Table 2.10). The bead diameters (Table 2.9) were used to
obtain the corresponding scaling factors which allow converting the distances from
pixels (px) to millimeters (mm). An average scaling factor of 0.219 mm/px was
applied to convert the distances within the fluoroscopy projection to millimeters and
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calculate the error associated with the measured distances by comparing the nominal
distances between adjacent beads within a plate to their corresponding distances
within the fluoroscopy projection (Table 2.10). The overall average error between the
nominal and projected distances was 4.7 ± 3.6 %.
Figure 2. 24 Original and post-processed images showing the projection of the beads inserted
into each of the superior and inferior plates of the 3D bone surrogates.
Considering that the height (h) between the superior and inferior planes in which the
beads were inserted was fixed at 32.32 mm and knowing the perpendicular distances
(in mm) between adjacent beads within the fluoroscopy projection, the analytical
calculations of the angles were repeated. The average projected angle was α΄ = 81.4 ± 
0.5º. This shows that the nominal and projected angles are very similar with an
average difference of 0.21º.
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2.7.2 2D Flow Model Injections
This section details the methods that were designed to allow injections into the 2D
flow models under a controlled environment. The experimental set-up is presented in
Figure 2.25.
Figure 2. 25 Schematic drawing of the experimental set-up designed for use with the developed
2D flow models. The call-out shows the main components which include: (A) a load cell attached
to the crosshead of a material testing machine, (B) a 3 mL syringe, (C) a specimen holder placed
on the top plate of the frame, (D) an LED light source, and (E) a camera with a high resolution
lens. A personal computer running LabVIEW software was used to allow data acquisition.
The material testing machine (Instron 3369, Instron Corp, Massachusetts, USA) was
used to control the displacement of the syringe plunger and achieve a constant flow
rate by keeping the testing machine’s crosshead speed constant. The loading profile
was customized to maintain a constant displacement of the syringe plunger and output
the displacement of the crosshead, which allowed measuring the flow rate. The load
cell (Model 31, Honeywell-Sensotec, Minneapolis, USA) was instrumented into the
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crosshead to measure the force (N) applied on the syringe plunger, thus calculate the
pressure (MPa) in the system. The frame was designed to keep the specimen holder
above the camera and parallel to the crosshead actuator, while allowing the syringe
plunger to be centered with respect to the load cell to ensure a uni-axial load was
applied along the plunger. A custom-built stainless steel syringe plunger was used to
withstand the loads applied on it without bending or breaking. A syringe adapter
(Figure 2.26) was used to reinforce the syringe and prevent it from bending or failing
at its attachment with the specimen holder through the threaded hole (G) using a
female luer to 1/4-28 UNF connector.
Figure 2. 26 The syringe adapter used to reinforce the syringe and prevent it from bending or
failing at its attachment with the specimen holder through the threaded hole (G) using a female
luer to 1/4-28 UNF connector. (F) shows the flow exit point.
The camera (1000m Series, Adimec, Eindhoven, the Netherlands) together with a high
resolution fixed focal length lens (25mm FL, Edmond Optics Ltd, York, UK) and an
LED light source (White LED Ring Light, Edmond Optics Ltd, York, UK) were used
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to monitor the flow distribution during the injection. LabVIEW software was used to
acquire the video and load cell data. A custom LabVIEW code (Appendix C) was
developed to allow real-time reading of the signals at a pre-defined sampling
frequency of 10 Hz and simultaneous logging of the data into two separate files. The
data acquisition was tested and validated to ensure that the load cell and video data
were synchronized and saved simultaneously such that the number of load cell data
points corresponds to the number of video frames.
Specimen Preparation
Each flow model (Osteo, Lesion and Fracture) was placed in the specimen holder
(Figure 2.27).
Figure 2. 27 The specimen holder showing (A) the threadeding into which an aluminum ring is
screwed to press (B) the glass window against (C) the flow model which is placed on the surface of
(D) an aluminum cylinder with its pattern facing up. (E) is the injection inlet and (F) is the flow
exit point. Fluid injections are performed using a luer-lok syringe attached to the threaded hole
(G) via a female luer to 1/4-28 UNF connector.
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A syringe containing the marrow substitute was screwed into the corresponding
threaded hole of the specimen holder (G) and manually injected until the entire flow
model was filled. This simulates the rheological environment of the vertebral body in
terms of bone marrow present within the bony channels. Once the marrow substitute
was injected, the syringe was removed and the threaded hole (G) was further filled
with the marrow substitute to prevent air bubbles within the flow system. Following
this, a 3mL syringe (Becton Dickinson, New Jersey, USA) containing the injection
fluid (bone cement or silicone oil) was screwed into the same threaded hole (G) and
both the syringe and the specimen holder were placed into the experimental set-up
(Figure 2.25) on the top plate of the frame, ensuring that the superior surface of the
specimen holder was in direct contact with the superior surface of the plate (Figure
2.28).
Figure 2. 28 The top plate of the frame used to keep the specimen holder of the 2D flow models
locked in the same position above the camera and parallel to the ground. (E) shows the injection
inlet and (F) shows the flow exit point. Fluid injections are performed using a luer-lok syringe
which is attached to the threaded hole (G) via a female luer to 1/4-28 UNF connector.
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The pins (solid blue cylinder) on the superior surface of the plate were used to ensure
that the specimen holder was consistently locked in the same position with respect to
the camera.
Oil Injections
Newtonian fluid 10 and 60 Pa·s silicone oil (Si 10Pas and Si 60Pas, respectively) were
comparatively tested. The flow models were filled with 0.4 Pa·s marrow substitute
(M0.4) formulated using an aqueous solution of carboxymethyl cellulose 2.5% w/w.
Subsequently, a maximum volume of 1 mL of oil was injected into each model under
two constant flow rates, 1 and 3 mL/min, to assess the effect on the injection
behaviour. The injections were stopped when the oil had reached the boundary of the
models. Furthermore, to assess the effect of marrow viscosity on the injection
behaviour, the flow models were filled with 0.06 Pa·s marrow substitute (M0.06)
formulated using an aqueous solution of carboxymethyl cellulose 1.25% w/w, and 10
Pa·s silicone oil was injected into each flow model under a constant flow rate of 1
mL/min. All injections were performed at room temperature (19.0 ± 1.4ºC) into
separate models. This process was repeated three times.
Cement Injections
All the cement formulations (OC, OP, PL, SP1:1 and SP1:2) in Table 2.7 were
comparatively tested. The flow models were filled with 0.4 Pa·s marrow substitute
formulated using an aqueous solution of carboxymethyl cellulose 2.5% w/w.
Subsequently, a maximum volume of 1 mL of cement was injected into each model.
The injections were performed at a constant flow rate of 3 mL/min and stopped when
the cement had reached the boundary of the models. The same 3 mL syringe was used
to test the effect of three different injection time points (4, 6, and 8 min from the
addition of the liquid to the powder) on the flow behaviour. All injections were
performed at room temperature (19.0 ± 1.4ºC) into separate models. This process was
repeated three times.
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Data Analysis
The displacement of the testing machine’s crosshead was plotted against time and the
slope (mm/s) was multiplied by the cross-sectional area of the syringe (mm2) to
determine the injection flow rate. The load cell and video data were analyzed for the
duration of the injection. The load cell data was used to calculate the pressure drop in
the system with respect to time. The measured force (N) applied on the syringe
plunger was divided by the cross-sectional area of the syringe (mm2) to determine the
pressure drop in the system (MPa). In order to quantitatively describe the resulting
flow patterns, the video data was analyzed in Matlab. A custom Matlab script
(Appendix D) was developed to allow automated segmentation of the flow distribution
by subtracting the first frame of the video sequence, which shows the flow models
with no fluid injected, from the remaining frames. The following parameters were
calculated when the injection fluid (bone cement or silicone oil) had reached the
boundary of the flow models: i) the time to reach the boundary, which is determined
directly from the video sequences, ii) the filled area, which is a measure of the number
of pixels in the segmented region converted to squared-millimeters (mm2) using a
conversion factor then presented as a percent of the total area on the basis of a flow
model with an inner diameter of 40 mm, and (iii) the roundness (Eq. 38), which is a
shape descriptor most sensitive to elongation, calculated by comparing the area As of a
shape S to the maximum caliper diameter Ls of that shape measured for all
orientations [199]. A perfect circular pattern has a roundness of one, whereas the value
approaches zero for increasingly elongated contours.
roundness =
ସ୅౩
஠୐౩
మ (38)
Statistical Analysis
All data were presented as mean ± standard deviation. The influence of the model
structure (Osteo, Lesion and Fracture), the cement formulation (OC, OP, PL, SP1:2
and SP1:1), and the injection time point (4, 6 and 8 min) on the peak pressure, the time
to reach the boundary, the filled area, and the roundness was evaluated using a
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multivariate general linear model (GLM) with a significance level set at α = 0.05. The 
influence of the model structure (Osteo, Lesion and Fracture), the oil-marrow
combination (Si10-M0.4, Si60-M0.4 and Si10-M0.06), and the injection flow rate (1
and 3 mL/min) on the peak pressure, the time to reach the boundary, the filled area,
and the roundness was also evaluated using a multivariate general linear model (GLM)
with a significance level set at α = 0.05. All statistical analyses were performed in 
SPSS version 21 (SPSS Inc, Illinois, USA).
2.8 VISCOSITY MEASUREMENT
Rheological characteristics of the marrow substitute and the silicone oil formulations
as a function of shear rate were measured using a Malvern Kinexus rheometer
(Malvern Instruments Ltd, Malvern, UK) in rotation mode with a cone on plate
configuration (Figure 2.29).
Figure 2. 29 Schematic of the rotational rheometer with the cone-plate configuration that was
used to measure the viscosity of the marrow substitute and the oil formulations as a function of
shear rate. Adapted from [138].
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The cone used had a radius R = 25 mm and an angle α = 1º. The test fluid was 
contained within the annular space of the cone-plate and the temperature was set to
21ºC. The angular speed of the cone (Ω) was ramped to achieve varying shear rates 
from 0 to 100 s-1 (ramp time of 5 min) and 10 samples per decade were recorded.
Knowing the instantaneous angular rotation of the cone (Ω) and measuring the 
resisting torque (T) of the fluid on the bottom plate allowed measuring the dynamic
viscosity of the test fluid as a function of shear rate using proprietary software (rSpace
for Kinexus, Malvern Instruments Ltd, Malvern, UK).
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CHAPTER 3 Results
This chapter details the results of the work completed throughout the duration of this
project. All materials and methods outlined in the previous chapter were carried out in
full to satisfy the aims and objectives of this study. The first section summarizes the
benchmark analysis performed to identify a suitable rapid prototyping technique that
ensured accurate and reproducible manufacture of the 3D surrogates. The second
section presents the morphology analysis performed to assess the geometrical
variations within the bone surrogates. The third section summarizes the contact angle
analysis performed on the bone surrogate material to compare the surface wettability
to that of cortical bone. The fourth section presents the results of the rheological tests
performed on the bone marrow substitute and the silicone oil formulations. The fifth
section shows the imaging analysis of the bone cement powder composition. The final
section details the results of the injections performed to comparatively test the flow
behaviour of silicone oil as well as various bone cement formulations through the
visualization and quantitative analysis of fluid spreading at various time intervals.
3.1 BENCHMARK ANALYSIS
Figure 3.1 shows the benchmark parts that were manufactured via the selected RP
techniques (Table 2.2). Through part observation and visual inspection, the quality of
the Projet HD benchmark was the best as all the geometrical features appear to have
been built. The EnvisionTEC benchmark was comparable in terms of build capability,
however its form was the worst as evident in the square base feature which does not
appear straight or flat (Figure 3.2). Also, the top surface of the EnvisionTEC
benchmark had layer lines and the bottom surface had a distinct grid pattern.
Conversely, the SLS and HP benchmarks were not comparable in terms of build
capability. The lattice structures located in the center of their benchmarks did not build
properly due to the limited resolution of both techniques. The surface of the SLS
benchmark could be described as granular and rough, whereas the HP benchmark had
a distinct textured pattern on the top and bottom surfaces as well as obvious layer lines
along the vertical surfaces.
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Figure 3. 1 Top views of the benchmark parts manufactured by the selected RP techniques:
EnvisionTEC (top left), Projet HD (top right), HP (bottom left) and SLS (bottom right).
Figure 3. 2 The EnvisionTEC benchmark (right) with a distorted square base due to curing of
the liquid resin and the Projet HD benchmark (left) for comparison.
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Figure 3.3 shows the mean measurement and the range of measurement error across
all the benchmarks for 3 mm wall height and 1 mm wall width. It is evident that the
Projet HD and the EnvisionTEC benchmarks were the best in terms of dimensional
accuracy. The EnvisionTEC benchmark had a lower range of measurement error due
to the layer lines on its surface and its dark color allowing reliable edge detection of its
features using the profile projector. The Projet HD benchmark was clear and its
surface was smooth making the visualization and edge detection of its features more
difficult.
Figure 3. 3 Comparison of the measured wall dimensions across all the RP techniques for a
nominal height of 3 mm and a nominal width of 1 mm.
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Furthermore, the dimensional accuracy of the SLS benchmark was more comparable
relative to that of the Projet HD and the EnvisionTEC, while the HP benchmark was
evidently the worst. Figure 3.4 compares the mean measurement and the range of
measurement error between the Projet HD and the EnvisionTEC benchmarks for 0.12
mm solid beam width as well as 0.68 and 1.13 mm solid beam spacing. The results for
the SLS and HP benchmarks were not included, as measurements could not be
obtained for features at this dimensional level due to the limited resolution of both
techniques. The analysis of the results showed that the Projet HD and the
EnvisionTEC techniques were generally comparable in terms of geometrical accuracy
and repeatability.
Figure 3. 4 Comparison of the measured solid beam dimensions between Projet and
EnvisionTEC for a nominal spacing of 1.13 and 0.68 mm and a nominal width of 0.12 mm.
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The data presented in Figure 3.4 is the mean of three independent measurements
performed on three solid beams. The higher variability in the Projet HD is mainly due
to the higher measurement error within each solid beam. For both techniques, the
mean inter-variability in the measured width and spacing of the three solid beams was
3 and 2 µm, respectively, in all cardinal directions (x, y and z). Table 3.1 summarizes
the overall linear dimensional accuracy of each RP technique based on the total mean
difference between measurements obtained for all visible linear geometrical features
and their respective actual, true dimensions in SolidWorks. The data is presented as
the mean ± standard deviation of all measurements.
Table 3. 1 Overall linear dimensional accuracy of each RP technique.
RPTechnique Features Included AccuracyGeometry Size(mm) x (mm) y (mm) z (mm)
Projet HD Walls, Slots,Beams 0.06 – 4.0 0.027 ± 0.02 0.029 ± 0.02 0.032 ± 0.02EnvisionTEC Walls, Slots,Beams 0.06 – 4.0 0.027 ± 0.02 0.028 ± 0.03 0.044 ± 0.02SLS Walls, Beams 0.2 – 4.0 0.404 ± 0.14 0.487 ± 0.16 0.122 ± 0.07HP Walls 0.3 – 4.0 0.574 ± 0.31 0.532 ± 0.25 0.127 ± 0.07
Figure 3.5 shows the surface texture analysis performed on the four benchmark parts
and the human femur, and Table 3.2 summarizes the measured three-dimensional
height parameters.
Table 3. 2 ISO 25178 height parameters measured using non-contact light interferometer.
Height Parameter Sa(µm) Sp(µm) Sv(µm)Projet HD 1.72 13.62 -11.49EnvisionTEC 2.77 16.44 -27.38HP 6.30 37.63 -40.94SLS 18.85 94.67 -74.18Human Femur 19.76 88.55 -106.25
113
Figure 3. 5 Three-dimensional views of the surface texture analysis performed on the
manufactured benchmark parts and a dry human femur.
The data revealed that the surface roughness was lowest for the Projet HD and highest
for the human femur as evident in the measured Sa (average roughness), Sp (maximum
peak height) and Sv (maximum valley depth) which were generally lowest for the
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Projet HD benchmark and highest for the human femur. Although the surface
roughness was similar between the SLS benchmark and the human femur, the results
showed that the build resolution of the SLS technique is not suitable for
manufacturing the proposed 3D bone surrogates. The overall analysis of the results
revealed that only the Projet HD and the EnvisionTEC techniques have high
geometrical accuracy and repeatability suitable to manufacture features at the
dimensional level proposed in the 3D bone surrogates. However, the quality of the
Projet HD benchmark was the best relative to the EnvisionTEC benchmark which had
the worst form with a distorted square base. Thus, the Projet HD technique was chosen
for manufacturing the proposed three-dimensional bone surrogates. Figure 3.6 shows
an osteoporosis type bone surrogate manufactured via the Projet HD technique to
simulate osteoporotic trabecular bone with a nominal strut thickness and spacing of
0.2 and 0.9 mm, respectively.
Figure 3. 6 Top views of the CAD model developed in SolidWorks (left) and the physical bone
surrogate manufactured via Projet HD 3D printer (right).
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3.2 MORPHOLOGY ANALYSIS
3.2.1 3D Bone Surrogate Morphology
MicroCT was used to assess the variability in the morphology of eight osteoporosis
type (Osteo) 3D bone surrogates. Figure 3.7 shows an example of the cylindrical
volume of interest (15 mm in diameter and 15 mm in length) that was consistently
defined at the centre of each 3D Osteo surrogate and used to obtain the bone volume
fraction (BV/TV) in %, trabecular thickness (Tb.Th) in mm, and trabecular separation
(Tb.Sp) in mm (refer to Section 2.2.2). Figure 3.8 shows the histograms associated
with the respective thickness and spacing maps.
Figure 3. 7 (a) Cylindrical volume of interest defined at the centre of the osteoporotic type 3D
bone surrogates with its associated thickness map (b) and spacing map (c).
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Figure 3. 8 Histograms of the trabecular thickness (top) and trabecular separation (bottom)
obtained from the CT data of eight osteoporotic type (Osteo) 3D bone surrogates. The black lines
represent the nominal horizontal and vertical thickness (Th and Tv) and spacing (Sh and Sv),
respectively.
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The histogram of the thickness map revealed three distinct peaks at approximately
0.18, 0.27 and 0.34 mm. The first two peaks were associated with the horizontal and
vertical struts of the 3D bone surrogates, which had a nominal thickness of 0.15 and
0.25 mm, respectively. The third peak could be related to manufacturing artifacts
associated with residual support material within the structure. On the other hand, the
histogram of the spacing map revealed one distinct peak at approximately 0.89 mm,
which corresponded to the nominal spacings in the horizontal (i.e. between vertical
struts) and vertical (i.e. between horizontal struts) planes of the 3D surrogates which
were 0.8 and 1.0 mm, respectively. The variability in the morphology of the
osteoporosis 3D bone surrogates was very low with an overall strut thickness (Tb.Th)
of 0.25 ± 0.04 mm and an overall pore spacing (Tb.Sp) of 0.89 ± 0.03 mm. The
average porosity which was obtained from the microCT data (100 - BV/TV) and
validated using Archimedes' principle was 82.6 ± 1.1 %.
Figure 3.9 presents the flow rate and the pressure that were measured to
experimentally derive the permeability of a cube (2 × 2 × 2 cm3) with structure similar
to an osteoporosis type 3D bone surrogate. The computed permeability based on
Darcy’s law (Equations 19 and 20) was 43.1 ± 6.0 × 10-10 m2.
Figure 3. 9 The flow rate plotted against the pressure to compute the permeability of the
osteoporosis type 3D bone surrogates.
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3.2.2 2D Flow Model Morphology
This section presents the geometrical variations in the structure of the 2D flow models.
Lateral visualization of the osteoporosis flow models revealed that the structure was
conical rather than cylindrical in shape (see Figure 2.14). The overall edge-to-edge
(Dee) and valley-to-valley (Dvv) distances were 934 ± 3.2 and 1251 ± 0.5 µm,
respectively. The average height (h) of the profiles was 433 ± 4.4 µm. The measured
porosity of the osteoporosis flow models was 87.9 ± 2.0 %. Figures 3.10 to 3.12
present the results of the measurements performed on the lateral profiles of the left and
right cuts through the sagittal plane of three osteoporosis flow models. It is evident
that the geometrical variations between and within the flow models was very low.
Figure 3. 10 The edge-to-edge distances (Dee) measured on the lateral profiles of the left (L) and
right (R) cuts performed through the sagittal plane of three osteoporosis type flow models.
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Figure 3. 11 The valley-to-valley distances (Dvv) measured on the lateral profiles of the left (L)
and right (R) cuts performed through the sagittal plane of three osteoporosis type flow models.
Figure 3. 12 The total heights (h) measured on the lateral profiles of the left (L) and right (R)
cuts performed through the sagittal plane of three osteoporosis type flow models.
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3.3 CONTACT ANGLE ANALYSIS
Figure 3.13 presents a representative sample of the static contact angle analysis
performed on the material used to manufacture the 3D bone surrogates and the 2D
flow models as well as cortical bone from a human femur and an ovine vertebra.
Figure 3.14 compares the contact angle measurements performed on each material. No
significant difference (p = 0.21) was found in the surface wettability of all materials.
The range of contact angle measurements was 49 to 77º for the Projet material used to
manufacture the 3D bone surrogates, 60 to 74º for the photopolymer used to
manufacture the 2D flow models, 60 to 75º for bone form a human femur, and 58 to
69º for bone from an ovine vertebra. The Projet material had the highest range of
contact angle measurements, however the measurements were obtained from material
manufactured at four different time points. The mean difference in contact angle
measurements performed on Projet material manufactured in one time point was 14º.
Figure 3. 13 A representative sample of the static contact angle analysis performed on the
materials used to manufacture the 3D bone surrogates and the 2D flow models as well as cortical
bone from a human femur and an ovine vertebra.
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Figure 3. 14 The range of contact angle measurements performed on the materials used to
manufacture the 3D bone surrogates and the 2D flow models as well as cortical bone from a
human femur and an ovine vertebra.
3.4 RHEOLOGICAL TESTING
Figure 3.15 presents the dynamic viscosity of the bone marrow substitutes as a
function of shear rate. The marrow substitute, prepared using an aqueous solution of
carboxymethyl cellulose 1.25% w/w, maintained an average viscosity of 0.063 ± 0.002
Pa·s at shear rates ranging from 1 to 100 s-1. However, the one prepared using an
aqueous solution of carboxymethyl cellulose 2.5% w/w had an average viscosity of
0.392 ± 0.034 Pa·s at similar shear rates. The results revealed that both marrow
substitutes exhibited Newtonian fluid characteristics (viscosity independence to shear
rate) at a temperature of 21 °C. The decrease in the viscosity of the 2.5% w/w
carboxymethyl cellulose solution at shear rates above 40 s-1 indicates the state of shear
thinning behaviour following a low shear plateau where the viscosity is relatively
constant. At higher shear rates, the molecules start to unfold causing the viscosity to
decrease. This effect is negligible in the 1.25% w/w carboxymethyl cellulose solution
mainly due to the higher concentration of water.
45
50
55
60
65
70
75
80
3D Surrogate
Material
2D Flow Model
Material
Human Femur Ovine Vertebra
Co
nt
ac
tA
ng
le
(º)
122
Figure 3. 15 Dynamic viscosity as a function of shear rate for the bone marrow substitute
prepared using an aqueous solution of carboxymethyl cellulose 1.25% w/w (top) and 2.5% w/w
(bottom). All measurements were performed at 21ºC.
Figure 3.16 presents the dynamic viscosity as a function of shear rate for 60 Pa·s
silicone oil with and without the addition of 20% v/v Lipiodol. The viscosity
measurements were performed at a temperature of 21 ºC. When no Lipiodol was
present, the average viscosity of the silicone oil was maintained at 52.8 ± 2.4 Pa·s for
shear rates below 40 s-1 then decreased to 41.1 ± 1.7 Pa·s for shear rates ranging from
40 to 100 s-1. With the addition of Lipiodol, the silicone oil formulation had an
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average viscosity of 48.0 ± 1.5 Pa·s at shear rates below 40 s-1. The average viscosity
decreased to 39.9 ± 2.4 Pa·s at shear rates ranging from 40 to 100 s-1.
Figure 3. 16 Dynamic viscosity as a function of shear rate for the 60 Pa·s silicone oil (top) and
the 60 Pa·s oil-Lipiodol formulation (bottom). All measurements were performed at 21ºC.
For shear rates below 40 s-1, the results showed that the addition of Lipiodol decreased
the overall viscosity of the silicone oil by 5 Pa·s (from approximately 53 to 48 Pa·s)
but did not alter its fluid characteristics as both formulations exhibited Newtonian
0
10
20
30
40
50
60
0.1 1 10 100
Vi
sc
os
ity
[P
a·
s]
Shear rate [s-1]
0
10
20
30
40
50
60
0.1 1 10 100
Vi
sc
os
ity
[P
a·
s]
Shear rate [s-1]
124
fluid behaviour (viscosity independence to shear rate). The results also showed that
both oil formulations exhibited shear thinning behaviour at shear rates ranging from
40 to 100 s-1 with their viscosity reaching a lower limit of approximately 40 Pa·s.
Figure 3.17 presents the dynamic viscosity as a function of shear rate for the 10
Pa·s silicone oil formulation, which was prepared using 10 Pa·s silicone oil and 20%
v/v Lipiodol. The data revealed that the presence of Lipiodol did not affect the
viscosity of the silicone oil, which was maintained at 9.52 ± 0.08 Pa·s for shear rates
ranging from 1 to 100 s-1. The results also showed that the oil-Lipiodol formulation
maintained the characteristics of the silicone oil and exhibited Newtonian fluid
characteristics (viscosity independence to shear rate) at a temperature of 21 °C.
Figure 3. 17 Dynamic viscosity as a function of shear rate for the 10 Pa·s silicone oil-Lipiodol
formulation. All measurements were performed at 21ºC.
0
10
20
30
40
50
60
0.1 1 10 100
Vi
sc
os
ity
[P
a·
s]
Shear rate [s-1]
125
3.5 CEMENT POWDER IMAGING
Qualitative SEM analysis of the powder components (Figure 3.18) showed that
Opacity+ (OC) and Osteopal V (OP) have similar as well as more uniform particle
size and distribution (~19–69 and 18–55 µm, respectively) when compared to Parallax
(PL) and Simplex P (SP), which have the largest and widest range of particle sizes
(~11–105 and 7–83 µm, respectively). The non-circular particles in the images are the
radiopacifiers, which appear to be large in OC and OP (both containing 45% w/w
ZrO2) and more granular in PL and SP (containing 30 and 10% w/w BaSO4,
respectively). Also, the angular-shaped particles observed in the OC powder are
hydroxyapatite crystals.
Figure 3. 18 SEM micrographs of the different powder components. The angular-shaped
particles (white arrows) observed in the OC powder are hydroxyapatite crystals. The non-
circular particles are the radiopacifiers, which appear to be large in OC and OP and more
granular in PL and SP.
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3.6 3D BONE SURROGATE INJECTIONS
3.6.1 Needle Placement
The quantification of the needle tip placement within the 3D bone surrogates (Figure
3.19a) revealed that the average needle length (d) from the posterior wall was 23.0 ±
1.4 mm and the average needle angle (α) with respect to the posterior wall was 69.7 ± 
2.3º. As the nominal CAD distance (d) is 25 mm and the nominal CAD angle (α) is 
69.8º, the average error was 8% for the needle length (d) and 0.1% for the needle
angle (α). Figure 3.19b shows the location of the needle tips (blue hollow circles) with 
respect to the fluoroscopy field of view. The distance between the fluoroscopy
centroid (solid white circle) and the average location of the needle tips (solid red
square) was 11.3 ± 2.8 mm.
Figure 3. 19 (a) Measurements performed to quantify the error in the needle placement within
the 3D surrogates. (b) Needle tip locations (blue hollow circles) with respect to the fluoroscopy
field of view. The solid white circle represents the fluoroscopy centroid and the solid red square
represents the average needle tip location.
(a)
(b)
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3.6.2 Oil Injections
Flow Distribution
Figure 3.20 presents the resulting flow distribution after 5 mL of 10 and 60 Pa·s
silicone oil (Si10 and Si60) were separately injected under a constant flow rate of 3
mL/min into each three-dimensional bone surrogate: osteoporosis (Osteo), multiple
myeloma (MM) and metastasis (Lesion). The simulated flow distribution obtained
numerically by R. P. Widmer for the Si60 oil is also included for comparison.
Figure 3. 20 Representative images of typical flow patterns after 5mL of 10 and 60 Pa·s silicone
oil (Si10 and Si60) were separately injected into each 3D bone surrogate. The flow contours (blue)
were obtained via image subtraction. The simulated flow distribution for Si60 is included for
comparison.
Qualitative analysis showed that the experimental flow distribution in each surrogate
was similar for both oils, independent of viscosity. Also, in the Osteo and MM
surrogates there was a high tendency for anterior leakage only (neither oils reached the
posterior wall), while in the Lesion surrogate there was a tendency for posterior
leakage only (although both oils reached the anterior wall). The computer simulation
predicted anterior leakage in all the bone surrogates, thus matching the experiments in
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the Osteo and MM surrogates only. The posterior leakage observed experimentally in
the Lesion surrogate was not predicted in the simulation. Figure 3.21 compares the
experimental and computational flow evolution after 1, 3 and 5 mL of 60 Pa·s silicone
oil was injected into each 3D bone surrogate.
Figure 3. 21 Experimental and computational comparison between the typical flow evolution
after 1, 3 and 5 mL of 60 Pa·s silicone oil was injected into each 3D bone surrogate.
In the Osteo surrogate, the experiments showed that the oils had a tendency to flow
laterally along the path of the right needle insertion channel. This behaviour was not
observed in the MM and Lesion surrogates due to the flow being preferentially along
the lesions. The flow distribution obtained numerically via the computer simulation
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was similar to that observed experimentally in the Osteo and MM surrogates, although
in the simulation the flow extended further towards the posterior wall. Furthermore, in
the MM surrogate, the simulation predicted lateral flow into the right needle insertion
channel which was not observed experimentally. In the Lesion surrogate, the flow
distribution obtained numerically did not match that observed experimentally since the
simulated flow was preferentially horizontal and never reached the posterior wall.
Mean Spreading Distance
Figure 3.22 presents the mean spreading distance (MSD) as a function of time after 5
mL of Si10 and Si60 oils were separately injected into the Osteo, MM and Lesion
surrogates. The MSD obtained numerically via the computer simulation for the Si60
oil is also included for comparison. The results showed that an increase in the oil
viscosity from 10 to 60 Pa·s did not have a significant effect on the MSD. This agreed
with the qualitative analysis which showed that the experimental flow distribution of
both oils was similar in each surrogate (Figure 3.20).
Figure 3. 22 The mean spreading distance as a function of time after 10 and 60 Pa·s silicone oil
(Si10 and Si60) were separately injected into each 3D bone surrogate at a constant flow rate of 3
mL/min. The spreading distance obtained numerically for Si60 is included for comparison. The
experimental data is presented as mean ± SD.
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Relative to the Osteo surrogate, the presence of structural voids in the MM surrogate
only, caused a significant (p < 0.05) decrease in the MSD (11.1%) from 25.7 to 22.9
mm after 5 mL of oil was injected, independent of viscosity. This decrease in MSD
can also be observed qualitatively in the resulting contours describing the fluid shape
(Figure 3.20). Following the injection of 5 mL of Si60, the MSD measured using the
simulated flow distribution was higher than that measured experimentally. In the
Osteo surrogate, the numerical MSD (28.9 mm) was 12.5% higher than the
experimental (25.7 mm). In the MM and Lesion surrogates the difference between the
numerical and experimental MSD was more pronounced. In the MM surrogate, the
numerical MSD (28.8 mm) was 26.2% higher than the experimental (22.9 mm), and in
the Lesion surrogate, the MSD obtained numerically (32.4 mm) was 25.2% higher
than that measured experimentally (25.9 mm).
Leakage Time
Figure 3.23 presents the leakage time after the Si10 and Si60 oils were separately
injected into the Osteo, MM and Lesion surrogates at a constant flow rate of 3
mL/min. The leakage time obtained numerically for the Si60 oil is also included for
comparison. The results showed that increasing the starting viscosity from 10 to 60
Pa·s did not have a significant effect on the leakage time, independent of structure.
However, introducing structural voids significantly increased the leakage time
independent of the oil viscosity. Relative to the Osteo surrogate, the large void (Ø 19.0
mm) in the Lesion surrogate caused a more pronounced increase in the leakage time
compared to the three small voids (Ø 6.0 mm each) in the MM surrogate. The leakage
time for the Si10 and Si60 oils in the Osteo surrogate (uniform structure) was 21.6 ±
2.0 and 27.2 ± 1.7 s, respectively. In the MM surrogate, the leakage time for the Si10
and Si60 oils increased by 35.1 and 29.8%, respectively. In the Lesion surrogate, the
leakage time of the Si10 oil doubled (21.9 s increase) while that of the Si60 oil
increased by 77.8%.
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Figure 3. 23 The leakage time after 10 and 60 Pa·s silicone oil (Si10 and Si60) were separately
injected into each 3D bone surrogate at a constant flow rate of 3 mL/min. The leakage time
obtained numerically for Si60 is included for comparison. The experimental data is presented as
mean ± SD. No significant differences were found between the oils in each surrogate type. The
only significant differences (p < 0.05) were for each oil between the different surrogate types with
Osteo being the control. These are labelled * and **.
Injection Pressure
Figure 3.24 presents the pressure required to inject the Si10 and Si60 oils into the
Osteo, MM and Lesion surrogates as a function of time. The results showed that
increasing the oil viscosity from 10 to 60 Pa·s had a significant (p < 0.05) increase on
the injection pressure. The peak pressure required for injecting 5 mL of the Si10 and
Si60 oils into the structure of each bone surrogate at 3 mL/min increased on average
from 0.033 to 0.183 MPa. Furthermore, introducing structural voids did not have a
significant effect on the peak injection pressure, independent of the oil viscosity.
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Figure 3. 24 The inlet pressure as a function of time for the 10 and 60 Pa·s silicone oil (Si10 and
Si60) injected into each 3D bone surrogate at a constant flow rate of 3 mL/min. The experimental
data is presented as mean ± SD.
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3.6.3 Cement Injections
Flow Distribution
Figure 3.25 presents the resulting flow distribution after 5 mL of Simplex P bone
cement (SP1:1, Table 2.7) was separately injected under a constant flow rate of 3
mL/min at 4 and 8 min (SP4 and SP8) after mixing into each three-dimensional bone
surrogate: osteoporosis (Osteo), multiple myeloma (MM) and metastasis (Lesion). The
simulated flow distribution obtained numerically by R. P. Widmer for the SP4 cement
is also included for comparison.
Figure 3. 25 Representative images of typical flow distribution after 5mL of Simplex P cement
was separately injected 4 and 8 min after mixing (SP4 and SP8) into each 3D bone surrogate. The
flow contours (blue) were obtained via image subtraction. The simulated flow distribution for SP4
is included for comparison.
In the Osteo surrogate, the cement injected at 4 min (SP4) had a tendency to flow
laterally into the right needle insertion channel, which was kept open on the inside but
closed off on the outer surface of the posterior wall. This behaviour was not observed
in the MM and Lesion surrogates, independent of cement injection time, mainly due to
the flow being preferentially along the lesions. Furthermore, qualitative analysis
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showed that the experimental flow distribution in the MM surrogate was similar for
both cements (SP4 and SP8). In the lesion surrogate, the SP4 cement never reached
the anterior wall, whereas the SP8 cement reached the anterior wall and had a wider
anterior fill. Figure 3.26 compares the experimental and computational flow evolution
after 1, 3 and 5 mL of Simplex P cement was injected at 4 min after cement mixing
(SP4) into each 3D bone surrogate.
Figure 3. 26 Experimental and computational comparison between the typical flow evolution
after 1, 3 and 5 mL of Simplex P cement injected at 4 min after mixing (SP4) into each 3D bone
surrogate.
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The flow distribution obtained numerically via the computer simulation was very
similar to those observed experimentally in the Osteo surrogate. The simulated flow
distribution was also similar to those observed experimentally in the MM surrogate;
although, the simulation predicted lateral flow, while the experimental flow was
preferentially along the lesions and extended more towards the posterior wall. In the
Lesion surrogate, the flow distribution obtained numerically did not match that
observed experimentally since the simulated flow was preferentially towards the
anterior boundary and into the right needle insertion channel. Qualitative analysis of
the experimental data showed that in the Osteo and MM surrogates there was a high
tendency for anterior leakage only (the cements never reached the posterior wall),
while in the Lesion surrogate there was a tendency for posterior leakage only
(although SP8 cement reached the anterior wall). The computer simulation predicted
anterior leakage in all the bone surrogates, thus matching the experiments in the Osteo
and MM surrogates only. The posterior leakage observed experimentally in the Lesion
surrogate was not predicted in the simulation, although the simulation predicted that
the cement would reach the posterior wall.
Mean Spreading Distance
Figure 3.27 presents the mean spreading distance (MSD) as a function of time after 5
mL of SP4 and SP8 cements were separately injected into the 3D bone surrogates. The
MSD obtained numerically via the computer simulation for the SP4 cement is also
included for comparison. The experimental results showed that an increase in the
injection time (i.e. cement viscosity) from 4 to 8 min after cement mixing did not have
a significant effect on the MSD. This agreed with the qualitative analysis which
showed that the experimental flow contours describing the shape of SP4 and SP8 were
similar, mainly in the MM and Lesion surrogates (Figure 3.25). The results also
showed that the presence of structural voids in the MM and Lesion surrogates did not
have a significant effect on the MSD, independent of the injection time. After injecting
5 mL of SP4 cement, the MSD measured using the simulated flow distribution was
significantly higher than that measured experimentally. In the Osteo surrogate, the
numerical MSD (28.9 mm) was 22.7% higher than the experimental (23.5 mm), and in
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the MM surrogate the numerical MSD (29.3 mm) was 16.3% higher than the
experimental (25.2 mm). This is interesting especially when qualitatively the
computational and experimental flow distributions were better matched in the Osteo
surrogate. In the Lesion surrogate, the difference in the MSD obtained numerically
(33.6 mm) and that measured experimentally (25.0 mm) was more pronounced
(34.2%), which is not surprising especially when the simulated flow reached the
anterior wall and was preferentially horizontal, while the experimental flow never
reached the anterior wall and was along the lesion.
Figure 3. 27 The mean spreading distance as a function of time after Simplex P cement was
separately injected at 4 and 8 min after mixing (SP4 and SP8) into each 3D bone surrogate at a
constant flow rate of 3 mL/min. The spreading distance obtained numerically for SP4 is included
for comparison. The experimental data is presented as mean ± SD.
Sphericity
Figure 3.28 (a) presents the sphericity after 5 mL of SP4 and SP8 cements were
separately injected into the Osteo, MM and Lesion surrogates. The sphericity obtained
numerically for the SP4 cement is also included for comparison. Figure 3.28 (b)
provides a set of representative images for the resulting (experimental) cement bolus
in each surrogate. In the Osteo and MM surrogates, the surperior surface of the cement
bolus was flat indicating that the cement had reached the superior plate of the
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specimen holder. In the Lesion surrogate however, it is evident that the cement flow
was generally along the lesion in the inferior direction.
Figure 3. 28 (a) The sphericity after 5 mL of Simplex P cement was separately injected at 4 and 8
min after cement mixing (SP4 and SP8) into each 3D bone surrogate at a constant flow rate of 3
mL/min. The sphericity obtained numerically for SP4 is included for comparison. The
experimental data is presented as mean ± SD and the signifcant differences (p < 0.05) are labelled
* and . (b) Rrepresentative images of the SP4 cement bolus obtained from the experiments
after 5 mL was injected into each 3D bone surrogate.
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The analysis of the experimental data showed that increasing the injection time from 4
to 8 min after cement mixing significantly (p < 0.05) increased the sphericity in the
Lesion surrogate only. The increase in sphericity was 12.6%, from 0.683 to 0.769 for
SP4 and SP8, respectively. Furthermore, introducing structural voids significantly
decreased the sphericity of the SP4 cement only, which was 0.767 ± 0.006, 0.708 ±
0.018 and 0.683 ± 0.018 in the Osteo, MM, and Lesion surrogates, respectively.
Relative to the Osteo surrogate, the presence of the large void in the Lesion surrogate
(Ø 19.0 mm) caused a more pronounced decrease (11.0%) in sphericity compared to
the presence of three small voids (Ø 6.0 mm each) in the MM surrogate (7.7%). The
sphericity obtained numerically via the computer simulation for the SP4 cement
(0.812) was similar to that measured experimentally in the Osteo surrogate only (5.9%
difference). In the MM and Lesion surrogates the sphericity obtained numerically was
higher than that measured experimentally. In the MM surrogate, the numerical
sphericity (0.813) was 14.9% higher than that measured experimentally, although the
simulated flow distribution was qualitatively similar. In the Lesion surrogate, the
difference in the sphericity obtained numerically (0.751) and that measured
experimentally was less pronounced (10%), which is interesting especially when the
simulated flow was preferentially horizontal while the experimental flow was along
the lesion.
Leakage Time
Figure 3.29 presents the leakage time after the SP4 and SP8 cements were separately
injected into the Osteo, MM and Lesion surrogates at a constant flow rate of 3
mL/min. The leakage time obtained numerically for the SP4 cement is also included
for comparison. The experimental results showed that increasing the injection time
from 4 to 8 min after cement mixing significantly (p < 0.05) increased the leakage
time in the Osteo surrogate by 39.1% (from 28.4 to 39.5 s for SP4 and SP8,
respectively) and in the MM surrogate by 49.4% (from 29.9 to 44.7 s for SP4 and SP8,
respectively). The leakage time in the Lesion surrogate remained the same
independent of the cement injection time (55.4 and 54.5 s for SP4 and SP8,
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respectively). Relative to the Osteo surrogate (uniform structure) the structural void in
the Lesion surrogate only caused a significant increase (95.3%) in the leakage time for
the SP4 cement only. The leakage time obtained from the computer simulation was
chosen to represent the time when any of the outlets (i.e. anterior or posterior) first
became fully infiltrated by the cement (i.e. the time when the leakage likeliness first
reached one). In the Osteo surrogate, the leakage time obtained numerically (25.2 s)
was 11.2% lower than that measured experimentally. For the MM surrogate, the
numerical leakage data could not be obtained as the leakage likeliness in the
simulation never reached one. For the Lesion surrogate, the leakage time obtained
numerically (30.8 s) was 44.3% lower than that measured experimentally, which is not
surprising as the simulation predicted anterior leakage while the experiments showed a
tendency for posterior leakage only.
Figure 3. 29 The leakage time after Simplex P cement was separately injected at 4 and 8 min
after mixing (SP4 and SP8) into each 3D bone surrogate at a constant flow rate of 3 mL/min. The
leakage time obtained numerically for SP4 is included for comparison. The experimental data is
presented as mean ± SD and the signifcant differences (p < 0.05) are labelled * and .
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Injection Pressure
Figure 3.30 presents the pressure required to inject the SP4 and SP8 cements into the
Osteo, MM and Lesion surrogates as a function of time. The results showed that
increasing the injection time from 4 to 8 min after cement mixing significantly (p <
0.05) increased the peak injection pressure by 183.0% in the Osteo surrogate (from
0.143 to 0.404 MPa for SP4 and SP8, respectively), 54.2% in the MM surrogate (from
0.154 to 0.237 MPa) and 133.7% in the Lesion surrogate (from 0.101 to 0.235 MPa).
Furthermore, the presence of structural voids generally decreased the peak injection
pressure independent of the cement injection time. For the SP4 cement, the structural
voids in the MM surrogate did not have a significant effect on the peak injection
pressure which was similar to that recorded in the Osteo surrogate (7.6% difference).
However, the structural void in the Lesion surrogate decreased the peak injection
pressure by 29.5% relative to the Osteo surrogate. For the SP8 cement, the structural
voids in the MM and Lesion surrogates decreased the peak injection pressure by
41.4% relative to the Osteo surrogate.
Figure 3. 30 The inlet pressure as a function of time after Simplex P cement was separately
injected at 4 and 8 min after mixing (SP4 and SP8) into each 3D bone surrogate at a constant flow
rate of 3 mL/min. The pressure obtained numerically for SP4 is included for comparison. The
experimental data is presented as mean ± SD.
141
3.7 2D FLOW MODEL INJECTIONS
3.7.1 Oil Injections
Figure 3.31 presents the resulting flow distribution when the oil reached the boundary
of the 2D flow models. Table 3.3 summarizes the results of the multivariate general
linear model (GLM) used to study the influence of the model structure (Osteo, Lesion
and Fracture), the oil-marrow combination (Si10-M0.06, Si10-M0.4 and Si60-M0.4),
and the injection flow rate (1 and 3 mL/min) on the peak pressure, the time to reach
the boundary, the filled area, and the roundness.
Figure 3. 31 Flow distribution when the silicone oils reached the boundary of the 2D flow models
at constant flow rate of 1 mL/min. The flow contours (blue) were obtained via image subtraction.
The peak pressure significantly increased with an increase in the injection flow
rate, independent of the structure and silicone oil viscosity (Figure 3.32). The oil-
marrow combination significantly affected the peak pressure with Si10-M0.4 and
Si60-M0.4 generally showing the lowest and highest recorded pressures, respectively.
The structure significantly affected the peak pressure with the presence of fracture
causing a more significant decrease compared to the presence of lesion.
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Figure 3. 32 The peak pressure required to deliver the silicone oils into the 2D flow models at
two injection flow rates.
The increase in the injection flow rate significantly decreased the time it took the oil to
reach the boundary, independent of the structure and oil viscosity (Figure 3.33). For
the Si10-M0.4 oil-marrow combination, the oil had the fastest time to reach the
boundary, while for the Si10-M0.06 and Si60-M0.4 combinations, the oils had a
similar time to reach the boundary, independent of structure.
Figure 3. 33 The time it took the silicone oils to reach the boundary of the 2D flow models at two
injection flow rates.
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However, the structure had a significant effect on the time to reach the boundary with
the presence of fracture causing a more significant decrease compared to the presence
of lesion. The increase in the injection flow rate generally did not have a significant
effect on the percent filled area, independent of the structure and oil viscosity (Figure
3.34). The oil-marrow combination significantly affected the percent filled area with
the Si10-M0.4 and Si10-M0.06 generally showing the lowest and highest filled area,
respectively. The structure also had a significant effect on the percent filled area with
the presence of fracture causing a more significant decrease compared to the presence
of lesion.
Figure 3. 34 The percent filled area when the silicone oils reach the boundary of the 2D flow
models at two injection flow rates.
The injection flow rate did not have a significant effect on the roundness
independent of the structure and oil viscosity (Figure 3.35). Similar to the filled area
results, the oil-marrow combination significantly affected the roundness with the Si10-
M0.4 and Si10-M0.06 generally showing the lowest and highest roundness values,
respectively. The structure again had a significant effect on the roundess with the
presence of fracture causing a more significant decrease compared to the presence of
lesion.
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Figure 3. 35 The roundness of the flow contours when the silicone oils reach the boundary of the
2D flow models at two injection flow rates.
Table 3. 3 Parameter estimates from the GLM analysis. Only statistically significant factors
and interactions are shown (p<0.05). The combination of the Osteo model, the Si60-M0.4 and the
3 mL/min flow rate correspond to the intercept. For any deviations from this combination, the
corresponding parameter estimates are added to the intercept value.
Parameter Estimates
Filled Area (%) Roundness Time toboundary (s)
Peak Pressure
(MPa)
B Std.Error B
Std.
Error B
Std.
Error B
Std.
Error
Intercept 51.29 1.48 0.83 0.01 9.03 0.62 0.27 0.01
Fracture -37.57 2.09 -0.58 0.02 -6.57 0.88 -0.16 0.02
Lesion -20.84 2.09 -0.23 0.02 -3.47 0.88 -0.06 0.02
Si10-M0.06 14.19 2.09 0.08 0.02 - - -0.12 0.02
Si10-M0.4 -20.60 2.09 -0.12 0.02 -4.43 0.88 -0.17 0.02
FlowRate = 1.0 mL/min - - - - 14.00 0.88 -0.08 0.02
[Fracture] * [Si10-M0.06] - - - - 4.13 1.24 0.12 0.03
[Fracture] * [Si10-M0.4] 18.19 2.96 0.11 0.03 3.27 1.24 0.09 0.03
[Lesion] * [Si10-M0.06] -7.21 2.96 0.11 0.03 - - 0.08 0.03
[Lesion] * [Si10-M0.4] 16.53 2.96 0.08 0.03 2.80 1.24 - -
[Fracture] * [FlowRate 1.0] - - - - -10.73 1.24 - -
[Lesion] * [FlowRate 1.0] - - - - -4.07 1.24 - -
[Si10-M0.4] * [FlowRate 1.0] 9.63 2.96 - - -5.03 1.24 0.06 0.03
[Fracture] * [Si10-M0.4] *
[FlowRate 1.0] - - - - 5.10 1.75 - -
[Lesion] * [Si10-M0.4] *
[FlowRate 1.0] -11.46 4.18 - - - - - -
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3.7.2 Cement Injections
Figure 3.36 presents the resulting flow distribution when the cement reached the
boundary of the 2D flow models. All injections were performed under a constant flow
rate of 3 mL/min.
Figure 3. 36 Representative flow distribution for the various structures when the cements
reached the boundary of the 2D flow models for the early injection time point of 4 min from the
addition of the liquid to the powder. The flow contours (blue) were obtained via image
subtraction.
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Table 3.4 summarizes the results of the multivariate general linear model (GLM) used
to study the influence of the structure (Osteo, Lesion and Fracture), the cement
formulation (OC, OP, PL, SP1:2 and SP1:1), and the injection time point (4, 6 and 8
min) on the peak pressure, the time to reach the boundary, the filled area, and the
roundness.
The peak pressure significantly increased with injection time and was generally
independent of the model structure (Figure 3.37). The cement formulation
significantly affected the peak pressure with SP1:1 and SP1:2 generally showing the
lowest and highest recorded pressures, respectively. Furthermore, the injection
pressure for OP significantly decreased in both lesion and fracture models, equally.
Figure 3. 37 The pressure required to deliver the cements at a constant flow rate of 3 mL/min
into the 2D flow models for the various structures and injection time points after cement mixing.
The early injection time point (4 min) as well as the presence of lesion or fracture
significantly decreased the time it took the cements to reach the boundary (Figure
3.38). PL and SP1:1 were the fastest cements to reach the boundary, however the
behaviour of PL was improved in both lesion and fracture models. Relative to SP1:1,
the time it took PL to reach the boundary significantly increased in the lesion and
fracture models and became comparable to that of OC, OP and SP1:2.
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Figure 3. 38 The time it took the cements to reach the boundary of the 2D flow models for the
various structures and injection time points after cement mixing.
The percent filled area was generally independent of the injection time, except for
SP1:1 and OP which showed a significant decrease in filled area when injected at 4
min after cement mixing (Figure 3.39). The structure, however, significantly affected
the filled area with the presence of fracture causing a more significant decrease
compared to the presence of lesion. SP1:2 had the highest percent filled area for all
structures, whereas PL had the lowest for the Osteo model and SP1:1 had the lowest
for both lesion and fracture models. The behaviour of PL was improved in both lesion
and fracture models (relative to SP1:1) as evident in the significant increase in its
percent filled area, which became comparable to that of OC and OP.
The roundness significantly decreased in the presence of fracture only and was
generally independent of the injection time (Figure 3.40). Similar to the filled area
results, SP1:2 showed the highest roundness in all structures, whereas PL had the
lowest in the Osteo model and SP1:1 had the lowest in both lesion and fracture
models. Relative to SP1:1, the roundness for PL significantly increased in the lesion
and fracture surrogates and became comparable to that of OC and OP.
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Figure 3. 39 The percent filled area when the cements reached the boundary of the 2D flow
models for the various structures and injection time points after cement mixing.
Figure 3. 40 The roundness of the flow contours when the cements reached the boundary of the
flow models for the various structures and injection time points after cement mixing.
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Table 3. 4 Parameter estimates from the GLM analysis. Only statistically significant factors
and interactions are shown (p<0.05). The combination of the Osteo model, SP1:2 and injection
time 8 min correspond to the intercept. For any deviations from this combination, the
corresponding parameter estimates are added to the intercept value.
Parameter Estimates
Filled Area (%) Roundness Time toboundary (s)
Peak Pressure
(MPa)
B Std.Error B
Std.
Error B
Std.
Error B
Std.
Error
Intercept 74.10 3.14 0.87 0.03 36.70 1.89 2.94 0.22
Fracture -30.90 4.44 -0.38 0.04 -14.03 2.67 - -
Lesion -19.50 4.44 - - -13.97 2.67 - -
OC - - - - - - -1.94 0.31
OP -9.05 4.44 - - - - - -
PL -28.60 4.44 -0.22 0.04 -19.30 2.67 -1.42 0.31
SP1:1 - - - - -10.80 2.67 -2.71 0.31
4min - - - - -6.27 2.67 -1.46 0.31
6min - - - - - - -0.71 0.31
[Fracture] * [OP] - - - - - - -1.59 0.44
[Fracture] * [PL] - - - - 11.70 3.78 - -
[Fracture] * [SP1:1] -22.90 6.28 0.26 0.06 - - - -
[Lesion] * [OC] -16.38 6.28 -0.13 0.06 - - - -
[Lesion] * [OP] -13.78 6.28 - - - - -1.78 0.44
[Lesion] * [PL] - - - - 15.83 3.78 1.48 0.44
[Lesion] * [SP1:1] -16.64 6.28 -0.24 0.06 - - - -
[OC] * [4min] - - - - - - 1.37 0.44
[OP] * [4min] -12.83 6.28 - - - - 0.93 0.44
[OP] * [6min] - - -0.12 0.06 - - - -
[PL] * [6min] - - - - - - 1.03 0.44
[SP1:1] * [4min] -22.42 6.28 - - - - 1.36 0.44
[Lesion] * [OC] * [4min] 18.05 8.88 - - - - - -
[Lesion] * [OC] * [6min] - - 0.21 0.08 - - - -
[Lesion] * [OP] * [4min] 21.76 8.88 - - - - - -
[Lesion] * [OP] * [6min] - - 0.28 0.08 - - - -
[Lesion] * [PL] * [4min] 22.42 8.88 - - - - - -
[Lesion] * [PL] * [6min] - - 0.16 0.08 - - - -
[Fracture] * [SP1:1] *
[4min]
27.26 8.88 - - 10.60 5.34 - -
[Lesion] * [SP1:1] *
[4min]
24.04 8.88 - - - - - -
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CHAPTER 4 Discussion
This chapter discusses the findings and significance of this project which focuses on
the in vitro assessment of cement injection behaviour in cancellous bone. A novel
methodology was developed to help study the influence of cement properties on
injection behaviour and discern subtle differences in the flow behaviour of bone
cement formulations. There has been substantial progress in fulfilling the aim of this
project using a methodical approach defined by the study objectives (Table 4.1).
Table 4. 1 Summary of the study objectives and key findings.
Objective Status Key Findings
Develop and manufacture3D bone surrogates. Completed 3D bone surrogates were designed in a CADsoftware then manufactured using Projet3D printer a.
Develop and manufacture2D bone surrogates. Completed 2D bone surrogates were designed in agraphic suite then manufactured usingflexography b.
Perform morphologycharacterization. Completed
- Structural variation in thickness andspacing was low (< 0.05 mm).
- Morphology was similar to bone:
 Porosity of 82.6 ± 1.1 % (3D) and
87.9 ± 2.0 % (2D).
 Permeability of 43.1 ± 6.0 × 10-10 m2.
Perform surfacecharacterization. Completed
Material wettability was comparable tobone with contact angles ranging from:
- 49 to 77° (3D material).
- 60 to 74° (2D material).
- 60 to 75° (human cortical bone).Develop methods to allowfluid injection under acontrolled environment. Completed
System was robust and repeatable:
- Flow rate was kept constant at 3 mL/min.
- Needle placement was consistent.
- 1% error in measured vs. nominal volume.Comparatively assess theflow behaviour of variousformulations. Completed Subtle differences in the biomaterial flowproperties can be discerned.
a Projet HD 3000, 3D Systems, South Carolina, USA.
b AFP-SH/DSH, Asahi Photoproducts Europe, Brussels, Belgium
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The overall aim was to manufacture cost-effective, reproducible and pathologically
specific bone surrogates with morphology and surface properties similar to bone.
Biomaterial flow properties could then be ascertained following injections into the
surrogates under a controlled environment. Bespoke methodology was developed to
control the injection flow rate, measure the injection pressure, and allow visualization
and quantitative analysis of the spreading distribution. This will help study cement-
fluid interaction to better understand how rheological properties affect the cement flow
within vertebral cancellous bone and ultimately provide a better prediction of the
cement placement within the vertebral body, which has been identified as a critical
parameter in the biomechanical behaviour post-augmentation.
4.1 BONE SURROGATES
Researchers have tended to avoid the use of cadaveric tissues due to their inherent
uniqueness and variability, which render the experiments irreproducible and make the
scientific understanding of how the cement flows within cancellous bone difficult
[166, 178]. Bone surrogates allow researchers to focus on the importance of geometry
when the variability in the biological tissue is eliminated. Therefore, the relative
importance of different geometrical or structural variations within the bone can be
highlighted and evaluated through varying the structural geometry within the
surrogates [200]. This allows for the pathological representation to remain fixed
between investigations and the effects of subtle differences in the cement formulations
to be assessed in a reproducible manner. Furthermore, bone surrogates have
advantages in terms of health and safety, cost and limited ethical issues associated
with their usage.
4.1.1 Surrogate Manufacturing
The 2D bone surrogates were manufactured using flexography, a technology used
extensively within the print industry where a high degree of reproducibility is
required. However, a suitable rapid prototyping (RP) technique had to be selected to
allow manufacturing of the 3D bone surrogates and to ensure reliability of their
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reproduction. There are several factors that influence the build resolution and the
surface finish of an RP technique:
- The first factor is data preparation which includes errors caused by the STL file
generation and the selection of the part build orientation. The STL file format
represents the surface geometry of a three-dimensional CAD model using triangles
to describe a polyhedral approximation of the boundary. Complex geometries
introduce undesirable anomalies in the boundary surface, such as gaps or holes.
These errors mostly occur in cylindrical geometries or curved surfaces. Since only
two triangles are required to fully describe the boundary of a square, the unit cell of
the proposed 3D bone surrogates was based on square beams. This reduces the
overall number of triangles used to describe the surface geometry of the 3D models
(i.e. file size) and minimizes such errors due to STL file generation. Also, the
selection of the part build orientation is critical for minimizing the build time and
the costs as well as achieving optimal build resolution.
- The second factor includes errors caused by process specific parameters during part
building. When a thermal RP process is employed, such as in the SLS and the 3D
printer techniques, the main source of error is material shrinkage which does not
always occur uniformly as areas at high temperatures tend to shrink more than
those at lower temperatures, and geometrical features such as thick walls tend to
increase the shrinkage. However, to compensate for material shrinkage, a
coefficient is calculated on test geometry and a scaling factor is applied to the STL
file in all directions. Conversely, when a liquid based RP process such as the
EnvisionTEC Perfactory is employed, the main source of error is warping caused
by the phase change during the curing of the liquid resin. This is a major problem
for all liquid based RP systems and means have been sought to optimize the curing
process and reduce its effects.
- The third factor is part finishing or post-processing. This is the final step in any RP
technique and mainly consists of cleaning and removing all excess material
including the support material; however, this may also include applying a surface
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treatment such as sanding, coating and/or spraying. Thus, the varying amount of
material that has to be removed and the finishing technique applied are key
determinants of the final surface finish and the extent loss of geometrical features
degrading the build resolution [190-192].
The analysis of the benchmark results revealed that the Projet 3D Printer (Projet HD
3000, 3D Systems, South Carolina, USA) was the most suitable for manufacturing the
proposed three-dimensional bone surrogates. The main challenge with the selected RP
technique was removal of the support material without damaging the structure.
However, this was resolved using an ultrasonic cleaner with an oil-soluble fluid (citrus
greaser).
4.1.2 Surrogate Morphology
It is extremely important to control the surrogate morphology as bone cement
precursors are heterogeneous, especially their powder component which varies in
composition, size and molecular weight of the pre-polymerized polymer beads as well
as the morphology of the radiopacifier particles. All these factors have a significant
effect on the interaction between the liquid and the powder components during mixing
and injection, resulting in different flow behaviour for different cement formulations.
Previous bone surrogates used in experimental studies on cement flow [136, 166, 178,
180] have been made of open-porous aluminum foam with their porosity controlled to
represent osteoporotic bone. However, the geometrical structure within a group of
respective surrogates was irregular and uncontrolled. Thus, the surrogates were
inherently unique. Achieving constant geometrical structure is crucial to reduce the
variability, render the experiments reproducible and shift the focus onto understanding
the influence of cement properties on the injection behaviour. This also allows for the
injections to be performed at various time intervals after cement mixing into separate
bone surrogates while assuming that the injections are being performed into the same
structure.
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The developed 2D and 3D bone surrogates within this study can be assumed
constant in geometrical structure as the variability in their morphology was very low.
The morphology analysis showed that the 3D osteoporosis (Osteo) bone surrogates
had an overall strut thickness and pore spacing of 0.25 ± 0.04 and 0.89 ± 0.03 mm,
respectively. The variability in the structure of the 2D Osteo flow models measured on
their lateral profiles revealed that the overall edge-to-edge and valley-to-valley
distances were 934 ± 3.2 and 1251 ± 0.5 µm, respectively (refer to Figure 2.14). The
main disadvantage of the developed 2D and 3D bone surrogates is that they have a
uniform structure and do not simulate the highly complex geometrical structures and
architectural inhomogeneities of vertebral cancellous bone. The uniform structure in
the 2D surrogates was chosen to reflect that of the 3D surrogates. However, the
uniform structure in the 3D surrogates was chosen to simplify the representation of the
bone morphology, facilitate the manufacturing process and ensure the reliable
reproduction of the surrogates. When complex structures are involved, more support
material is required during the manufacturing process. Thus, it is more difficult to
remove the support material without damaging the actual structure, especially when
regions within the structure (i.e. vertebral cancellous bone) are thin and not well
connected.
Although the structure of the proposed bone surrogates was uniform, their porosity
was comparable to that of vertebral cancellous bone. The porosity of the 2D Osteo
models was 87.9 ± 2.0 % and that of the 3D Osteo surrogates obtained from the
microCT data (100 - BV/TV) was 82.6 ± 1.1 %. Figure 4.1 compares the bone volume
fraction (BV/TV) of the 3D Osteo surrogates to that reported in the literature [25, 31-
34] for human osteoporotic vertebral cancellous bone. It is evident that the BV/TV of
the 3D osteo surrogates was higher relative to that reported in all the studies included
in the comparison. However, BV/TV is the percent material volume within the total
volume of interest and is biased by the trabecular thickness and spacing. Thus, it is not
surprising that BV/TV of the 3D Osteo surrogates was higher especially when the strut
thickness of the surrogates was higher while the intercolumnar spacing of the
surrogates was very similar.
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Figure 4. 1 Scatter plot showing the bone volume fraction of the 3D Osteo surrogate compared
to that reported by Lochmuller et al. [31], Chen et al. [32], Hulme et al. [33], Gong et al. [34] and
Hildebrand et al. [25] plotted against the microCT scan resolution used in each study.
Figure 4.2 compares the thickness (Tb.Th) and spacing (Tb.Sp) of the developed 3D
Osteo bone surrogates to those reported for human osteoporotic vertebral cancellous
bone. It is evident that the overall beam thickness (Tb.Th) of the 3D surrogates was
comparable to that reported by Hulme et al. [33] but higher than that reported by
Lochmuller et al. [31], Chen et al. [32], Gong et al. [34] and Hildebrand et al. [25].
Increasing the beam thickness of the 3D surrogates was necessary due to
manufacturing limitations. However, the overall pore size (Tb.Sp) of the 3D
surrogates was very similar to that reported in the aforementioned studies. Matching
the pore size was important for assessing the cement flow behaviour. Small pores (0.8
mm) in the cancellous bone reduce the void volume available for cement flow, thus
the cement’s interstitial velocity increases to preserve the continuity with the entering
superficial flow. This leads to an increase in the shear rate, which causes a decrease in
the viscosity, as the cements are known to exhibit shear-thinning behaviour.
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Figure 4. 2 Scatter plot showing the thickness (Tb.Th, bottom) and the spacing (Tb.Sp, top) of
the 3D Osteo surrogate compared to those reported by Lochmuller et al. [31], Chen et al. [32],
Hulme et al. [33], Gong et al. [34] and Hildebrand et al. [25] plotted against the microCT scan
resolution used in each study. Gong et al. did not report any spacing data in their study thus
Tb.Sp could not be included in the comparison.
It is important to note that the spatial resolution (82 µm) of the microCT scan used
in the study by Hulme et al. [33] was significantly lower than the spatial resolution (24
µm) used in this thesis and the remainder four studies included in the comparison.
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High spatial resolution is required for reliable measures of the morphometric indices.
Kothari et al. [28] showed that morphometric indices, particularly the trabecular
thickness (Tb.Th), have a strong dependency on spatial resolution and require a very
high resolution to obtain reliable measures. Thus, it is important that the spatial
resolution is high when measuring morphometric indices and similar when comparing
these indices between different studies. Consequently, data from Hulme et al. [33]
should be excluded from the comparison. Relative to the trabecular thickness (Tb.Th)
reported by Lochmuller et al. [31], Chen et al. [32], Gong et al. [34] and Hildebrand et
al. [25], Tb.Th reported by Hulme et al. [33] was higher mainly due to the low
resolution of their microCT scan [28]. However, the BV/TV reported by Hulme et al.
[33] was comparable to that reported in the aforementioned studies. This is not
surprising especially when the trabecular separation (Tb.Sb) reported by Hulme et al.
[33] was higher. Since Tb.Sp is not significantly affected by the scan resolution [28],
the data suggests that the vertebral specimens measured by Hulme et al. [33] are
highly osteoporotic, which is not properly reflected by their reported Tb.Th mainly
due to the low resolution of their microCT scan.
A key advantage is that developed bone surrogates are reproducible and
representative of a range of skeletal pathologies including osteoporotic bone (Osteo),
metastatic infiltration (Lesion) and multiple myeloma (MM). To achieve the Lesion
and MM surrogates, voids were incorporated into the Osteo structure (refer to Figure
2.1). This allowed studying how the presence of structural voids affects the flow
behaviour of the cement formulations mainly from a geometrical perspective. The
structural void (Ø = 19.0 mm) in the 2D and 3D Lesion surrogates occupied 11% of
the total volume of the surrogate. The size of the void was based on data reported by
Ahn et al. [183] and the location was chosen, breaching the posterior wall, to simulate
a worst case scenario. The size and location of the voids in the 3D MM surrogates
were based on in-house microCT scans of six human vertebrae from three donors
whose cause of death was multiple myeloma. Three spherical voids, 6.0 mm in
diameter each, were incorporated into the 3D MM structure and occupied 9% of the
total volume of the surrogate.
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Previous experimental studies on cement flow [136, 166, 178, 180] have used
open-porous aluminum foam to represent osteoporotic bone. Although the porosity of
the foam was well controlled, its geometric structure was inherently random. The
proposed bone surrogates overcome the limitations of previous materials as their
geometric structure is well controlled and can be tailored to mimic the morphology of
specific bone conditions at different skeletal sites in the body. Another advantage is
that the developed 2D and 3D bone surrogates have a boundary to simulate the
vertebral shell which confines the flow and controls the intravertebral pressure,
significantly affecting the filling pattern [185]. The boundary including the inlet and
the flow exit points were kept constant for all the surrogates (refer to Figure 2.5 and
Figure 2.13). The openings in the boundary simulate breaches through the cortex due
to a fracture, a lesion and/or a blood vessel exchanging blood in and out of the
vertebral body. This is important as such breaches create paths of least resistance
providing means for leakage into the surrounding structures.
The surrogates also simulate the rheological environment within the vertebral
body. The measured permeability of the 3D Osteo surrogate (43.1 ± 6.0 × 10-10 m2)
was comparable to that reported by Nauman et al. [201] for human vertebral
cancellous bone, which was 80.5 ± 47.5 × 10-10 and 35.9 ± 19.0 × 10-10 m2 in the
longitudinal and transverse directions, respectively. Furthermore, based on contact
angle measurements, the surface wettability of the 2D and 3D surrogates matches that
of bone. The range of contact angle measurements was 49 to77º for the Projet material
used to manufacture the 3D bone surrogates, 60 to 74º for the photopolymer used to
manufacture the 2D flow models and 60 to75º for cortical bone form a human femur.
Also, the presence of the marrow substitute simulates the two-phase flow that occurs
within the vertebral body. An aqueous solution of carboxymethyl cellulose (Mw
~250,000 - Sodium carboxymethyl cellulose, Sigma-Aldrich, MO, USA) 2.5% w/w
was used as the bone marrow substitute with a nominal viscosity of 0.4 Pa·s which has
been reported for red bovine marrow [156]. In previous studies, Bohner et al. [136]
and Loeffel et al. [180] both used melted cow butter, whereas Baroud et al. [166] and
Mohamed et al. [178] both used a water/gelatin solution. A true representation of the
rheological properties of human red bone marrow present within the cancellous bone
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channels is extremely important as such properties significantly affect the cement flow
behaviour [136].
4.2 3D FLOW MODEL INJECTIONS
Injections performed using the 3D bone surrogates aimed to test the influence of
viscosity and structure on the flow behaviour. A novel methodological approach is
presented to test how osteoporotic bone quality and the presence of lytic lesions due to
metastatic infiltration and multiple myeloma affect the injection biomechanics from a
geometrical perspective. Only two studies on cement flow in cancellous bone have
examined the influence of structure on the spreading behaviour and the risk of leakage
[136, 180]. These two studies have only focused on the effect of bone porosity and
have not considered the effect of lytic lesions due to spinal metastasis and multiple
myeloma. Furthermore, the results of these two studies are conflicting. Bohner et al.
[136] presented a theoretical model (Equation 33) to assess the effect of several
parameters on the risk of leakage and showed that increasing the matrix porosity (i.e.
pore diameter) decreases the tendency of leakage. On the other hand, the experimental
results reported by Loeffel et al. [180] showed that increasing the pore diamter of
foam surrogates causes irregular flow patterns and therefore exhibits a higher risk of
cement leakage. They recommend that the cement starting viscosity should be
proportional to the degree of osteoporosis (i.e. higher pore diameter requires higher
cement starting viscosity). In the current study, the 3D bone surrogates that mimic
metastatic infiltration (Lesion) and multiple myeloma (MM) were achieved by
introducing spherical voids into the surrogate representing osteoporotic bone quality
(Osteo), which had a uniform structure. Thus, the Osteo surrogate can be used as a
control to highlight and evaluate how the viscosity affects the injection biomechanics
in the presence of structural voids.
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4.2.1 Injection Parameters
Injection parameters such as the needle position, the needle gauge, the flow rate and
the injected volume were kept constant for all the injections to shift the focus onto the
influence of the structure and the time-dependent viscosity arising from cement
composition. All the injections were performed at room temperature (21.5 ± 0.1ºC)
using a unilateral approach. The needles were consistently placed through the left
insertion channel while the entry point on the outside of the right insertion channel
(i.e. outer surface of the posterior boundary) was closed off to prevent any fluid from
escaping through the cortex (refer to Figure 2.18). The needle insertion channel
incorporated into the 3D surrogates allowed consistent needle placement during
injection. Based on the results, the mean needle depth (d) from the posterior wall in
the posteroanterior direction was 23.0 ± 1.4 mm and the mean needle inclination (α) 
with respect to the posterior wall was 69.7 ± 2.3º (Figure 4.3).
Figure 4. 3 Measurements performed to quantify the error in the needle placement within the
3D surrogates.
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This shows that the error associated with the needle placement within the 3D bone
surrogates was negligible. Achieving a constant needle placement is essential to
minimize error and ensure that the flow inlet (i.e. needle tip) is in the same location for
all the injections. The needle depth in the posteroanterior direction was chosen to
allow cement deposition in the anterior third of the surrogates. This is the weight-
bearing portion and generally the target site for cement deposition within the vertebral
body during vertebral augmentation procedures [99]. Furthermore, the inclination of
the needle insertion channel was chosen to mimic that of human thoracolumbar
pedicles [21, 188]. The 12-gauge needles were chosen to represent the mean needle
gauge used in the thoracolumbar spine. Typically, 13-gauge needles are used in the
upper thoracic spine, whereas 11-gauge needles are used in the lower thoracic and
lumbar spine [99].
In all the experiments performed using the 3D surrogates, the injection flow rate
was kept constant at 3 mL/min and maintained for the duration of the injection. Figure
4.4 presents the measured displacement of the syringe plunger plotted against time.
Figure 4. 4 Typical displacement of the syringe plunger plotted against time for Simplex P
cement injected at 4 min (blue) and that in injected at 8 min (red).
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An LVDT was used to determine the displacement of the syringe plunger and obtain a
second, independent measure of flow rate. The mean slope for the measured
displacement of the syringe plunger plotted against time was 0.302 ± 0.001 mm/s.
Multiplying this slope by the cross-sectional area of the syringe (165.13 mm2)
confirms that the flow rate was constant at 2.99 ± 0.01 mL/min. The chosen flow rate
was similar to that reported in previous cadaveric studies [202, 203] and falls within
the range reported during clinical percutaneous vertebroplasty (PVP) which is 1.2 to
12.0 mL/min [204]. However, in clinical PVP intermittent injections are typically
performed with pauses due to changing of syringes and/or changing of the needle
position, which is often slightly retracted backwards due to excessive pressurization
[204]. The continuous injection was necessary to simplify the injection parameters.
However, due to the versatility of the proposed methodology, injecting the cement in
multiple steps can be easily achieved and the effect will be addressed in future
experiments. The injected volume of 5 mL was chosen to represent the volume of
cement frequently injected into throracolumbar vertebrae during clinical PVP [123,
205-208]. Multiplying the total displacement of the syringe plunger by the cross-
sectional area of the syringe confirmed that the injected volume was 4.95 ± 0.01 mL.
This validates that the compliance of the system is negligible since there is only 1%
error between the measured and the nominal injected volume.
4.2.2 Fluid Injections
The injections aimed to test the influence of viscosity and structure on the mean
spreading distance, the sphericity, the leakage time and the injection pressure. Silicone
oil with constant Newtonian viscosity of 10 and 60 Pa·s (independence to shear rate,
refer to Figures 3.16 and 3.17) as well as Simplex P (SP1:1, Table 2.7) bone cement
injected at 4 and 8 min after mixing (i.e. from the addition of the liquid to the powder)
were injected into each 3D bone surrogate (Osteo, MM and Lesion) to assess the effect
of viscosity and structure on the injection behaviour.
In the Osteo surrogate, the silicone oils and the Simplex P injected at 4 min (SP4)
had a tendency to flow along the path of the right needle insertion channel, which was
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kept open on the inside but closed off on the outer surface of the posterior wall. This
channel creates a low resistance path (high permeability) simulating a blood vessel
and/or a fracture plane within the vertebral body. The results suggest that when the
viscosity is below 50 Pa·s, such as the case for both silicone oils (refer to Figures 3.16
and 3.17) and SP4 (based on data presented by Widmer et al. [198]), the injected fluid
has a high tendency to follow low-resistance paths present within the structure. The
results also suggest that there is a critical viscosity at which the injected fluid is less
affected by such low-resistance paths as Simplex P injected at 8 min (SP8), which has
a viscosity of approximately 70 Pa·s (based on data presented by Widmer et al. [198]),
did not have a tendency to flow along the path of the right needle insertion channel.
This agrees with the study by Loeffel et al. [180] who reported that increasing the
cement starting viscosity from 50 to 100 Pa·s significantly increases the compactness
of the cement, thus producing a more favorable flow pattern. In the MM and Lesion
surrogates however, the flow was preferentially along the voids and did not follow the
path of the right needle insertion channel, independent of viscosity and the injected
fluid. This shows that the presence of structural voids, such as those incorporated into
the current surrogates, has a dominating effect that dictates the tendency of the flow
behaviour.
This study highlights the effect of structure on the flow behaviour. Independent of
viscosity and the injected fluid, qualitative analysis showed that in the Osteo and MM
surrogates there was a tendency for anterior leakage only, while in the Lesion
surrogate there was a tendency for posterior leakage only. The injected fluid in the
Osteo and MM surrogates never reached the posterior wall. This was expected in the
Osteo surrogate especially when the structure was uniform and the target site for
cement deposition was at the anterior third (refer to Figure 4.3). Moreover, the leakage
patterns observed in this study were similar to those reported in cadaveric studies on
cement leakage. Figure 4.5 compares the anterior leakage typically observed in a 3D
Osteo surrogate to that reported by Lador et al. [209] who studied the points and
pattern of cement extravasation in 23 human vertebrae with simulated compression
fractures.
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Figure 4. 5 Anterior leakage observed in the 3D Osteo surrogates (black arrows) compared to
that reported by Lador et al. [209] (white arrows).
Lador et al. [209] showed that the most common type of leakage classified as severe
was through small breaches in the cortex due to anterior blood vessels. This type of
leakage occurred in 83% of the samples (19 out of 23), thus highlighting the
importance of monitoring all vertebral walls for cement extravasation through
breaches in the cortex to avoid complications and minimize possible life-threatening
risks to the patients. This is important as leakage into the surrounding vasculature can
reach remote areas of the body, such as the lungs, and cause pulmonary embolisms
[210-212]. Figure 4.6 compares the posterior leakage typically observed in a 3D
Lesion surrogate to that reported by Reidy et al. [203] who studied the cement filling
pattern in seven osteoporotic human vertebrae with simulated lytic lesion occupying
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approximately 15% of the vertebral body volume. Their results showed that the
cement leakage through the posterior venous foramen of the vertebra into the spinal
canal occurred in 86% of the samples (6 out of 7). This highlights the importance of
monitoring cement extravasation through the posterior wall in patients with metastatic
involvement to avoid complications such as nerve root or spinal cord compression
[213].
Figure 4. 6 Posterior leakage observed in the 3D Lesion surrogates (black arrows) compared to
that reported by Reidy et al. [203] (white arrows).
As the needle placement was kept constant for all the surrogates, the structural
voids in the MM surrogate were positioned so that the target site for cement
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disposition was between the two anterior voids (refer to Figure 2.5) to simulate a
surgeon’s choice during clinical PVP [108]. This creates low-resistance paths in the
anterior and posterior directions with the goal of filling the two anterior voids. In a
clinical scenario, extreme caution would be taken when the cement reaches the
posterior void and injections would be terminated if the cement approaches the
posterior wall to avoid leakage into the spinal canal or the neural foramina [108]. This
study shows that although in the MM surrogate there are three spherical voids
collinear along the anteroposterior direction with one of the voids breaching the
posterior wall, even low viscosity cements (for example SP4) injected between the
two anterior voids do not reach the posterior wall. Care must be taken to prevent
anterior leakage only. In the Lesion surrogate, the large spherical void (Ø 19.0 mm)
was positioned so that the needle target site was at the anterior side of the void to
simulate a surgeon’s choice during clinical PVP and deposit the cement in the weight-
bearing portion of the vertebral body [99]. The results suggest that at viscosities below
50 Pa·s (i.e. both oils and SP4), the injected fluid never reaches the anterior wall and
is preferentially along the void. At higher viscosities however, the injected fluid (i.e.
SP8) reaches the anterior wall and has a more favorable filling pattern (refer to Figure
3.25). It is interesting to note that the structural void in the Lesion surrogate generally
increased the leakage time under the chosen injection parameters. This is not
surprising especially when posterior leakage occurred and the target site for cement
deposition was at the anterior third. Also, the void volume is large, thus the volume
the injection has to fill is larger. Furthermore, increasing the fluid starting viscosity
did not have a significant effect on the leakage time in the Lesion surrogate. However,
increasing the cement injection time from 4 to 8 min after mixing (i.e. cement
viscosity) significantly increased the leakage time in the Osteo and MM surrogates,
thus decreasing the risk of leakage. This is consistent with the study by Baroud et
al.[166] who also reported immediate leakage when the cement was injected at 5 min
after cement mixing into foam material simulating human osteoporotic vertebral bone.
In this study, the sphericity could not be measured for the oil injections as the oils
did not remain in the same position when the samples were microCT scanned post-
injection but propagated downwards due to gravitational forces. For the cement
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injections however, the sphericity was used to quantitatively describe the final shape
of the cement bolus post-injection once the cement had set. A perfect sphere has a
sphericity of one and the value approaches zero for randomly elongated geometries.
Thus, the sphericity can be used to describe the uniformity of the cement distribution.
We were able to show that increasing the cement starting viscosity in the Osteo and
MM surrogates does not affect the uniformity of the cement distribution, as the
sphericity remained the same. In the Lesion surrogates however, increasing the cement
starting viscosity significantly (p < 0.05) increases the sphericity causing a more
uniform filling pattern. Loeffel et al. [180] were the only group to study the influence
of viscosity on the cement spreading pattern in human cadaveric vertebrae as well as
foam material with similar morphological properties. They monitored the cement
injection using uni-planar fluoroscopy and used circularity to quantitatively describe
the final shape of the cement bolus post-injection by comparing the area (As) and the
perimeter (Ps) of the resulting cement pattern (S) to the perimeter (Pc) of a circle with
the same area as the cement contour ൫Circularity = ܲ௖ ௦ܲ⁄ = 2ඥߨܣ௦ ௦ܲൗ ൯. Their
results showed that the measured circularity was similar in the cadaveric samples as
well as the foam material, although in the cadaveric samples there was a rapid drop in
circularity at the beginning of the injection possibly due to inhomogeneities in the
trabecular structure of the human vertebra. Nonetheless, this suggests that bone
surrogates can be used to achieve clinically relevant representation of cement filling
patterns. Loeffel et al. [180] also found that increasing the cement viscosity from 50
to 100 Pa·s, resulted in significantly denser and more circular cement patterns (higher
circularity). In the current study however, the silicone oil viscosity was increased from
10 to 50 Pa·s and that of the Simplex P injected at 4 and 8 min from mixing (SP4 and
SP8, respectively) was increased from approximately 30 to 70 Pa·s (based on data
presented by Widmer et al. [198]). Thus, all the viscosities tested were below 100
Pa·s, which may explain why there was no significant difference observed in the
measured sphericity.
The mean spreading distance (MSD) was also measured in this study as the
sphericity is a shape descriptor invariant of size. MSD can be used to quantitatively
describe the flow behaviour where a decrease in MSD would signify a more localized
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filling pattern. We were able to show that increasing the starting viscosity of the
silicone oil and that of the Simplex P bone cement does not have a significant (p <
0.05) effect on the MSD, independent of structure. Loeffel et al. [180] reported that a
minimal increase in the cement starting viscosity from 50 to 100 Pa·s significantly
decreased the MSD. In the current study however, all the viscosities tested were below
100 Pa·s, which may explain why there was no significant difference observed in the
MSD. The structure, on the other hand, had a significant effect on the MSD. Relative
to the Osteo surrogate, the presence of structural voids in the MM surrogate only,
caused a significant (p < 0.05) decrease in the MSD from 25.7 to 22.9 mm after 5 mL
of silicone oil was injected, independent of viscosity. This shows that the three
spherical voids, 6.0 mm in diameter each, present in the MM surrogate positively
affect the flow behaviour causing a more localized filling pattern. This does not agree
with the study by Loeffel et al. [180] who showed that increasing the average pore
diameter from 1.2 to 2.3 mm significantly increases the MSD, thus negatively
affecting the compactness of the spreading distribution.
As expected, the injection pressure measured in this study significantly (P < 0.05)
increased with an increase in the cement injection time (4 vs. 8 min from mixing) and
the oil starting viscosity. This is consistent with the study by Kerbs et al. [204] who
also reported significantly (P < 0.001) higher in vivo cement injection pressure during
the later phase of the cement polymerization (7 vs. 11 min from mixing). Furthermore,
the presence of structural voids generally decreased the peak injection pressure
independent of the cement injection time. The void in the Lesion surrogate caused a
more pronounced decrease, especially for low viscosity cements such as SP4. As the
cement viscosity increased (i.e. SP8) the decrease in the peak injection pressure was
similar in the Lesion and MM surrogates. This is not consistent with the study by
Reidy et al. [203] who reported no significant difference in the force required to inject
bone cement into osteoporotic human vertebrae with and without simulated lytic
lesion occupying approximately 15% of the vertebral body volume. However, in the
study by Reidy et al. [203], the lesion was filled with soft tumour tissue. It is
important to note that the overall hydraulic permeability of the vertebra is mainly a
function of the cortical shell, the porosity and the rheological proprieties of the “fluid”
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phases (tumour and/or marrow) present within the trabecular network. From a
geometrical perspective only, the presence of lytic lesion (structural void) increases
the porosity thus the overall hydraulic permeability of the vertebra, which decreases
the peak injection pressure as evident in the results of this thesis. On the other hand,
soft tumour tissue (with higher viscosity relative to bone marrow) present within the
lesion decreases the overall hydraulic permeability of the vertebra. This may explain
why there was no significant difference in the force reported by Reidy et al. [203]
which was required to inject bone cement into osteoporotic human vertebrae with and
without simulated lytic lesion. Further experiments are required to elucidate the effects
of soft tumour tissue on the injection biomechanics.
In the oil injections, introducing structural voids did not have a significant effect
on the peak injection pressure, independent of the oil viscosity. This suggests that the
increase in the overall hydraulic permeability of the surrogates due to the presence of
structural voids has a less significant effect on the oils which exhibit Newtonian fluid
behaviour relative to the cements which are a suspension of particles. Furthermore, it
is important to note that the reported pressure is the pressure (Ps) required to inject
the fluid into the structure of the bone surrogates. When the pressure (Pn) required to
inject the fluid through the needle is in included, the total pressure (Pt = Ps + Pn)
becomes independent of the structure (Figure 4.7). This is mainly due to the pressure
required to inject the fluid (oil or cement) through the 12-gauge needle dominating
over that required to distribute the fluid into the structure. This finding highlights the
role of syringe tip diameter and needle gauge in controlling the pressure required to
deliver the cement into porous structures such as cancellous bone, although the choice
of needle gauge is mainly dictated by the vertebral level being augmented. Figure 4.7
also shows that increasing the fluid starting viscosity significantly increases the total
pressure independent of structure.
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Figure 4. 7 The peak pressure at the syringe plunger required to inject the silicone oils (Si10
and Si 60) as well as the Simplex P bone cements (SP4 and SP8) through the needle and into the
structure of the bone surrogates. The data is presented as mean ± SD and the signifcant
differences (p < 0.05) are labelled with a bar ( ).
4.2.3 Experimental vs. Computational
This section discusses the results of the experimental-computational cross-validation
study comparing the data obtained from the experiments performed in this thesis to
that obtained from the computer simulation developed by R. P. Widmer. The
advantage of the experimental methodology presented is that it provides a clinically
relevant representation of cement flow patterns and a tool for validating computational
simulations. The design of the experimental set-up facilitates the modeling aspect of
the computer simulation. The injection parameters (i.e. needle gauge, needle
placement, flow rate, injected volume) were well controlled and kept constant for all
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the injections. The boundary including the openings and the needle insertion channels
(Figure 2.2) were kept constant for all the bone surrogates. Furthermore, the structure
of the surrogates was uniform to reduce the variability in the morphology (i.e.
thickness and spacing) and the structural geometry, thus achieving a near constant
intrinsic permeability coefficient, particularly in the Osteo surrogate. It is important to
control the structural properties as these dictate the permeability tensor and in
combination with the applied pressure gradient the ﬂow in the porous medium. The 
experimental-computational cross-validation demonstrates that the computational
model developed (by R. P. Widmer) to simulate the ﬂow of two immiscible ﬂuids 
through porous media agrees with the experimental data in the Osteo and MM
surrogates. The difference between the experimental data and the simulations was
more pronounced in the Lesion surrogate, as the experimental flow was preferentially
along the void towards the posterior wall, while the simulated flow was preferentially
horizontal and towards the anterior wall.
The computer simulation is based on the assumption that the ﬂow process of two 
immiscible ﬂuids is mainly governed by the structural properties of the porous 
medium and the rheological properties of the ﬂuids present within the porous medium. 
Thus, the accuracy of the simulation depends inherently on (i) how the permeability
coefficients are determined and (ii) how the viscosities of the two fluids are measured.
In the current simulation, the coefficients of the permeability were estimated using the
Kozeny equation [214], which is given by:
݇௦ = ܿఉయ
ௌೡ
మ (37)
where β (m3/m3) is the porosity of the surrogates, Sv is the specific surface of the
surrogates (m-1) and c is a correlation constant called the Kozeny constant. The
Kozeny equation is based on hydraulic radius theories that assume the porous medium
to be hydraulically equivalent to a bed of thin tubes. Such theories are a consequence
of the observation that the permeability has the dimensions of length squared. Thus,
the equations are designed to estimate this length, which is termed the hydraulic
radius. The premises of hydraulic radius theories include: (i) fluid motion is similar to
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motion through a batch of capillaries, (ii) pores are distributed randomly (iii) pores are
not isolated, (iv) pore-size is reasonably uniform and (v) the porous medium has a low
porosity. These assumptions hold well in the Osteo surrogate and may explain the
strong agreement between the simulations and the experimental data, which is
reflected in the low discrepancy in the flow distribution, the spreading distance and the
sphericity measured experimentally and those obtained numerically via the computer
simulation. The presence of the large structural void in the Lesion surrogate violates
assumptions (iv) and (v) as the pore size is not uniform due to the presence of the large
void (11% of surrogate volume) and the porous medium has a 100% porosity (i.e.
infinite permeability) inside the void. Thus, the equations hold on average and may
explain the weaker agreement between the simulations and the experimental data in
the Lesion surrogate.
A further source of error for this discrepancy in the Lesion surrogate may be due
to the difference between the experimental needle tip position and the nominal
position of the inlet (i.e. needle tip) in the CAD model which was adopted in the
simulation. The distance between the posterior wall and the needle tip measured
experimentally on the superior view of the fluoroscopy projection (Figure 4.3) was on
average 2 mm shorter (i.e. closer to the posterior wall) compared to nominal position
of the inlet in the simulations. This could have a significant effect on the flow
behavior and may explain the difference between the simulated and the experimental
flow patterns (i.e. the experimental flow being preferentially along the void towards
the posterior wall, while the simulated flow being preferentially horizontal towards the
anterior wall). Additional experiments are needed to clarify the effect of needle tip
position (i.e. injection inlet) on the flow behaviour, especially in the presence of a
large structural void. It is important to note that there was also strong agreement
between the simulations and the experimental data in the MM surrogate even in the
presence of the three small voids (9% of surrogate volume). This suggests that the
assumptions and consequently the equations hold and the effect of such voids on the
estimation of the permeability coefficients may be negligible.
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In the current simulation, the viscosities of the ﬂuid phases were governed using a 
power law, which adjusts the viscosity of each ﬂuid phase depending on the time and 
the shearing rate. Although the viscosities of all the fluids tested in this study (i.e. the
Simplex P bone cement, the silicone oil and the marrow substitute) were measured
experimentally and well characterized with respect to time and shear rate, the accuracy
of the simulation is inherently dependent on how the shear rate is determined. In this
simulation, the shear rate was computed from the Darcy ﬂux (Equation 36), which is 
the apparent velocity vector that represents the average fluid velocity in the porous
medium. Thus, the shear rate is approximated at the macroscopic length scale and may
differ by orders of magnitudes from the effective pore-scale deformation rates.
Furthermore, the simulation neglects other factors that may affect the rheology of the
fluids such as the ﬂuid temperature or the yield stresses. More importantly, the 
simulation expresses Darcy’s law in the form of one single constitutive equation in
terms of the mixture of the two ﬂuid phases and does not take into account the 
potential effect of the ﬂuid-ﬂuid interface induced by the surface tension. However, 
this study shows that the computer simulation developed by R. P. Widmer is an
effective tool that can be used to predict the cement placement in cancellous bone,
which has been identified as a critical parameter in the biomechanical behaviour of the
construct post-augmentation.
4.3 2D FLOW MODEL INJECTIONS
4.3.1 Cement Injections
The cement injections performed into the developed 2D flow models aimed to study
the influence of the structure (Osteo, Lesion and Fracture), the cement formulation
(OC, OP, PL, SP1:2 and SP1:1), and the injection time point (4, 6 and 8 min) on the
peak pressure, the time to reach the boundary, the filled area, and the roundness. The
goal was to validate the proposed methodology in discerning differences between the
tested cement formulations and to highlight the influence of the cement composition
on the spreading behaviour. We were able to show that varying the liquid-to-powder
(L/P) ratio drastically alters the cement injection behaviour as evident in all the
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measured parameters for SP1:1 compared to SP1:2. The results also showed that OP
and OC have similar injection behaviour, which is not surprising as these two cement
formulations have very similar composition and particle size (Table 2.7, Figure 3.18).
Furthermore, we were able to show that the injection behaviour of certain cement
formulations, such as PL, improves in the presence of lesion or fracture, thus
suggesting the notion of pathology specific cements. It is important to note that the
rheological properties play a crucial role in the cement flow behaviour during injection
and within a porous structure such as cancellous bone. Although many factors
influence the injection biomechanics, the cement viscosity has been identified as a key
determinant of the cement flow behaviour [136, 165, 166]. There are two processes
that contribute to the rise in viscosity as a function of time: swelling of the polymer
particles in the monomer and polymerization of the monomer itself. This implies that
the rate of viscosity rise is affected by various factors including particle size (surface
area), shape, and distribution as well as the composition of the polymer particles and
molecular weight distribution of the polymer components [140].
The peak injection pressure recorded in this study was comparable to that reported
during clinical PVP and showed a similar increase with injection time [204]. However,
our results showed that the peak pressure was independent of structure (refer to Figure
3.37). This may be due to the pressure required to inject the cement through the inlet
(Ø2.4 mm) dominating over that required to distribute the cement into the structure.
Filled area and roundness were used to quantitatively describe the resulting flow
contours. Both indicators were needed as roundness is a shape descriptor invariant of
size. Mean spreading distance and circularity have been previously used [180],
however we found that areal measurements (compared to point measurements)
reduced the error associated with irregular shapes, while roundness was most sensitive
to elongation, with a high value for roundness signifying a more circular pattern,
which is an indication of uniform spreading. Contrary to data reported by Loeffel et al.
[180], our results showed that increasing the elapsed time from mixing, thus cement
viscosity, generally did not have a significant effect on both indicators, especially
roundness. This may be due to the cements used in our study having a high starting
viscosity at the early injection time point of 4 min compared to the range reported by
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Loeffel et al. (50 to 100 Pa·s). The filled area significantly decreased when SP1:1 was
injected at 4 min after cement mixing, however this cement formulation has a
viscosity in the range reported by Loeffel et al. (based on data presented by Widmer et
al. [198]). Our results showed that the presence of a fracture significantly decreases
the filled area compared to the presence of lesion and is more likely to cause irregular
flow patterns, emphasizing the influence of structure on the cement spreading. In this
study, there was a high leakage rate at the early injection time point (4 min)
independent of structure and cement formulation, which is consistent with the study
performed by Baroud et al.[166] who also reported immediate leakage when the
cement was injected at 5 min after cement mixing. This suggests that there is a critical
injection point at which the risk of leakage can be significantly reduced. Our results
also emphasized the influence of structure on the time to reach the boundary and
showed that the presence of lesion or fracture increases the risk of leakage.
The parameters measured in this study can be translated into parameters of interest
to help in the design of new injectable biomaterials. Peak injection pressure can be
used as an indication for the ease of injectability. Our results showed that, as expected,
the injectability seems to increase with L/P ratio as the recorded pressure was lowest
for SP1:1, which has the highest L/P ratio (Table 2.7). The pressure was generally
highest for SP1:2 and PL indicating that the injectability was lowest for these two
cement formulations, which differ from OP and OC in terms of powder composition,
wider range of particle sizes, and radiopacifier composition and concentration. A
relatively high amount of small-sized polymer beads has been found to increase the
polymerization rate, while a high amount of large-sized beads prolongs the onset of
curing [150, 215]. Our results suggest that the injectability was lower for cements
containing BaSO4; these also had a lower filler concentration (19 and 29.4% w/w for
SP1:2 and PL, respectively) than those containing ZrO2 (both OC and OP contained
45% w/w). Hernández et al. [216] showed that a PMMA cement with 10% w/w
BaSO4 has a similar viscosity-time curve but a much earlier onset of viscosity rise
compared to the same cement with no radiopacifier. Their results also showed that the
same PMMA cement with 10% w/w bismuth salicylate as the radiopacifier had a
significantly lower viscosity and much longer onset of viscosity rise compared to the
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cement with 10% w/w BaSO4. This highlights the effect of varying the radiopacifier
composition on the viscosity of the cement, thus the injection behaviour of that cement
suspension. However, further research is needed to elucidate the effect of varying the
concentration of the radiopacifier on the injection behaviour of the cement. Our results
also suggest that the injectability seems to decrease with an increase in the DMPT
concentration. OC and OP have very similar powder composition and particle size,
however the injectability was lower for OP, which has a DMPT concentration twice
higher compared to OC (Table 2.7). This is consistent with the study performed by
Pascual et al. [217] who reported that the cement setting time was lowered as the
DMPT and BPO concentrations increased. The roundness and time to reach the
boundary can be used to predict the uniformity of the cement spreading and the risk of
leakage. High values for these parameters indicate a more uniform spreading pattern
and a reduced risk of leakage. Due to boundary we are imposing (i.e. flow exit point,
fracture plane and lesion), a high filled area would also signify that the cement is less
affected by the structure. A low viscosity cement (such as SP1:1) would have a low
filled area as it will follow the path of least resistance and reach the boundary quicker.
Based on our results, cement formulations with a high L/P ratio (such as SP1:1)
should be avoided in the presence of a large lytic lesion or fracture.
An important limitation of this study is that the flow rate was kept constant at 3
mL/min and the effect of varying flow rates was not considered. This is significant as
acrylic cements are known to exhibit shear thinning behaviour. A second limitation is
that the models only allow fluid flow in one plane and do not simulate a three-
dimensional flow, which occurs in the vertebral body. However, these models
represent an alternative simulated environment to quickly and effectively study the
flow behaviour of different bone cement formulations without the use of ex-vivo
models.
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4.3.2 Oil Injections
The oil injections performed into the developed 2D flow models aimed to study the
influence of the structure (Osteo, Lesion and Fracture), the oil-marrow combination
(Si10-M0.06, Si10-M0.4 and Si60-M0.4), and the injection flow rate (1 and 3
mL/min) on the peak pressure, the time to reach the boundary, the filled area, and the
roundness. Silicone oil of constant Newtonian viscosity (independence to shear rate
i.e. flow rate) was chosen to reduce the complexity and shift the focus onto
understanding the influence of the oil-marrow viscosity ratio and the flow rate on the
injection behaviour.
The injections showed that the structure had a significant effect on all the
measured parameters with the presence of fracture causing a more significant decrease
compared to the presence of lesion. This suggests that at low viscosities (10 and 60
Pa·s) the presence of fracture in the structure causes lower injection pressure, higher
risk of leakage and more irregular filling patterns compared to the presence of lesion.
It is important to note that for the cement injections the peak pressure was independent
of structure. A possible explanation is that the cement is a suspension of particles thus
requires a significantly higher pressure to inject through the inlet (Ø2.4 mm) compared
to that required to inject the oil, which behaves as a Newtonian fluid. Furthermore, the
oil viscosity is relatively low, thus the pressure required to distribute the oil into the
structure is significant and not dominated by that required to inject it through the inlet.
This study also showed that the oil-marrow combination has a significant effect on
all the measured parameters. The Si10-M0.4 and Si60-M0.4 oil-marrow combination
generally showed the lowest and highest recorded pressures, respectively. This shows
that the pressure increases as a function of the oil viscosity and is less affected by the
viscosity of the marrow substitute. The Si10-M0.4 and Si10-M0.06 oil-marrow
combinations had the lowest and highest viscosity ratios, respectively. Furthermore,
the viscosity ratio of the Si60-M0.4 (150) was closer to that of the Si10-M0.06 (167).
The results suggest that the filled area and roundness increase with the oil-to-marrow
viscosity ratio independent of structure since Si10-M0.4 and Si10-M0.06 had the
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lowest and highest values, respectively. An increase in the oil-to-marrow viscosity
ratio also caused a significant increase in the time to reach the boundary, thus
decreasing the risk of leakage. The oil in the Si10-M0.4 oil-marrow combination was
the fastest to reach the boundary, while the oils in the Si10-M0.06 and Si60-M0.4 oil-
marrow combinations both had an equal and slower time to reach the boundary,
independent of structure. This agrees with the study by Bohner et al. [136] who also
showed that the risk of leakage increases with an increase in the marrow viscosity (i.e.
decrease in the cement-to-marrow viscosity ratio). This confirms that the marrow
viscosity has a significant effect on the flow behaviour and must be taken into
consideration when assessing injectable biomaterials in cancellous bone.
This study also showed that an increase in the injection flow rate from 1 to 3
mL/min significantly increased the peak pressure independent of structure and silicone
oil viscosity. This is consistent with Darcy’s law (Equations 19) which shows that the
flow rate is directly proportional to the injection pressure. The increase in the injection
flow rate significantly decreased the time it took the oil to reach the boundary thus
increasing the risk of leakage, independent of the structure and the oil viscosity. This
does not agree with the study by Bohner et al. [136] who presented a theoretical model
of cement flow in cancellous bone with a special focus on the characterization of
cement leakage. Their theoretical model (Equation 33) predicts that the risk of leakage
is not a function of flow rate. However, they recommend injecting the cement at a
slow flow rate as the cements are known to exhibit shear thinning behaviour. Thus, at
high flow rates the cements experience higher shear rates which would cause their
viscosity to decrease and the risk of leakage to increase. Furthermore, the increase in
the injection flow rate generally did not have a significant effect on the percent filled
area and the roundness, independent of the structure and oil viscosity. This agrees with
the study by Loeffel et al. [180] who also showed that the injection flow rate did not
have a significant effect on the mean spreading distance and circularity which were
used in their study to quantify the resulting flow contours.
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4.4 3D VS. 2D SURROGATES
The 2D flow models were developed to represent the cross-section of the 3D
surrogates. However, this was mainly implemented in the Osteo and Lesion surrogates
only. Thus, the discussion is focused on results related to these two surrogates and the
differences among the results were assessed using Kruskal-Wallis one-way analysis of
variance by ranks. Also, the association between the measured 2D and 3D parameters
was assessed using the Spearman’s rank correlation coefficient (rs). In all cases, a
nominal significance level of α = 0.05 was used. All statistical analyses were 
performed using designated software (R v. 3.0.1, R Foundation for Statistical
Computing, Vienna, Austria).
The flow rate in all the 2D and 3D bone surrogates was well controlled and kept
constant at 3 mL/min, and the same load cell was used to measure the injection
pressure. The injection inlet in the 2D models (Ø = 2.4 mm) was comparable to the
inner diameter of the 12-gauge needles (Ø = 2.1 mm) used to perform the injections
into the 3D surrogates. Furthermore, the porosity of the 2D Osteo model (87.9 ± 2.0
%) was comparable to that of the 3D Osteo surrogate (82.6 ± 1.1 %), while the large
circular void in the 2D Lesion model had the same diameter (Ø = 19.0 mm) as the
spherical void in the 3D Lesion surrogate. The analysis of the results revealed that the
peak pressure required to inject the Silicone oil and the Simplex P bone cement into
the structure of the 3D Osteo and Lesion surrogates was not significantly different (p =
0.112) from that measured during the injections performed using the 2D flow models.
However, the total pressure measured during the injections performed using the 3D
surrogates, which includes the pressure required to inject the fluid through the needle,
was significantly higher (p < 0.05) compared to that measured during the injections
performed using the 2D models. This is not surprising especially when the 2D
injection pressure does not account for the pressure drop along the 4 inch needle,
which was shown in this study to have a significant effect on the peak injection
pressure. Thus, the pressure drop along the needle should be separately calculated and
added to the injection pressure measured using the 2D flow models to achieve more
accurate and clinically relevant estimations of the injection pressure.
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In all the surrogates the time to reach the boundary was measured to provide an
indication for the risk of leakage. Quantitative analysis of the data showed that the
leakage time measured in the 3D surrogates was significantly higher (p < 0.05) than
that measured during injections performed using the 2D flow models. This is not
surprising especially when the 2D models only allow fluid flow in one plane.
However, a correlation was found between the leakage time measured during
injections performed using the 2D models and that measured during injections
performed using the 3D surrogates (rs = 0.77, p = 0.10). Furthermore, relative to the
2D Osteo model the presence of the large structural void in the 2D Lesion model
significantly decreased the leakage time, while in the 3D surrogates the opposite was
observed. However, this is mainly due to the type of leakage observed in the 3D
surrogates (i.e. anterior leakage in the Osteo surrogate vs. posterior leakage in the
Lesion surrogate). Figure 4.5 illustrates the superior view of the 2D and 3D bone
surrogates showing the positions of the inlets and outlets (i.e. openings in the
boundary) in each surrogate.
Figure 4. 8 Schematic representation showing the positions of the inlets (black dot) and outlets
(breaches in the boundary) on the superior view of (a) the 3D surrogate and (b) the 2D flow
model.
It is evident that in the 3D surrogates the distance between the inlet and the left
anterior outlet (8.5 mm) is shorter compared to the distance between the inlet and the
posterior outlet (21.5 mm). Thus, it is reasonable for the leakage time to increase in
the 3D Lesion surrogate, especially when the flow was preferentially along the void in
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the posterior direction. Further experiments are needed to clarify the correlation
between the 2D and 3D surrogates with respect to the measured leakage time. It is also
necessary to adjust the boundary of the 2D models to better match that of the 3D
surrogates.
The roundness and the sphericity were used to quantify the resulting cement (SP4
and SP8) spreading patterns in the 2D and 3D bone surrogates, respectively.
Roundness is commonly used in the 2D shape characterization of particles [199],
while sphericity is its equivalence in the 3D image analysis of objects [197]. Both
indicators provide a measure of compactness and approach zero for increasingly
elongated contours. Thus, these indicators can be used as a measure of predictability
providing an indication for the uniformity of the cement spreading pattern. The
analysis of the data revealed that there was no significant difference (p = 0.70)
between the roundness measured using the resulting cement flow contours in the 2D
Osteo model compared to the sphericity measured using the final shape of the cement
bolus in the 3D Osteo surrogate. However, the sphericity measured using the 3D
Lesion surrogate was significantly higher (p < 0.05) than the roundness measured
using the 2D Lesion model. Although there was significant difference between the two
indicators in the Lesion surrogates, a strong correlation was observed between the
roundness measured using the resulting flow contours in the 2D Lesion model
compared to the sphericity measured using the final shape of the cement bolus in the
3D Lesion surrogate (rs = 0.89, p = 0.03).
The 3D surrogates provide a clinically relevant representation of in vivo cement
flow patterns, while the 2D flow models only allow fluid flow in one plane and do not
simulate the three-dimensional flow that occurs in the vertebral body. However, the
use of 2D flow models has a key advantage over three-dimensional surrogates in terms
of monitoring the cement spreading during the injection, which is performed using a
camera instead of a fluoroscope. This simplifies the experimental set-up and avoids
exposure to x-rays. Furthermore, the 2D flow models represent an alternative
simulated environment to quickly and effectively study the flow behaviour of different
bone cement formulations without the use of ex-vivo model. The injections performed
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using the 2D flow models point to the suitability of this methodology in discerning
differences between the tested cement formulations. Table 4.2 summarizes the pros
and cons for assessing cement injection behaviour in cancellous bone using the
developed bone surrogates.
Table 4. 2 The pros and cons of using the developed 2D and 3D bone surrogates for assessing
cement injection behaviour in cancellous bone.
2D Flow Models 3D Bone Surrogates
 Alternative simulated environment
 Fast, robust and repeatable
 Cost-effective
 Injection parameters well controlled
 Simplified set-up using a camera tomonitor the flow distribution
 Effective in discerning biomaterialflow properties
 Clinically relevant representation
 Fast, robust and repeatable
 Cost-effective
 Pathologically representative
 Injection parameters well controlled
 Versatile set-up and easily adaptable
 Effective in discerning biomaterialflow properties
- Fluid flow in one plane only
- Fixed injection inlet - Fluoroscopy required to monitor flowdistribution
- CT scan required to measure the finalshape of cement bolus
The bone surrogates developed in this thesis are cost-effective, reproducible and
pathologically representative with morphology and surface properties similar to bone.
They overcome limitations of previous bone surrogates as their geometrical structure
is constant and can be tailored to mimic the morphology of specific bone conditions at
different skeletal sites. This is crucial to reduce the variability, render the experiments
reproducible and shift the focus onto understanding the influence of cement properties
on the injection behaviour. This also allows for the pathological representation to
remain fixed between investigations and the effects of subtle differences in the cement
formulations to be assessed in a reproducible manner following injections into the
surrogates under a controlled environment.
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CHAPTER 5 Conclusions and Future Work
The rheological properties play a crucial role in the cement flow behaviour during
injection and within a porous structure such as cancellous bone. However, many
factors influence the injection biomechanics making the scientific understanding of
cement flow and cement placement within the vertebral body particularly challenging.
This thesis presents a novel methodology to help study the influence of cement
properties on injection behaviour. The developed methodology provides a tool for
discerning subtle differences in bone cement formulations and allows comprehensive
assessment of cement flow behaviour in a fast, robust and reproducible manner. This
has been achieved using a methodical approach defined by the study objectives:
Objective 1: Development and manufacturing of reproducible and pathologically
representative 2D and 3D bone surrogates
Objective 2: Assessment of bone surrogate morphology and surface properties.
Objective 3: Development of methods for allowing controlled injections into the 2D
and 3D bone surrogates.
Objective 4: Comprehensive assessment of bone cements via in vitro experiments.
5.1 CONCLUSIONS
Novel 2D and 3D bone surrogates were developed to represent osteoporosis and other
skeletal pathologies including spinal metastasis and multiple myeloma. These
surrogates overcome limitations of previous materials as their geometrical structure
was well controlled. Thus, the pathological representation could remain fixed between
investigations and the effects of subtle differences in the flow behaviour of the cement
formulations could be assessed in a reproducible manner. Controlling the surrogate
environment was extremely important as bone cement precursors are heterogeneous,
especially their powder component which varies in composition, size and molecular
weight of the pre-polymerized polymer beads as well as the morphology of the
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radiopacifier particles. All these factors have a significant effect on the interaction
between the liquid and the powder components during mixing and injection, resulting
in different flow behaviour for different cement formulations.
The 2D flow models were manufactured using flexography (AFP-SH/DSH, Asahi
Photoproducts Europe, Brussels, Belgium), while the 3D bone surrogates were
manufactured using Projet 3D Printer (Projet HD 3000, 3D Systems, South Carolina,
USA). The morphology analysis revealed that the variability in the 2D and 3D bone
surrogates was very low, indicating that the geometrical structure of the surrogates
was constant. Achieving bone surrogates with constant geometrical structure was
crucial to reduce the variability, render the experiments reproducible and shift the
focus onto understanding the influence of cement properties on the injection
behaviour. The morphology analysis also revealed that the overall pore size of the
surrogates was very similar to that reported for human osteoporotic vertebral
cancellous bone, indicating that the surrogates were pathologically representative. A
further advantage is that the 2D and 3D surrogates had a boundary to simulate the
vertebral shell which confines the flow and controls the intravertebral pressure,
significantly affecting the filling pattern. The boundary including the flow inlet (i.e.
needle placement for 3D surrogates) and the flow exit points were kept constant for all
the surrogates. The openings in the boundary simulated breaches through the cortex
due to a fracture, a lesion and/or a vessel exchanging blood in and out of the vertebral
body. Furthermore, the surrogates simulated the rheological environment within the
vertebral body. Based on contact angle measurements, the surface wettability of the
2D and 3D bone surrogates matched that of bone. Also, the presence of the marrow
substitute simulated the two-phase flow that occurs within the vertebral body.
Bespoke methodology was developed to control the injection volume and flow
rate, measure the injection pressure, and allow visualization and quantitative analysis
of the spreading distribution. Two experimental testing rigs were designed to control
the displacement of the syringe plunger and achieve a constant injection volume and
flow rate. One testing rig uses a syringe pump to control the injections into the 3D
surrogates, while the other uses a materials testing machine to control the injections
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into the 2D flow models. The rig with the syringe pump can also be used to control
injections into the 2D flow models. Furthermore, both testing rigs were designed so
that the same load cell could be instrumented and used to measure the injection
pressure. For the 3D bone surrogates, a fluoroscope was used to monitor the flow
distribution. However, the 2D flow models have a key advantage over the currently
developed and previously used 3D bone surrogates in terms of monitoring the flow
distribution during the injection, which was performed using a camera instead of a
fluoroscope. This simplifies the experimental set-up and avoids exposure to x-rays.
Silicone oil of constant Newtonian viscosity (10 and 50 Pa·s) and Simplex P bone
cement (SP1:1 at 4 and 8 min after mixing) were separately injected into each 3D bone
surrogate to assess how viscosity and structure such as osteoporotic bone quality
(Osteo) and the presence of structural voids due to multiple myeloma (MM) and
metastatic infiltration (Lesion) affect the injection behaviour. The study showed that:
 Low viscosity fluids (below 50 Pa·s) have a high tendency to follow low-
resistance paths present within the Osteo structure.
 Fluid flow is preferentially along the structural voids in the MM and Lesion
surrogates, independent of viscosity and the injected fluid.
 Care must be taken to prevent posterior leakage in the Lesion surrogate and
anterior leakage in the Osteo and MM surrogates. Even 5 mL of low viscosity
cement injected between the two anterior voids in the MM surrogate does not
reach the posterior wall.
 Increasing the fluid starting viscosity in the Osteo and MM surrogates does not
have a significant effect on the uniformity of the spreading distribution;
however, it significantly decreases the risk of leakage.
 Increasing the fluid starting viscosity in the Lesion surrogate does not have a
significant effect on the leakage risk; however, it significantly increases the
sphericity causing a more uniform filling pattern.
 Increasing the fluid starting viscosity significantly increases the injection
pressure; however, it does not have a significant effect on the mean spreading
distance (MSD), independent of structure.
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 The presence of structural voids in the MM surrogate only, causes a significant
decrease (relative to the Osteo surrogate) in the MSD indicating a more
localized filling pattern.
 The presence of structural voids generally decreases the peak injection
pressure independent of the cement injection time.
The cement injections performed into the developed 2D flow models validated the
proposed methodology in discerning differences between the tested cement
formulations (OC, OP, PL, SP1:2 and SP1:1) and highlighted the influence of the
structure (Osteo, Lesion and Fracture) and the cement viscosity (injections at 4, 6 and
8 min) on the spreading behaviour. The injections showed that:
 Varying the liquid-to-powder (L/P) ratio drastically alters the cement injection
behaviour. Cement formulations with a high L/P ratio, such as SP1:1, cause
irregular filling patterns and have a high risk of leakage, thus should be
avoided in the presence of a large lytic lesion or fracture.
 Cement formulations with similar composition and particle size, such as OP
and OC, have very similar injection behaviour.
 The injection behaviour of certain cement formulations, such as PL, improves
in the presence of lesion or fracture, suggesting the notion of pathology
specific bone cements.
 Early injections (4min from mixing) significantly increase the risk of leakage
independent of structure and cement formulation, suggesting there is a critical
injection point at which the risk of leakage can be significantly reduced.
 Later injections (6 and 8 min from mixing) generally do not have a significant
effect on the roundness and the filled area, independent of structure and cement
formulation (except SP1:1).
 The presence of structural voids significantly increases the risk of leakage;
however, the presence of a fracture significantly decreases the filled area
compared to the presence of lesion and is more likely to cause irregular flow
patterns.
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The oil injections performed into the developed 2D flow models aimed to study
the influence of the structure (Osteon, Lesion and Fracture), the oil-marrow
combination (Si10-M0.06, Si10-M0.4 and Si60-M0.4), and the injection flow rate (1
and 3 mL/min) on the injection behaviour. The injections showed that:
 The presence of fracture in the structure causes lower injection pressure, higher
risk of leakage and more irregular filling patterns compared to the presence of
lesion.
 The injection pressure increases as a function of the oil viscosity and is less
affected by the viscosity of the marrow substitute, independent of structure.
 Increasing the oil-to-marrow viscosity ratio significantly decreases the risk of
leakage and causes more uniform filling patterns, independent of structure.
 Increasing the injection flow rate does not have a significant effect on the
percent filled area and the uniformity of the spreading distribution; however, it
significantly increases the peak pressure and the risk of leakage, independent
of the structure and silicone oil viscosity.
The presented methodology provides a novel tool for quick, robust differentiation
in the injection behaviour of various biomaterial formulations through controlling the
surrogate morphology, controlling the injection parameters, measuring the injection
pressure, and allowing the visualization and quantitative analysis of the spreading
distribution. The advantage of the experimental methodology presented is that it
provides a clinically relevant representation of cement flow patterns and a tool for
validating computational simulations. As there are no standardized methods for
assessing cement injection behaviour in cancellous bone, the proposed methodology
may be beneficial for cement manufacturers to help test novel cement formulations.
The advantage is that the structure and the injection parameters are well controlled and
kept constant. Thus, the pathological representation can remain fixed between
investigations and the effects of subtle differences in the cement formulations can be
assessed in a reproducible manner. This also allows studying how cement
formulations behave in various pathological representations providing an indication
for their suitability, which may help in the development of pathology specific cements.
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A further benefit is that the developed methodology can be used as a training tool for
surgeons to help minimize their learning curve. This also helps surgeons better
understand how cement viscosity (i.e. injection time from mixing) and injection
parameters (i.e. injection flow rate, injection volume, needle placement and needle
gauge) affect the injection behaviour in different pathological representations.
5.2 FUTURE WORK
All the developed bone surrogates were filled with bone marrow substitute formulated
using an aqueous solution of carboxymethyl cellulose 2.5% w/w to reach a nominal
viscosity of 0.4 Pa·s which has been reported for red bovine marrow [156]. A true
representation of the rheological properties of red bone marrow is extremely important
as such properties significantly affect the cement flow behaviour [136]. Although
there has been data in the literature that describes the rheological properties of human
yellow bone marrow [157, 159], there is still a need to test the rheological properties
of human red bone marrow which is found within the bony channels of the vertebral
body. Furthermore, the developed surrogates did not simulate the soft tumour tissue
present within lytic lesions caused by metastatic infiltration and multiple myeloma.
This study only focused on how lesions in the structure affect the injection behaviour
from a geometrical perspective. Therefore, it is still necessary to study how the
presence of soft tumor tissue within the lesion affects the injection behaviour.
In the current study, all the injection parameters were well controlled and kept
constant for the duration of the injection. It would be interesting to investigate how
changes in the size and position of the injection inlet (i.e. needle size and placement
for 3D surrogates) affect the injection behaviour, particularly in the Lesion surrogates.
Furthermore, the developed methodology allowed injections into the surrogates under
a continuous, constant flow rate. However, the effect of varying flow rates (ramping
up) and intermittent injections typically performed in a clinical setting should be
addressed in future experiments. It is also interesting to compare injections performed
into the surrogates using the developed methodology to that manually performed by an
experienced surgeon.
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The use of 2D flow models has a key advantage over three-dimensional surrogates
in terms of monitoring the cement spreading during the injection, which is performed
using a camera instead of a fluoroscope. This simplifies the experimental set-up and
avoids exposure to x-rays. It would be interesting to develop a portable, compact
testing rig using a syringe pump to control injections into the 2D flow models and a
camera to monitor the flow distribution. Data acquisition and analysis could also be
automated to provide indication for the flow rate and the injection pressure as well as
the quantitative description of the flow behaviour including the risk of leakage (time to
reach the boundary), the percent filled area and the uniformity of the spreading pattern
(roundness). This compact testing rig can be used as a demonstration tool for medical
students or as a training tool for surgeons to better understand the influence of cement
properties, cement viscosity and porous structures on the injection behaviour.
A future modification to the experiment set-up should include a temperature
controlled environment as this has been shown to affect the cement viscosity rise, thus
the injection behaviour. This can be achieved by instrumenting a temperature
controlled heating plate into the specimen holder of the 2D flow models. A further
approach is to fill the surrogates with bone marrow substitute which has been heated
to body temperature (37 °C) before performing the cement injections. It is also
interesting to compare the injection behaviour under the developed methodology
which controls the injection flow rate (displacement control) to methodology designed
to control the injection pressure (force control).
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Appendix A
Technical drawing of the benchmark part.
204
205
Appendix B
Calibration curves for:
i. the LVDT used to measure the displacement of the syringe plunger.
ii. the load cell used to measure the force on the syringe plunger.
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Appendix C
LabVIEW codes developed to:
i. control the syringe pump through serial communication.
ii. acquire the load cell and LVDT data during injections into the 3D surrogates.
iii. acquire the video and load cell dat during injections into the 2D flow models.
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210
(ii)
211
(iii)
212
Appendix D
Matlab scripts developed to:
i. allow automated segmentation of the flow distribution.
ii. correct the inherent pincushion distortion in the fluoroscopy image.
213
(i)
% Open video file
path = '\\fengstore2\store5\SpineFX\Antony\3D_experiments\Osteo\SP\'
name = 'Osteo_SP1to1_r4.avi'
obj = mmreader([path name])
% read the frame number which corresponds to the time just before the
% injected fluid is observed in the specimen
% convert to greyscale, initialize the counter i and the time
F= read (obj, 285);
GF=rgb2gray(F);
i=1;
time=1;
% read specific frame numbers corresponding to the duration of the
injection
% at predefined increments in this case 50 frames (note sampling
frequency is % set at 25 Hz). Frames are read every 2 seconds for the
duration of the % injection
for n=310:50:2610
L= read(obj,n);
GL=rgb2gray(L);
HS=GF-GL;
% threshold / convert to logical
LHS=false(size(HS,1), size(HS,2));
for m=1:size(HS,1)
for n=1:size(HS,2)
if HS(m,n)>=4
LHS(m,n)=1;
else
LHS(m,n)=0;
end
end
end
% create image with a filled circle and use it for masking in order
% to remove boundary noise
t = 0:pi/20:2*pi;
R0 = 70; x0 = 402; y0 = 307;
xi = R0*cos(t)+x0;
yi = R0*sin(t)+y0;
roimask = poly2mask(xi,yi, size(LHS,1), size(LHS,2));
% multiply mask to image
MS=LHS.*roimask;
% remove unconnected regions
se = strel('disk',2); NS=imopen(MS,se);
% fill holes in the segmented region
se = strel('disk',3); SS=imclose(NS,se);
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% further removing of noise
se = strel('disk',4); SSS=imopen(SS,se);
% Show the raw image and overlay the contour of the segmented image
figure
imshow(L)
hold on
bound=bwboundaries(SSS);
for k = 1:numel(bound)
plot(bound{k}(:,2), bound{k}(:,1), 'b', 'Linewidth', 2);
end
% Export the images
filename = sprintf('4min_r4_%d.png', i);
saveas(gcf, filename, 'png')
% Measure the properties of the segmented (filled) area using image
% analysis
Stats=regionprops(SSS,'Area','Perimeter','Eccentricity','MajorAxisLen
gth','MinorAxisLength','Orientation', 'Centroid');
disp(['Area ' num2str(Stats.Area) ' px ' ]);
disp(['Perimeter ' num2str(Stats.Perimeter) ' px ' ]);
disp(['Eccentricity ' num2str(Stats.Eccentricity) ' px ' ]);
disp(['MajorAxis ' num2str(Stats.MajorAxisLength) ' px ' ]);
disp(['MinorAxis ' num2str(Stats.MinorAxisLength) ' px ' ]);
% Save the image analysis data into a matrix
Results(i,:)=[time, Stats.Area, Stats.Perimeter, Stats.Eccentricity,
Stats.MajorAxisLength, Stats.MinorAxisLength, Stats.Orientation,
Stats.Centroid];
% Export the binary image which shows only the filled area
SI=imcomplement(SSS);
imwrite(SI,['SSS',num2str(i),'.tif']);
% Increment the counter i and the time
% End the for loop
i=i+1;
time=time+2;
end
% Export the image analysis data into an excel sheet
Labels={'Time', 'Area', 'Perimeter', 'Eccentricity', 'MajorAxis',
'MinorAxis','Orientation', 'Centroid'};
xlswrite('4min_r41.xls', Labels, 1, 'B1');
xlswrite('4min_r41.xls', Results, 1, 'B2');
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(ii)
% Open video file, read specific frame number and show grayscale
% image
obj = mmreader('Calib107cm456.avi')
II= read (obj, 115);
I=rgb2gray(II);
imshow(I);
% Apply a linear transformation matrix to compress the image by 40 px
% along the vertical direction
I4 = imresize(I, [536 720]);
% Apply a radial distortion correction using the matlab function
% lensdistort
I5 = lensdistort(I4, 0.05, 'interpolation' , 'nearest', 'padmethod'
, 'symmetric', 'ftype', 4);
% Apply an edge detection function to outline the bead projections
IE= EDGE(I5,'canny', 0.05);
% Apply a mask to obtain the region of interest
t = 0:pi/20:2*pi;
R0 = 100; x0 = 395; y0 = 280;
xi = R0*cos(t)+x0;
yi = R0*sin(t)+y0;
roimask = poly2mask(xi,yi, size(IE,1), size(IE,2));
MS=IE.*roimask;
% Fill the bead outlines
LI=imclose(MS, strel ('disk', 2));
NS=imfill(LI,'holes');
% Remove noise
SS=imopen(NS,strel ('disk', 4));
% Show the corrected image and overlay the bead outlines
figure
imshow(I5)
hold on
bound=bwboundaries(SS);
for k = 1:numel(bound)
plot(bound{k}(:,2), bound{k}(:,1), 'b', 'Linewidth', 2);
end
% Export the binary image which shows only the filled beads
imwrite(SS,['SS_corrected.tif']);
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Conference Publications
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List of conference presentations:
1. A Bou Francis, N Kapur, RM Hall, Novel 2D bone surrogate models for
assessing cement injection behaviour in vertebroplasty, GRIBOI, Boston,
USA, April, 2013.
2. A Bou Francis, N Kapur, RM Hall, Novel methodology for assessing cement
injection behavior in vertebroplasty, EUROSPINE, Liverpool, UK, October,
2013.
3. A Bou Francis, N Kapur, RM Hall, Novel methodology for assessing cement
injection behaviour in vertebroplasty, CORS, Venice, Italy, October, 2013.
(Best Oral Presentation Award)
4. A Bou Francis, A López, C Persson, RM Hall, N Kapur, Assessing cement
injection behavior in vertebroplasty: An in-vitro study using flow models,
WCB, Boston, USA, July, 2014.
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